{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 301148, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:24:07Z", "timestamp": 1574497447781}, "reference-count": 220, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2011, 3, 2]], "date-time": "2011-03-02T00:00:00Z", "timestamp": 1299024000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Dig Dis Sci"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1007/s10620-010-1560-3", "type": "journal-article", "created": {"date-parts": [[2011, 3, 2]], "date-time": "2011-03-02T18:34:49Z", "timestamp": 1299090889000}, "page": "931-950", "source": "Crossref", "is-referenced-by-count": 160, "title": ["Adverse Effects of Long-Term Proton Pump Inhibitor Therapy"], "prefix": "10.1007", "volume": "56", "author": [{"given": "Edward", "family": "Sheen", "sequence": "first", "affiliation": []}, {"given": "George", "family": "Triadafilopoulos", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2011, 3, 2]]}, "reference": [{"key": "1560_CR1", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1111/j.1440-1746.1992.tb01489.x", "volume": "7", "author": "P Bamberg", "year": "1992", "unstructured": "Bamberg P, Caswell CM, Frame MH, Lam SK, Wong EC. A meta-analysis comparing the efficacy of omeprazole with H2-receptor antagonists for acute treatment of duodenal ulcer in Asian patients. J Gastroenterol Hepatol. 1992;7:577\u2013585.", "journal-title": "J Gastroenterol Hepatol"}, {"key": "1560_CR2", "first-page": "467", "volume": "7", "author": "S Eriksson", "year": "1995", "unstructured": "Eriksson S, Langstrom G, Rikner L, Carlsson R, Naesdal J. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eur J Gastroenterol Hepatol. 1995;7:467\u2013475.", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "1560_CR3", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1046/j.1365-2036.2001.01012.x", "volume": "15", "author": "JP Gisbert", "year": "2001", "unstructured": "Gisbert JP, Gonzalez L, Calvet X, Roque M, Gabriel R, Pajares JM. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer. Aliment Pharmacol Ther. 2001;15:917\u2013926.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR4", "doi-asserted-by": "crossref", "first-page": "757", "DOI": "10.1046/j.1365-2036.2003.01766.x", "volume": "18", "author": "JP Gisbert", "year": "2003", "unstructured": "Gisbert JP, Khorrami S, Calvet X, Gabriel R, Carballo F, Pajares JM. Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists\u2013their efficacy with antibiotics in Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003;18:757\u2013766.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR5", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1111/j.1572-0241.2005.41217.x", "volume": "100", "author": "KR DeVault", "year": "2005", "unstructured": "DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2005;100:190\u2013200.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR6", "doi-asserted-by": "crossref", "first-page": "728", "DOI": "10.1038/ajg.2009.115", "volume": "104", "author": "FL Lanza", "year": "2009", "unstructured": "Lanza FL, Chan FK, Quigley EM. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009;104:728\u2013738.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR7", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1136/gut.2006.101634", "volume": "56", "author": "P Malfertheiner", "year": "2007", "unstructured": "Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut. 2007;56:772\u2013781.", "journal-title": "Gut"}, {"key": "1560_CR8", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1016/j.amjmed.2009.04.014", "volume": "122", "author": "T Ali", "year": "2009", "unstructured": "Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122:896\u2013903.", "journal-title": "Am J Med"}, {"key": "1560_CR9", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1007/s11894-010-0141-0", "volume": "12", "author": "T Ito", "year": "2010", "unstructured": "Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010;12:448\u2013457.", "journal-title": "Curr Gastroenterol Rep"}, {"key": "1560_CR10", "author": "D Metz", "first-page": "3", "year": "2007", "unstructured": "Metz D. Proton pump inhibitor therapy: safety issues. In: Howden CW, ed. Advances in digestive disease. Bethesda, MD: AGA Institute Press; 2007:3\u201314.", "volume-title": "Advances in digestive disease"}, {"key": "1560_CR11", "doi-asserted-by": "crossref", "first-page": "1500", "DOI": "10.1053/gast.2002.32978", "volume": "122", "author": "RS Sandler", "year": "2002", "unstructured": "Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500\u20131511.", "journal-title": "Gastroenterology"}, {"key": "1560_CR12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3109/00365529109111222", "volume": "188", "author": "HP Festen", "year": "1991", "unstructured": "Festen HP. Intrinsic factor secretion and cobalamin absorption. Physiology and pathophysiology in the gastrointestinal tract. Scand J Gastroenterol Suppl. 1991;188:1\u20137.", "journal-title": "Scand J Gastroenterol Suppl"}, {"key": "1560_CR13", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1111/j.1365-2036.1992.tb00553.x", "volume": "6", "author": "H Koop", "year": "1992", "unstructured": "Koop H. Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole. Aliment Pharmacol Ther. 1992;6:399\u2013406.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR14", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1046/j.1365-2036.1996.27169000.x", "volume": "10", "author": "BE Schenk", "year": "1996", "unstructured": "Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG. Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin. Aliment Pharmacol Ther. 1996;10:541\u2013545.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR15", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1016/S0002-9343(98)00087-4", "volume": "104", "author": "B Termanini", "year": "1998", "unstructured": "Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome. Am J Med. 1998;104:422\u2013430.", "journal-title": "Am J Med"}, {"key": "1560_CR16", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1016/j.jamda.2007.10.004", "volume": "9", "author": "TS Dharmarajan", "year": "2008", "unstructured": "Dharmarajan TS, Kanagala MR, Murakonda P, Lebelt AS, Norkus EP. Do acid-lowering agents affect vitamin B12 status in older adults? J Am Med Dir Assoc. 2008;9:162\u2013167.", "journal-title": "J Am Med Dir Assoc"}, {"key": "1560_CR17", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1016/j.jclinepi.2003.08.015", "volume": "57", "author": "RJ Valuck", "year": "2004", "unstructured": "Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol. 2004;57:422\u2013428.", "journal-title": "J Clin Epidemiol"}, {"key": "1560_CR18", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1111/j.1365-2036.2008.03601.x", "volume": "27", "author": "WP Elzen den", "year": "2008", "unstructured": "den Elzen WP, Groeneveld Y, de Ruijter W, et al. Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals. Aliment Pharmacol Ther. 2008;27:491\u2013497.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR19", "doi-asserted-by": "crossref", "first-page": "1110", "DOI": "10.1111/j.1365-2036.2008.03658.x", "volume": "27", "author": "BI Hirschowitz", "year": "2008", "unstructured": "Hirschowitz BI, Worthington J, Mohnen J. Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2008;27:1110\u20131121.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR20", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1080/01639360903574734", "volume": "29", "author": "NR Rozgony", "year": "2010", "unstructured": "Rozgony NR, Fang C, Kuczmarski MF, Bob H. Vitamin B(12) deficiency is linked with long-term use of proton pump inhibitors in institutionalized older adults: could a cyanocobalamin nasal spray be beneficial? J Nutr Elder. 2010;29:87\u201399.", "journal-title": "J Nutr Elder"}, {"key": "1560_CR21", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1046/j.1365-2796.1996.20846000.x", "volume": "240", "author": "A Bellou", "year": "1996", "unstructured": "Bellou A, Aimone-Gastin I, De Korwin JD, et al. Cobalamin deficiency with megaloblastic anaemia in one patient under long-term omeprazole therapy. J Intern Med. 1996;240:161\u2013164.", "journal-title": "J Intern Med"}, {"key": "1560_CR22", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1097/00004836-200001000-00006", "volume": "30", "author": "CW Howden", "year": "2000", "unstructured": "Howden CW. Vitamin B12 levels during prolonged treatment with proton pump inhibitors. J Clin Gastroenterol. 2000;30:29\u201333.", "journal-title": "J Clin Gastroenterol"}, {"key": "1560_CR23", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1007/978-1-4684-9111-1_12", "volume": "249", "author": "ET Champagne", "year": "1989", "unstructured": "Champagne ET. Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol. 1989;249:173\u2013184.", "journal-title": "Adv Exp Med Biol"}, {"key": "1560_CR24", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0016-5085(19)34096-X", "volume": "55", "author": "ME Conrad", "year": "1968", "unstructured": "Conrad ME, Schade SG. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile. Gastroenterology. 1968;55:35\u201345.", "journal-title": "Gastroenterology"}, {"key": "1560_CR25", "first-page": "108", "volume": "92", "author": "W Bezwoda", "year": "1978", "unstructured": "Bezwoda W, Charlton R, Bothwell T, Torrance J, Mayet F. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J Lab Clin Med. 1978;92:108\u2013116.", "journal-title": "J Lab Clin Med"}, {"key": "1560_CR26", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1007/BF01298866", "volume": "36", "author": "J Golubov", "year": "1991", "unstructured": "Golubov J, Flanagan P, Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci. 1991;36:405\u2013408.", "journal-title": "Dig Dis Sci"}, {"key": "1560_CR27", "doi-asserted-by": "crossref", "first-page": "887", "DOI": "10.1097/01.SMJ.0000110405.63179.69", "volume": "97", "author": "VR Sharma", "year": "2004", "unstructured": "Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J. 2004;97:887\u2013889.", "journal-title": "South Med J"}, {"key": "1560_CR28", "first-page": "1068", "volume": "81", "author": "BS Skikne", "year": "1981", "unstructured": "Skikne BS, Lynch SR, Cook JD. Role of gastric acid in food iron absorption. Gastroenterology. 1981;81:1068\u20131071.", "journal-title": "Gastroenterology"}, {"key": "1560_CR29", "doi-asserted-by": "crossref", "first-page": "1291", "DOI": "10.1136/gut.2006.108613", "volume": "56", "author": "C Hutchinson", "year": "2007", "unstructured": "Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007;56:1291\u20131295.", "journal-title": "Gut"}, {"key": "1560_CR30", "doi-asserted-by": "crossref", "first-page": "S5", "DOI": "10.1038/ajg.2009.45", "volume": "104", "author": "KE McColl", "year": "2009", "unstructured": "McColl KE. Effect of proton pump inhibitors on vitamins and iron. Am J Gastroenterol. 2009;104:S5\u2013S9.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR31", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.7326/0003-4819-151-10-200911170-00016", "volume": "151", "author": "MA Broeren", "year": "2009", "unstructured": "Broeren MA, Geerdink EA, Vader HL, l Bake AW. Hypomagnesemia induced by several proton-pump inhibitors. Ann Intern Med. 2009;151:755\u2013756.", "journal-title": "Ann Intern Med"}, {"key": "1560_CR32", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1111/j.1365-2265.2008.03194.x", "volume": "69", "author": "T Cundy", "year": "2008", "unstructured": "Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf). 2008;69:338\u2013341.", "journal-title": "Clin Endocrinol (Oxf)"}, {"key": "1560_CR33", "doi-asserted-by": "crossref", "first-page": "180", "DOI": "10.1097/MOG.0b013e32833ff5d6", "volume": "27", "author": "T Cundy", "year": "2011", "unstructured": "Cundy T, Mackay J. Proton pump inhibitors and severe hypomagnesaemia. Curr Opin Gastroenterol. 2011;27:180\u2013185.", "journal-title": "Curr Opin Gastroenterol"}, {"key": "1560_CR34", "first-page": "A711", "volume": "153", "author": "J Doornebal", "year": "2009", "unstructured": "Doornebal J, Bijlsma R, Brouwer RM. An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia. Ned Tijdschr Geneeskd. 2009;153:A711.", "journal-title": "Ned Tijdschr Geneeskd"}, {"key": "1560_CR35", "doi-asserted-by": "crossref", "first-page": "1834", "DOI": "10.1056/NEJMc066308", "volume": "355", "author": "M Epstein", "year": "2006", "unstructured": "Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med. 2006;355:1834\u20131836.", "journal-title": "N Engl J Med"}, {"key": "1560_CR36", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.ando.2008.03.003", "volume": "69", "author": "M Francois", "year": "2008", "unstructured": "Francois M, Levy-Bohbot N, Caron J, Durlach V. Chronic use of proton-pump inhibitors associated with giardiasis: a rare cause of hypomagnesemic hypoparathyroidism? Ann Endocrinol (Paris). 2008;69:446\u2013448.", "journal-title": "Ann Endocrinol (Paris)"}, {"key": "1560_CR37", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1053/j.ajkd.2009.11.019", "volume": "56", "author": "EJ Hoorn", "year": "2010", "unstructured": "Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010;56:112\u2013116.", "journal-title": "Am J Kidney Dis"}, {"key": "1560_CR38", "first-page": "169", "volume": "67", "author": "MT Kuipers", "year": "2009", "unstructured": "Kuipers MT, Thang HD, Arntzenius AB. Hypomagnesaemia due to use of proton pump inhibitors\u2013a review. Neth J Med. 2009;67:169\u2013172.", "journal-title": "Neth J Med"}, {"key": "1560_CR39", "doi-asserted-by": "crossref", "first-page": "387", "DOI": "10.1093/qjmed/hcq021", "volume": "103", "author": "JD Mackay", "year": "2010", "unstructured": "Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM. 2010;103:387\u2013395.", "journal-title": "QJM"}, {"key": "1560_CR40", "doi-asserted-by": "crossref", "first-page": "2648", "DOI": "10.1111/j.1572-0241.2007.01509.x", "volume": "102", "author": "DC Metz", "year": "2007", "unstructured": "Metz DC, Sostek MB, Ruszniewski P, Forsmark CE, Monyak J, Pisegna JR. Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Am J Gastroenterol. 2007;102:2648\u20132654.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR41", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1053/j.ajkd.2010.03.013", "volume": "56", "author": "G Regolisti", "year": "2010", "unstructured": "Regolisti G, Cabassi A, Parenti E, Maggiore U, Fiaccadori E. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. Am J Kidney Dis. 2010;56:168\u2013174.", "journal-title": "Am J Kidney Dis"}, {"key": "1560_CR42", "doi-asserted-by": "crossref", "first-page": "a425", "DOI": "10.1136/bmj.39505.738981.BE", "volume": "337", "author": "N Shabajee", "year": "2008", "unstructured": "Shabajee N, Lamb EJ, Sturgess I, Sumathipala RW. Omeprazole and refractory hypomagnesaemia. BMJ. 2008;337:a425.", "journal-title": "BMJ"}, {"key": "1560_CR43", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1097/MOG.0b013e3282f37b59", "volume": "24", "author": "GA Quamme", "year": "2008", "unstructured": "Quamme GA. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol. 2008;24:230\u2013235.", "journal-title": "Curr Opin Gastroenterol"}, {"key": "1560_CR44", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1085/jgp.200609502", "volume": "127", "author": "M Li", "year": "2006", "unstructured": "Li M, Jiang J, Yue L. Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7. J Gen Physiol. 2006;127:525\u2013537.", "journal-title": "J Gen Physiol"}, {"key": "1560_CR45", "doi-asserted-by": "crossref", "first-page": "1317", "DOI": "10.1111/j.1365-2036.2008.03824.x", "volume": "28", "author": "JM Mullin", "year": "2008", "unstructured": "Mullin JM, Valenzano MC, Whitby M, et al. Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase. Aliment Pharmacol Ther. 2008;28:1317\u20131325.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR46", "doi-asserted-by": "crossref", "first-page": "539", "DOI": "10.1053/bega.2000.0197", "volume": "15", "author": "P Evenepoel", "year": "2001", "unstructured": "Evenepoel P. Alteration in digestion and absorption of nutrients during profound acid suppression. Best Pract Res Clin Gastroenterol. 2001;15:539\u2013551.", "journal-title": "Best Pract Res Clin Gastroenterol"}, {"key": "1560_CR47", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1056/NEJM198708273170903", "volume": "317", "author": "MS Sheikh", "year": "1987", "unstructured": "Sheikh MS, Santa Ana CA, Nicar MJ, Schiller LR, Fordtran JS. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med. 1987;317:532\u2013536.", "journal-title": "N Engl J Med"}, {"key": "1560_CR48", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/S0160-3450(15)32077-8", "volume": "NS27", "author": "CJ Carr", "year": "1987", "unstructured": "Carr CJ, Shangraw RF. Nutritional and pharmaceutical aspects of calcium supplementation. Am Pharm. 1987;NS27:49\u201350. (54\u201347).", "journal-title": "Am Pharm"}, {"key": "1560_CR49", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.3177/jnsv.44.869", "volume": "44", "author": "O Chonan", "year": "1998", "unstructured": "Chonan O, Takahashi R, Yasui H, Watanuki M. Effect of L-lactic acid on the absorption of calcium in gastrectomized rats. J Nutr Sci Vitaminol (Tokyo). 1998;44:869\u2013875.", "journal-title": "J Nutr Sci Vitaminol (Tokyo)"}, {"key": "1560_CR50", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.3177/jnsv.44.473", "volume": "44", "author": "O Chonan", "year": "1998", "unstructured": "Chonan O, Takahashi R, Yasui H, Watanuki M. Effect of L-lactic acid on calcium absorption in rats fed omeprazole. J Nutr Sci Vitaminol (Tokyo). 1998;44:473\u2013481.", "journal-title": "J Nutr Sci Vitaminol (Tokyo)"}, {"key": "1560_CR51", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1136/gut.26.3.252", "volume": "26", "author": "L Nilas", "year": "1985", "unstructured": "Nilas L, Christiansen C, Christiansen J. Regulation of vitamin D and calcium metabolism after gastrectomy. Gut. 1985;26:252\u2013257.", "journal-title": "Gut"}, {"key": "1560_CR52", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.7326/0003-4819-66-5-917", "volume": "66", "author": "P Ivanovich", "year": "1967", "unstructured": "Ivanovich P, Fellows H, Rich C. The absorption of calcium carbonate. Ann Intern Med. 1967;66:917\u2013923.", "journal-title": "Ann Intern Med"}, {"key": "1560_CR53", "doi-asserted-by": "crossref", "first-page": "573", "DOI": "10.1002/jbmr.5650070514", "volume": "7", "author": "JB Goerss", "year": "1992", "unstructured": "Goerss JB, Kim CH, Atkinson EJ, Eastell R, O\u2019Fallon WM, Melton LJ 3rd. Risk of fractures in patients with pernicious anemia. J Bone Miner Res. 1992;7:573\u2013579.", "journal-title": "J Bone Miner Res"}, {"key": "1560_CR54", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1007/BF01352010", "volume": "53", "author": "K Mizunashi", "year": "1993", "unstructured": "Mizunashi K, Furukawa Y, Katano K, Abe K. Effect of omeprazole, an inhibitor of H\u00a0+\u00a0, K(+)-ATPase, on bone resorption in humans. Calcif Tissue Int. 1993;53:21\u201325.", "journal-title": "Calcif Tissue Int"}, {"key": "1560_CR55", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1007/BF02556841", "volume": "38", "author": "J Tuukkanen", "year": "1986", "unstructured": "Tuukkanen J, Vaananen HK. Omeprazole, a specific inhibitor of H\u00a0+\u00a0-K\u00a0+\u00a0-ATPase, inhibits bone resorption in vitro. Calcif Tissue Int. 1986;38:123\u2013125.", "journal-title": "Calcif Tissue Int"}, {"key": "1560_CR56", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1053/j.gastro.2009.11.014", "volume": "138", "author": "LE Targownik", "year": "2010", "unstructured": "Targownik LE, Lix LM, Leung S, Leslie WD. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. Gastroenterology. 2010;138:896\u2013904.", "journal-title": "Gastroenterology"}, {"key": "1560_CR57", "doi-asserted-by": "crossref", "first-page": "364", "DOI": "10.1080/07315724.1995.10718522", "volume": "14", "author": "C Serfaty-Lacrosniere", "year": "1995", "unstructured": "Serfaty-Lacrosniere C, Wood RJ, Voytko D, et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr. 1995;14:364\u2013368.", "journal-title": "J Am Coll Nutr"}, {"key": "1560_CR58", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1016/j.amjmed.2005.02.007", "volume": "118", "author": "MB O\u2019Connell", "year": "2005", "unstructured": "O\u2019Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005;118:778\u2013781.", "journal-title": "Am J Med"}, {"key": "1560_CR59", "doi-asserted-by": "crossref", "first-page": "640", "DOI": "10.1172/JCI111254", "volume": "73", "author": "GW Bo-Linn", "year": "1984", "unstructured": "Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest. 1984;73:640\u2013647.", "journal-title": "J Clin Invest"}, {"key": "1560_CR60", "doi-asserted-by": "crossref", "first-page": "283", "DOI": "10.1007/s002239900431", "volume": "62", "author": "Y Adachi", "year": "1998", "unstructured": "Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S. Bone mineral density in patients taking H2-receptor antagonist. Calcif Tissue Int. 1998;62:283\u2013285.", "journal-title": "Calcif Tissue Int"}, {"key": "1560_CR61", "doi-asserted-by": "crossref", "first-page": "1922", "DOI": "10.1093/ndt/14.8.1922", "volume": "14", "author": "MW Taal", "year": "1999", "unstructured": "Taal MW, Masud T, Green D, Cassidy MJ. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant. 1999;14:1922\u20131928.", "journal-title": "Nephrol Dial Transplant"}, {"key": "1560_CR62", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1007/s00223-008-9170-1", "volume": "83", "author": "EW Yu", "year": "2008", "unstructured": "Yu EW, Blackwell T, Ensrud KE, et al. Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int. 2008;83:251\u2013259.", "journal-title": "Calcif Tissue Int"}, {"key": "1560_CR63", "doi-asserted-by": "crossref", "first-page": "1330", "DOI": "10.1053/j.gastro.2009.12.007", "volume": "138", "author": "NA Merriman", "year": "2010", "unstructured": "Merriman NA, Putt ME, Metz DC, Yang YX. Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology. 2010;138:1330\u20131337.", "journal-title": "Gastroenterology"}, {"key": "1560_CR64", "doi-asserted-by": "crossref", "first-page": "2947", "DOI": "10.1001/jama.296.24.2947", "volume": "296", "author": "YX Yang", "year": "2006", "unstructured": "Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296:2947\u20132953.", "journal-title": "JAMA"}, {"key": "1560_CR65", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1007/s00223-006-0021-7", "volume": "79", "author": "P Vestergaard", "year": "2006", "unstructured": "Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006;79:76\u201383.", "journal-title": "Calcif Tissue Int"}, {"key": "1560_CR66", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1503/cmaj.071330", "volume": "179", "author": "LE Targownik", "year": "2008", "unstructured": "Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008;179:319\u2013326.", "journal-title": "CMAJ"}, {"key": "1560_CR67", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1592/phco.28.8.951", "volume": "28", "author": "JA Kaye", "year": "2008", "unstructured": "Kaye JA, Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy. 2008;28:951\u2013959.", "journal-title": "Pharmacotherapy"}, {"key": "1560_CR68", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1053/j.gastro.2010.03.055", "volume": "139", "author": "DA Corley", "year": "2010", "unstructured": "Corley DA, Kubo A, Zhao W, Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010;139:93\u2013101.", "journal-title": "Gastroenterology"}, {"key": "1560_CR69", "doi-asserted-by": "crossref", "first-page": "1955", "DOI": "10.1001/jama.292.16.1955", "volume": "292", "author": "RJ Laheij", "year": "2004", "unstructured": "Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA. 2004;292:1955\u20131960.", "journal-title": "JAMA"}, {"key": "1560_CR70", "doi-asserted-by": "crossref", "first-page": "379", "DOI": "10.1046/j.1365-2036.2001.00888.x", "volume": "15", "author": "S Sanduleanu", "year": "2001", "unstructured": "Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15:379\u2013388.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR71", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1016/S1091-255X(00)80032-3", "volume": "4", "author": "J Theisen", "year": "2000", "unstructured": "Theisen J, Nehra D, Citron D, et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J Gastrointest Surg. 2000;4:50\u201354.", "journal-title": "J Gastrointest Surg"}, {"key": "1560_CR72", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1136/gut.39.1.54", "volume": "39", "author": "J Thorens", "year": "1996", "unstructured": "Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54\u201359.", "journal-title": "Gut"}, {"key": "1560_CR73", "doi-asserted-by": "crossref", "first-page": "1413", "DOI": "10.1016/0306-3623(94)00301-3", "volume": "26", "author": "C Aybay", "year": "1995", "unstructured": "Aybay C, Imir T, Okur H. The effect of omeprazole on human natural killer cell activity. Gen Pharmacol. 1995;26:1413\u20131418.", "journal-title": "Gen Pharmacol"}, {"key": "1560_CR74", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1046/j.1365-2036.2000.014s1074.x", "volume": "14", "author": "N Yoshida", "year": "2000", "unstructured": "Yoshida N, Yoshikawa T, Tanaka Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors\u2013inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000;14:74\u201381.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR75", "doi-asserted-by": "crossref", "first-page": "1118", "DOI": "10.1097/00003246-200205000-00026", "volume": "30", "author": "K Zedtwitz-Liebenstein", "year": "2002", "unstructured": "Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med. 2002;30:1118\u20131122.", "journal-title": "Crit Care Med"}, {"key": "1560_CR76", "doi-asserted-by": "crossref", "first-page": "627", "DOI": "10.2165/00002018-200831070-00008", "volume": "31", "author": "L Estborn", "year": "2008", "unstructured": "Estborn L, Joelson S. Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole: retrospective analysis of adverse events in 31 clinical trials. Drug Saf. 2008;31:627\u2013636.", "journal-title": "Drug Saf"}, {"key": "1560_CR77", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1046/j.1365-2036.2003.01744.x", "volume": "18", "author": "RJ Laheij", "year": "2003", "unstructured": "Laheij RJ, Van Ijzendoorn MC, Janssen MJ, Jansen JB. Gastric acid-suppressive therapy and community-acquired respiratory infections. Aliment Pharmacol Ther. 2003;18:847\u2013851.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR78", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1001/archinte.167.9.950", "volume": "167", "author": "SE Gulmez", "year": "2007", "unstructured": "Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007;167:950\u2013955.", "journal-title": "Arch Intern Med"}, {"key": "1560_CR79", "unstructured": "Gau J. Does Gastric Acid-Suppressive Therapy Increase the Risk of Pneumonia in Older Adults? Presented at AGS Meeting; 2007."}, {"key": "1560_CR80", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.7326/0003-4819-149-6-200809160-00005", "volume": "149", "author": "M Sarkar", "year": "2008", "unstructured": "Sarkar M, Hennessy S, Yang YX. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149:391\u2013398.", "journal-title": "Ann Intern Med"}, {"key": "1560_CR81", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1111/j.0953-0673.1996.00359.x", "volume": "10", "author": "M Hartmann", "year": "1996", "unstructured": "Hartmann M, Theiss U, Huber R, et al. Twenty-four-hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole. Aliment Pharmacol Ther. 1996;10:359\u2013366.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR82", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.1002/pds.1978", "volume": "19", "author": "S Dublin", "year": "2010", "unstructured": "Dublin S, Walker RL, Jackson ML, Nelson JC, Weiss NS, Jackson LA. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiol Drug Saf. 2010;19:792\u2013802.", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "1560_CR83", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.3109/00365528509093749", "volume": "111", "author": "RW Stockbruegger", "year": "1985", "unstructured": "Stockbruegger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111:7\u201316.", "journal-title": "Scand J Gastroenterol Suppl"}, {"key": "1560_CR84", "doi-asserted-by": "crossref", "first-page": "672", "DOI": "10.1016/S0140-6736(80)92826-3", "volume": "1", "author": "WS Ruddell", "year": "1980", "unstructured": "Ruddell WS, Axon AT, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet. 1980;1:672\u2013674.", "journal-title": "Lancet"}, {"key": "1560_CR85", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1136/gut.28.1.96", "volume": "28", "author": "CW Howden", "year": "1987", "unstructured": "Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut. 1987;28:96\u2013107.", "journal-title": "Gut"}, {"key": "1560_CR86", "doi-asserted-by": "crossref", "first-page": "574", "DOI": "10.1136/gut.8.6.574", "volume": "8", "author": "JD Gray", "year": "1967", "unstructured": "Gray JD, Shiner M. Influence of gastric pH on gastric and jejunal flora. Gut. 1967;8:574\u2013581.", "journal-title": "Gut"}, {"key": "1560_CR87", "first-page": "383", "volume": "17", "author": "DS Cothran", "year": "1997", "unstructured": "Cothran DS, Borowitz SM, Sutphen JL, Dudley SM, Donowitz LG. Alteration of normal gastric flora in neonates receiving ranitidine. J Perinatol. 1997;17:383\u2013388.", "journal-title": "J Perinatol"}, {"key": "1560_CR88", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.5694/j.1326-5377.1999.tb127696.x", "volume": "170", "author": "TL Holt", "year": "1999", "unstructured": "Holt TL, Coombes ID, Pillans PI, Scott IA. Neutropenia associated with omeprazole. Med J Aust. 1999;170:141\u2013142.", "journal-title": "Med J Aust"}, {"key": "1560_CR89", "first-page": "9952", "volume": "269", "author": "E Vannier", "year": "1994", "unstructured": "Vannier E, Dinarello CA. Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. J Biol Chem. 1994;269:9952\u20139956.", "journal-title": "J Biol Chem"}, {"key": "1560_CR90", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1136/bmj.289.6447.717", "volume": "289", "author": "BK Sharma", "year": "1984", "unstructured": "Sharma BK, Santana IA, Wood EC, et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed). 1984;289:717\u2013719.", "journal-title": "Br Med J (Clin Res Ed)"}, {"key": "1560_CR91", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1136/gut.35.4.455", "volume": "35", "author": "E Verdu", "year": "1994", "unstructured": "Verdu E, Viani F, Armstrong D, et al. Effect of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut. 1994;35:455\u2013460.", "journal-title": "Gut"}, {"key": "1560_CR92", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1136/gut.35.1.23", "volume": "35", "author": "M Fried", "year": "1994", "unstructured": "Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994;35:23\u201326.", "journal-title": "Gut"}, {"key": "1560_CR93", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.2165/00002018-200326020-00005", "volume": "26", "author": "LV Wilton", "year": "2003", "unstructured": "Wilton LV, Key C, Shakir SA. The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England. Drug Saf. 2003;26:121\u2013132.", "journal-title": "Drug Saf"}, {"key": "1560_CR94", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1046/j.1365-2125.2000.00262.x", "volume": "50", "author": "RM Martin", "year": "2000", "unstructured": "Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol. 2000;50:366\u2013372.", "journal-title": "Br J Clin Pharmacol"}, {"key": "1560_CR95", "doi-asserted-by": "crossref", "first-page": "887", "DOI": "10.1046/j.1365-2036.1997.00214.x", "volume": "11", "author": "H Leufkens", "year": "1997", "unstructured": "Leufkens H, Claessens A, Heerdink E, van Eijk J, Lamers CB. A prospective follow-up study of 5669 users of lansoprazole in daily practice. Aliment Pharmacol Ther. 1997;11:887\u2013897.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR96", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1002/pds.769", "volume": "11", "author": "AA Claessens", "year": "2002", "unstructured": "Claessens AA, Heerdink ER, van Eijk JT, Lamers CB, Leufkens HG. Characteristics of diarrhoea in 10, 008 users of lansoprazole in daily practice: which co-factors contribute? Pharmacoepidemiol Drug Saf. 2002;11:703\u2013708.", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "1560_CR97", "doi-asserted-by": "crossref", "first-page": "571", "DOI": "10.1097/00001648-199709000-00016", "volume": "8", "author": "LA Garcia Rodriguez", "year": "1997", "unstructured": "Garcia Rodriguez LA, Ruigomez A. Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk? Epidemiology. 1997;8:571\u2013574.", "journal-title": "Epidemiology"}, {"key": "1560_CR98", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1136/bmj.312.7028.414", "volume": "312", "author": "KR Neal", "year": "1996", "unstructured": "Neal KR, Scott HM, Slack RC, Logan RF. Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study. BMJ. 1996;312:414\u2013415.", "journal-title": "BMJ"}, {"key": "1560_CR99", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1017/S095026880700996X", "volume": "136", "author": "Y Doorduyn", "year": "2008", "unstructured": "Doorduyn Y, Van Pelt W, Siezen CL, et al. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect. 2008;136:1225\u20131234.", "journal-title": "Epidemiol Infect"}, {"key": "1560_CR100", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1136/bmj.308.6922.176", "volume": "308", "author": "KR Neal", "year": "1994", "unstructured": "Neal KR, Briji SO, Slack RC, Hawkey CJ, Logan RF. Recent treatment with H2 antagonists and antibiotics and gastric surgery as risk factors for Salmonella infection. BMJ. 1994;308:176.", "journal-title": "BMJ"}, {"key": "1560_CR101", "doi-asserted-by": "crossref", "first-page": "1418", "DOI": "10.1016/j.cgh.2007.09.010", "volume": "5", "author": "LA Garcia Rodriguez", "year": "2007", "unstructured": "Garcia Rodriguez LA, Ruigomez A, Panes J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol. 2007;5:1418\u20131423.", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "1560_CR102", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1017/S0950268805005406", "volume": "134", "author": "Y Doorduyn", "year": "2006", "unstructured": "Doorduyn Y, Van Den Brandhof WE, Van Duynhoven YT, Wannet WJ, Van Pelt W. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect. 2006;134:617\u2013626.", "journal-title": "Epidemiol Infect"}, {"key": "1560_CR103", "doi-asserted-by": "crossref", "first-page": "e817", "DOI": "10.1542/peds.2005-1655", "volume": "117", "author": "RB Canani", "year": "2006", "unstructured": "Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117:e817\u2013e820.", "journal-title": "Pediatrics"}, {"key": "1560_CR104", "doi-asserted-by": "crossref", "first-page": "2047", "DOI": "10.1111/j.1572-0241.2007.01275.x", "volume": "102", "author": "J Leonard", "year": "2007", "unstructured": "Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102:2047\u20132056. (quiz 2057).", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR105", "doi-asserted-by": "crossref", "first-page": "681", "DOI": "10.1016/S0035-9203(97)90523-X", "volume": "91", "author": "CA Evans", "year": "1997", "unstructured": "Evans CA, Gilman RH, Rabbani GH, Salazar G, Ali A. Gastric acid secretion and enteric infection in Bangladesh. Trans R Soc Trop Med Hyg. 1997;91:681\u2013685.", "journal-title": "Trans R Soc Trop Med Hyg"}, {"key": "1560_CR106", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.1001/archinte.146.3.520", "volume": "146", "author": "JL Ho", "year": "1986", "unstructured": "Ho JL, Shands KN, Friedland G, Eckind P, Fraser DW. An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med. 1986;146:520\u2013524.", "journal-title": "Arch Intern Med"}, {"key": "1560_CR107", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1111/j.1365-2036.1994.tb00333.x", "volume": "8", "author": "AJ Larner", "year": "1994", "unstructured": "Larner AJ, Hamilton MI. Review article: infective complications of therapeutic gastric acid inhibition. Aliment Pharmacol Ther. 1994;8:579\u2013584.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR108", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.3109/00365528509093751", "volume": "111", "author": "GC Cook", "year": "1985", "unstructured": "Cook GC. Infective gastroenteritis and its relationship to reduced gastric acidity. Scand J Gastroenterol Suppl. 1985;111:17\u201323.", "journal-title": "Scand J Gastroenterol Suppl"}, {"key": "1560_CR109", "first-page": "149", "volume": "28", "author": "SA Kader", "year": "1998", "unstructured": "Kader SA, Mansour AM, Mohran Z, el-Taoil A, Abdalla KF. A study on the relation between proton pump inhibitor and gastric giardiasis. J Egypt Soc Parasitol. 1998;28:149\u2013157.", "journal-title": "J Egypt Soc Parasitol"}, {"key": "1560_CR110", "doi-asserted-by": "crossref", "first-page": "775", "DOI": "10.1007/BF02349646", "volume": "30", "author": "H Reynaert", "year": "1995", "unstructured": "Reynaert H, Fernandes E, Bourgain C, Smekens L, Devis G. Proton-pump inhibition and gastric giardiasis: a causal or casual association? J Gastroenterol. 1995;30:775\u2013778.", "journal-title": "J Gastroenterol"}, {"key": "1560_CR111", "doi-asserted-by": "crossref", "first-page": "1229", "DOI": "10.1136/gut.27.10.1229-a", "volume": "27", "author": "JF Cadranel", "year": "1986", "unstructured": "Cadranel JF, Eugene C. Another example of Strongyloides stercoralis infection associated with cimetidine in an immunosuppressed patient. Gut. 1986;27:1229.", "journal-title": "Gut"}, {"key": "1560_CR112", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1136/gut.27.3.337", "volume": "27", "author": "CC Ainley", "year": "1986", "unstructured": "Ainley CC, Clarke DG, Timothy AR, Thompson RP. Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy. Gut. 1986;27:337\u2013338.", "journal-title": "Gut"}, {"key": "1560_CR113", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1111/j.1742-7843.2005.pto960202.x", "volume": "96", "author": "TC Martinsen", "year": "2005", "unstructured": "Martinsen TC, Bergh K, Waldum HL. Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005;96:94\u2013102.", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "1560_CR114", "doi-asserted-by": "crossref", "first-page": "1339", "DOI": "10.1093/jac/dkg254", "volume": "51", "author": "C Thomas", "year": "2003", "unstructured": "Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother. 2003;51:1339\u20131350.", "journal-title": "J Antimicrob Chemother"}, {"key": "1560_CR115", "first-page": "1201", "volume": "54", "author": "C Severe", "year": "2005", "unstructured": "Severe C. lostridium difficile-associated disease in populations previously at low risk\u2014four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201\u20131205.", "journal-title": "MMWR Morb Mortal Wkly Rep"}, {"key": "1560_CR116", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1093/infdis/151.2.355", "volume": "151", "author": "KH Wilson", "year": "1985", "unstructured": "Wilson KH, Sheagren JN, Freter R. Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis. 1985;151:355\u2013361.", "journal-title": "J Infect Dis"}, {"key": "1560_CR117", "doi-asserted-by": "crossref", "first-page": "S10", "DOI": "10.1038/ajg.2009.46", "volume": "104", "author": "MS Dial", "year": "2009", "unstructured": "Dial MS. Proton pump inhibitor use and enteric infections. Am J Gastroenterol. 2009;104:S10\u2013S16.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR118", "doi-asserted-by": "crossref", "first-page": "1272", "DOI": "10.1086/508453", "volume": "43", "author": "DO Lowe", "year": "2006", "unstructured": "Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis. 2006;43:1272\u20131276.", "journal-title": "Clin Infect Dis"}, {"key": "1560_CR119", "doi-asserted-by": "crossref", "first-page": "388", "DOI": "10.1093/jac/dkn163", "volume": "62", "author": "MH Wilcox", "year": "2008", "unstructured": "Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62:388\u2013396.", "journal-title": "J Antimicrob Chemother"}, {"key": "1560_CR120", "doi-asserted-by": "crossref", "first-page": "784", "DOI": "10.1001/archinternmed.2010.89", "volume": "170", "author": "MD Howell", "year": "2010", "unstructured": "Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170:784\u2013790.", "journal-title": "Arch Intern Med"}, {"key": "1560_CR121", "first-page": "141", "volume": "19", "author": "R Pounder", "year": "1990", "unstructured": "Pounder R, Smith J. Drug-induced changes of plasma gastrin concentration. Gastroenterol Clin North Am. 1990;19:141\u2013153.", "journal-title": "Gastroenterol Clin North Am"}, {"key": "1560_CR122", "doi-asserted-by": "crossref", "first-page": "1217", "DOI": "10.1136/gut.2005.090514", "volume": "55", "author": "EJ Kuipers", "year": "2006", "unstructured": "Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut. 2006;55:1217\u20131221.", "journal-title": "Gut"}, {"key": "1560_CR123", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1046/j.1365-2036.2000.00768.x", "volume": "14", "author": "L Laine", "year": "2000", "unstructured": "Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther. 2000;14:651\u2013668.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR124", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1046/j.1365-2036.1998.00349.x", "volume": "12", "author": "BE Schenk", "year": "1998", "unstructured": "Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther. 1998;12:605\u2013612.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR125", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1016/S0016-5085(99)70118-6", "volume": "116", "author": "D Gillen", "year": "1999", "unstructured": "Gillen D, Wirz AA, Ardill JE, McColl KE. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology. 1999;116:239\u2013247.", "journal-title": "Gastroenterology"}, {"key": "1560_CR126", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1053/j.gastro.2009.03.058", "volume": "137", "author": "C Reimer", "year": "2009", "unstructured": "Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009;137:80\u201387. (87 e81).", "journal-title": "Gastroenterology"}, {"key": "1560_CR127", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.3109/00365520903477348", "volume": "45", "author": "HL Waldum", "year": "2010", "unstructured": "Waldum HL, Qvigstad G, Fossmark R, Kleveland PM, Sandvik AK. Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint. Scand J Gastroenterol. 2010;45:389\u2013394.", "journal-title": "Scand J Gastroenterol"}, {"key": "1560_CR128", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1016/S0002-9440(10)64588-9", "volume": "157", "author": "SC Abraham", "year": "2000", "unstructured": "Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157:747\u2013754.", "journal-title": "Am J Pathol"}, {"key": "1560_CR129", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1016/S0016-5107(93)70057-7", "volume": "39", "author": "Y Kinoshita", "year": "1993", "unstructured": "Kinoshita Y, Tojo M, Yano T, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39:161\u2013163.", "journal-title": "Gastrointest Endosc"}, {"key": "1560_CR130", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1007/s004280000330", "volume": "437", "author": "G Oberhuber", "year": "2000", "unstructured": "Oberhuber G, Stolte M. Gastric polyps: an update of their pathology and biological significance. Virchows Arch. 2000;437:581\u2013590.", "journal-title": "Virchows Arch"}, {"key": "1560_CR131", "doi-asserted-by": "crossref", "first-page": "659", "DOI": "10.1055/s-2007-1009061", "volume": "26", "author": "M Stolte", "year": "1994", "unstructured": "Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26:659\u2013665.", "journal-title": "Endoscopy"}, {"key": "1560_CR132", "first-page": "1858", "volume": "92", "author": "HM el-Zimaity", "year": "1997", "unstructured": "el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92:1858\u20131860.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR133", "first-page": "A121", "volume": "9", "author": "FW Jackson", "year": "1998", "unstructured": "Jackson FW, Gordon S. Regression of fundic gland polyps after discontinuation of omeprazole [abstract]. Am J Gastroenterol Clin Biol. 1998;9:A121.", "journal-title": "Am J Gastroenterol Clin Biol"}, {"key": "1560_CR134", "doi-asserted-by": "crossref", "first-page": "2039", "DOI": "10.1007/BF02093608", "volume": "41", "author": "DK Driman", "year": "1996", "unstructured": "Driman DK, Wright C, Tougas G, Riddell RH. Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig Dis Sci. 1996;41:2039\u20132047.", "journal-title": "Dig Dis Sci"}, {"key": "1560_CR135", "doi-asserted-by": "crossref", "first-page": "684", "DOI": "10.1053/hupa.2000.7637", "volume": "31", "author": "A Cats", "year": "2000", "unstructured": "Cats A, Schenk BE, Bloemena E, et al. Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol. 2000;31:684\u2013690.", "journal-title": "Hum Pathol"}, {"key": "1560_CR136", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1023/A:1018814014139", "volume": "43", "author": "N Sakai", "year": "1998", "unstructured": "Sakai N, Tatsuta M, Hirasawa R, et al. Low prevalence of Helicobacter pylori infection in patients with hamartomatous fundic polyps. Dig Dis Sci. 1998;43:766\u2013772.", "journal-title": "Dig Dis Sci"}, {"key": "1560_CR137", "doi-asserted-by": "crossref", "first-page": "615", "DOI": "10.1093/ajcp/110.5.615", "volume": "110", "author": "U Choudhry", "year": "1998", "unstructured": "Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110:615\u2013621.", "journal-title": "Am J Clin Pathol"}, {"key": "1560_CR138", "first-page": "287", "volume": "157", "author": "JR Graham", "year": "1992", "unstructured": "Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Aust. 1992;157:287\u2013288.", "journal-title": "Med J Aust"}, {"key": "1560_CR139", "doi-asserted-by": "crossref", "first-page": "1341", "DOI": "10.1111/j.1365-2036.2006.03127.x", "volume": "24", "author": "M Jalving", "year": "2006", "unstructured": "Jalving M, Koornstra JJ, Wesseling J, Boezen HM SDEJ, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24:1341\u20131348.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR140", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1067/mge.2002.122583", "volume": "55", "author": "GB Kazantsev", "year": "2002", "unstructured": "Kazantsev GB, Schwesinger WH, Heim-Hall J. Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report. Gastrointest Endosc. 2002;55:600\u2013602.", "journal-title": "Gastrointest Endosc"}, {"key": "1560_CR141", "doi-asserted-by": "crossref", "first-page": "855", "DOI": "10.1111/j.1572-0241.1998.855_a.x", "volume": "93", "author": "S Naegels", "year": "1998", "unstructured": "Naegels S, Urbain D. Omeprazole and fundic gland polyps. Am J Gastroenterol. 1998;93:855.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR142", "first-page": "146", "volume": "33", "author": "M Stolte", "year": "1995", "unstructured": "Stolte M, Bethke B, Seifert E, et al. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment. Z Gastroenterol. 1995;33:146\u2013149.", "journal-title": "Z Gastroenterol"}, {"key": "1560_CR143", "first-page": "240", "volume": "60", "author": "H Vlierberghe Van", "year": "1997", "unstructured": "Van Vlierberghe H, De Vos M, De Cock G, Cuvelier C, Elewaut A. Fundic gland polyps: three other case reports suggesting a possible association with acid suppressing therapy. Acta Gastroenterol Belg. 1997;60:240\u2013242.", "journal-title": "Acta Gastroenterol Belg"}, {"key": "1560_CR144", "unstructured": "Collins S, Tydd T. Gastric polyps and long-term omeprazole [abstract]. J Gastroenterol Hepatology. 1998."}, {"key": "1560_CR145", "unstructured": "Mogadam M, Houk R. Long-term use of omeprazole is associated with development of benign epithelial gastric polyps [abstract]. Am J Gastroenterol. 1996;91:A151."}, {"key": "1560_CR146", "unstructured": "Reekmans A, Naegels S, Reynaert H, Urbain D. Fundic gland polyps and chronic PPI treatment: a prospective study [abstract]. Gastroenterology. 2001.", "DOI": "10.1016/S0016-5085(08)81208-5", "doi-asserted-by": "crossref"}, {"key": "1560_CR147", "doi-asserted-by": "crossref", "first-page": "716", "DOI": "10.1309/XFWR-LXA7-7TK1-N3Q8", "volume": "116", "author": "M Vieth", "year": "2001", "unstructured": "Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116:716\u2013720.", "journal-title": "Am J Clin Pathol"}, {"key": "1560_CR148", "doi-asserted-by": "crossref", "first-page": "1590", "DOI": "10.1016/0016-5085(93)90187-H", "volume": "105", "author": "M Stolte", "year": "1993", "unstructured": "Stolte M. Fundic gland polyps: a rare, innocuous, and reversible disturbance. Gastroenterology. 1993;105:1590\u20131591.", "journal-title": "Gastroenterology"}, {"key": "1560_CR149", "doi-asserted-by": "crossref", "first-page": "1005", "DOI": "10.1016/S0002-9440(10)64047-3", "volume": "158", "author": "SC Abraham", "year": "2001", "unstructured": "Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Pathol. 2001;158:1005\u20131010.", "journal-title": "Am J Pathol"}, {"key": "1560_CR150", "doi-asserted-by": "crossref", "first-page": "916", "DOI": "10.1080/00365520310005433", "volume": "38", "author": "M Jalving", "year": "2003", "unstructured": "Jalving M, Koornstra JJ, Boersma-van Ek W, et al. Dysplasia in fundic gland polyps is associated with nuclear beta-catenin expression and relatively high cell turnover rates. Scand J Gastroenterol. 2003;38:916\u2013922.", "journal-title": "Scand J Gastroenterol"}, {"key": "1560_CR151", "doi-asserted-by": "crossref", "first-page": "718", "DOI": "10.1097/01.MP.0000018976.15044.9B", "volume": "15", "author": "M Torbenson", "year": "2002", "unstructured": "Torbenson M, Lee JH, Cruz-Correa M, et al. Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol. 2002;15:718\u2013723.", "journal-title": "Mod Pathol"}, {"key": "1560_CR152", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1309/4QUNJ4F27QK7RR0G", "volume": "122", "author": "SC Abraham", "year": "2004", "unstructured": "Abraham SC, Park SJ, Cruz-Correa M, et al. Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps. Am J Clin Pathol. 2004;122:740\u2013746.", "journal-title": "Am J Clin Pathol"}, {"key": "1560_CR153", "doi-asserted-by": "crossref", "first-page": "1735", "DOI": "10.1016/S0002-9440(10)64450-1", "volume": "161", "author": "SC Abraham", "year": "2002", "unstructured": "Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol. 2002;161:1735\u20131742.", "journal-title": "Am J Pathol"}, {"key": "1560_CR154", "doi-asserted-by": "crossref", "first-page": "862", "DOI": "10.1097/01.MP.0000024146.29531.5B", "volume": "15", "author": "J Wei", "year": "2002", "unstructured": "Wei J, Chiriboga L, Yee H, et al. Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps. Mod Pathol. 2002;15:862\u2013869.", "journal-title": "Mod Pathol"}, {"key": "1560_CR155", "doi-asserted-by": "crossref", "first-page": "298", "DOI": "10.1111/j.1572-0241.2002.05461.x", "volume": "97", "author": "TM Attard", "year": "2002", "unstructured": "Attard TM, Yardley JH, Cuffari C. Gastric polyps in pediatrics: an 18-year hospital-based analysis. Am J Gastroenterol. 2002;97:298\u2013301.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR156", "doi-asserted-by": "crossref", "first-page": "16", "DOI": "10.3109/00365528609034615", "volume": "21", "author": "JH Svendsen", "year": "1986", "unstructured": "Svendsen JH, Dahl C, Svendsen LB, Christiansen PM. Gastric cancer risk in achlorhydric patients. A long-term follow-up study. Scand J Gastroenterol. 1986;21:16\u201320.", "journal-title": "Scand J Gastroenterol"}, {"key": "1560_CR157", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1136/gut.28.8.921", "volume": "28", "author": "DC Carter", "year": "1987", "unstructured": "Carter DC. Cancer after peptic ulcer surgery. Gut. 1987;28:921\u2013923.", "journal-title": "Gut"}, {"key": "1560_CR158", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1016/S0140-6736(86)91041-X", "volume": "1", "author": "CP Caygill", "year": "1986", "unstructured": "Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986;1:929\u2013931.", "journal-title": "Lancet"}, {"key": "1560_CR159", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1159/000200923", "volume": "51", "author": "JW Freston", "year": "1992", "unstructured": "Freston JW. Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy. Digestion. 1992;51:102\u2013114.", "journal-title": "Digestion"}, {"key": "1560_CR160", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1007/BF01600253", "volume": "420", "author": "R Fiocca", "year": "1992", "unstructured": "Fiocca R, Villani L, Luinetti O, et al. Helicobacter colonization and histopathological profile of chronic gastritis in patients with or without dyspepsia, mucosal erosion and peptic ulcer: a morphological approach to the study of ulcerogenesis in man. Virchows Arch A Pathol Anat Histopathol. 1992;420:489\u2013498.", "journal-title": "Virchows Arch A Pathol Anat Histopathol"}, {"key": "1560_CR161", "doi-asserted-by": "crossref", "first-page": "2108", "DOI": "10.1053/gast.1997.v112.agast972108", "volume": "112", "author": "CE Rubin", "year": "1997", "unstructured": "Rubin CE. Are there three types of Helicobacter pylori gastritis? Gastroenterology. 1997;112:2108\u20132110.", "journal-title": "Gastroenterology"}, {"key": "1560_CR162", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1002/1097-0142(19940715)74:2<556::AID-CNCR2820740205>3.0.CO;2-J", "volume": "74", "author": "GN Stemmermann", "year": "1994", "unstructured": "Stemmermann GN. Intestinal metaplasia of the stomach. A status report. Cancer. 1994;74:556\u2013564.", "journal-title": "Cancer"}, {"key": "1560_CR163", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1126/science.287.5452.482", "volume": "287", "author": "DL Weeks", "year": "2000", "unstructured": "Weeks DL, Eskandari S, Scott DR, Sachs G. A H\u00a0+\u00a0-gated urea channel: the link between Helicobacter pylori urease and gastric colonization. Science. 2000;287:482\u2013485.", "journal-title": "Science"}, {"key": "1560_CR164", "first-page": "1401", "volume": "90", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90:1401\u20131406.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR165", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1136/gut.36.1.12", "volume": "36", "author": "RP Logan", "year": "1995", "unstructured": "Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995;36:12\u201316.", "journal-title": "Gut"}, {"key": "1560_CR166", "doi-asserted-by": "crossref", "first-page": "1018", "DOI": "10.1056/NEJM199604183341603", "volume": "334", "author": "EJ Kuipers", "year": "1996", "unstructured": "Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018\u20131022.", "journal-title": "N Engl J Med"}, {"key": "1560_CR167", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1053/gast.1999.0029900319", "volume": "117", "author": "L Lundell", "year": "1999", "unstructured": "Lundell L, Miettinen P, Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology. 1999;117:319\u2013326.", "journal-title": "Gastroenterology"}, {"key": "1560_CR168", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1111/j.1365-2036.2006.02792.x", "volume": "23", "author": "L Lundell", "year": "2006", "unstructured": "Lundell L, Havu N, Miettinen P, et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther. 2006;23:639\u2013647.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR169", "doi-asserted-by": "crossref", "first-page": "784", "DOI": "10.1056/NEJMoa001999", "volume": "345", "author": "N Uemura", "year": "2001", "unstructured": "Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784\u2013789.", "journal-title": "N Engl J Med"}, {"key": "1560_CR170", "doi-asserted-by": "crossref", "first-page": "1808", "DOI": "10.1111/j.1572-0241.2007.01393.x", "volume": "102", "author": "WD Chey", "year": "2007", "unstructured": "Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102:1808\u20131825.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR171", "doi-asserted-by": "crossref", "first-page": "934", "DOI": "10.1002/cncr.11105", "volume": "97", "author": "IM Modlin", "year": "2003", "unstructured": "Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13, 715 carcinoid tumors. Cancer. 2003;97:934\u2013959.", "journal-title": "Cancer"}, {"key": "1560_CR172", "doi-asserted-by": "crossref", "first-page": "1610", "DOI": "10.1007/s00464-005-0232-4", "volume": "19", "author": "N Hodgson", "year": "2005", "unstructured": "Hodgson N, Koniaris LG, Livingstone AS, Franceschi D. Gastric carcinoids: a temporal increase with proton pump introduction. Surg Endosc. 2005;19:1610\u20131612.", "journal-title": "Surg Endosc"}, {"key": "1560_CR173", "doi-asserted-by": "crossref", "first-page": "S39", "DOI": "10.1007/s10620-005-2805-4", "volume": "50", "author": "HL Waldum", "year": "2005", "unstructured": "Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50:S39\u2013S44.", "journal-title": "Dig Dis Sci"}, {"key": "1560_CR174", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1046/j.1365-2036.1999.00033.x", "volume": "13", "author": "M Robinson", "year": "1999", "unstructured": "Robinson M. Current perspectives on hypergastrinemia and enterochromaffin-like-cell hyperplasia. Aliment Pharmacol Ther. 1999;13:5\u201310.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR175", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1159/000199387", "volume": "35", "author": "L Bardram", "year": "1986", "unstructured": "Bardram L, Thomsen P, Stadil F. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome. Digestion. 1986;35:116\u2013122.", "journal-title": "Digestion"}, {"key": "1560_CR176", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1016/0016-5085(85)90131-3", "volume": "88", "author": "K Borch", "year": "1985", "unstructured": "Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 1985;88:638\u2013648.", "journal-title": "Gastroenterology"}, {"key": "1560_CR177", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1016/0016-5085(93)90266-F", "volume": "104", "author": "G Rindi", "year": "1993", "unstructured": "Rindi G, Luinetti O, Cornaggia M, Capella C, Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994\u20131006.", "journal-title": "Gastroenterology"}, {"key": "1560_CR178", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1016/S0016-5085(00)70135-1", "volume": "118", "author": "EC Klinkenberg-Knol", "year": "2000", "unstructured": "Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118:661\u2013669.", "journal-title": "Gastroenterology"}, {"key": "1560_CR179", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1159/000200921", "volume": "51", "author": "E Solcia", "year": "1992", "unstructured": "Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion. 1992;51:82\u201392.", "journal-title": "Digestion"}, {"key": "1560_CR180", "unstructured": "Solcia E, Rindi G, Havu N, Elm G. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol Suppl. 1989;166:129\u2013137 (discussion 138\u2013129).", "DOI": "10.3109/00365528909091260", "doi-asserted-by": "crossref"}, {"key": "1560_CR181", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.3109/00365528609090884", "volume": "118", "author": "E Carlsson", "year": "1986", "unstructured": "Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G. Pharmacology and toxicology of omeprazole\u2013with special reference to the effects on the gastric mucosa. Scand J Gastroenterol Suppl. 1986;118:31\u201338.", "journal-title": "Scand J Gastroenterol Suppl"}, {"key": "1560_CR182", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1159/000200887", "volume": "51", "author": "H Lee", "year": "1992", "unstructured": "Lee H, Hakanson R, Karlsson A, Mattsson H, Sundler F. Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach. Digestion. 1992;51:125\u2013132.", "journal-title": "Digestion"}, {"key": "1560_CR183", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1016/0016-5085(91)90197-S", "volume": "100", "author": "H Mattsson", "year": "1991", "unstructured": "Mattsson H, Havu N, Brautigam J, Carlsson K, Lundell L, Carlsson E. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology. 1991;100:311\u2013319.", "journal-title": "Gastroenterology"}, {"key": "1560_CR184", "doi-asserted-by": "crossref", "first-page": "1284", "DOI": "10.1136/gut.26.12.1284", "volume": "26", "author": "D Poynter", "year": "1985", "unstructured": "Poynter D, Pick CR, Harcourt RA, et al. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut. 1985;26:1284\u20131295.", "journal-title": "Gut"}, {"key": "1560_CR185", "doi-asserted-by": "crossref", "first-page": "785", "DOI": "10.1113/jphysiol.1976.sp011495", "volume": "259", "author": "R Hakanson", "year": "1976", "unstructured": "Hakanson R, Larsson LI, Liedberg G, Oscarson J, Sundler F, Vang J. Effects of antrectomy or porta-caval shunting on the histamine-storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence histochemical, electron microscopic and chemical study. J Physiol. 1976;259:785\u2013800.", "journal-title": "J Physiol"}, {"key": "1560_CR186", "doi-asserted-by": "crossref", "first-page": "1089", "DOI": "10.3109/00365528809090174", "volume": "23", "author": "M Simonsson", "year": "1988", "unstructured": "Simonsson M, Eriksson S, Hakanson R, et al. Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol. 1988;23:1089\u20131099.", "journal-title": "Scand J Gastroenterol"}, {"key": "1560_CR187", "doi-asserted-by": "crossref", "first-page": "692", "DOI": "10.1002/ijc.2910430425", "volume": "43", "author": "SA Watson", "year": "1989", "unstructured": "Watson SA, Durrant LG, Crosbie JD, Morris DL. The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int J Cancer. 1989;43:692\u2013696.", "journal-title": "Int J Cancer"}, {"key": "1560_CR188", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1136/gut.41.3.330", "volume": "41", "author": "M Renga", "year": "1997", "unstructured": "Renga M, Brandi G, Paganelli GM, et al. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut. 1997;41:330\u2013332.", "journal-title": "Gut"}, {"key": "1560_CR189", "doi-asserted-by": "crossref", "first-page": "275", "DOI": "10.1016/S0016-5085(98)70193-3", "volume": "115", "author": "CM Thorburn", "year": "1998", "unstructured": "Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 1998;115:275\u2013280.", "journal-title": "Gastroenterology"}, {"key": "1560_CR190", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1111/j.1365-2036.2007.03450.x", "volume": "26", "author": "M Singh", "year": "2007", "unstructured": "Singh M, Dhindsa G, Friedland S, Triadafilopoulos G. Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas. Aliment Pharmacol Ther. 2007;26:1051\u20131061.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR191", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.1053/j.gastro.2007.06.022", "volume": "133", "author": "YX Yang", "year": "2007", "unstructured": "Yang YX, Hennessy S, Propert K, Hwang WT, Sedarat A, Lewis JD. Chronic proton pump inhibitor therapy and the risk of colorectal cancer. Gastroenterology. 2007;133:748\u2013754.", "journal-title": "Gastroenterology"}, {"key": "1560_CR192", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1053/j.gastro.2007.06.014", "volume": "133", "author": "DJ Robertson", "year": "2007", "unstructured": "Robertson DJ, Larsson H, Friis S, Pedersen L, Baron JA, Sorensen HT. Proton pump inhibitor use and risk of colorectal cancer: a population-based, case-control study. Gastroenterology. 2007;133:755\u2013760.", "journal-title": "Gastroenterology"}, {"key": "1560_CR193", "doi-asserted-by": "crossref", "first-page": "966", "DOI": "10.1111/j.1572-0241.2007.01665.x", "volume": "103", "author": "EM Soest van", "year": "2008", "unstructured": "van Soest EM, van Rossum LG, Dieleman JP, et al. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol. 2008;103:966\u2013973.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR194", "unstructured": "McCarthy DM, McLaughlin T, Yazdani C, El Serag HB, Griffis DL. Effects of co-therapy with early proton pump inhibitors (PPIs) on the occurrence of side effects of other drugs with potential for interaction with PPIs: a cohort study. Gastroenterology. 2002;122(4)(Suppl. 1):A210 (abstract S1345)."}, {"key": "1560_CR195", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1046/j.1365-2036.2003.01550.x", "volume": "17", "author": "J Labenz", "year": "2003", "unstructured": "Labenz J, Petersen KU, Rosch W, Koelz HR. A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole. Aliment Pharmacol Ther. 2003;17:1015\u20131019.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR196", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.2165/00002018-200629090-00002", "volume": "29", "author": "H Blume", "year": "2006", "unstructured": "Blume H, Donath F, Warnke A, Schug BS. Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf. 2006;29:769\u2013784.", "journal-title": "Drug Saf"}, {"key": "1560_CR197", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1007/s00228-008-0538-y", "volume": "64", "author": "S Shi", "year": "2008", "unstructured": "Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008;64:935\u2013951.", "journal-title": "Eur J Clin Pharmacol"}, {"key": "1560_CR198", "first-page": "595", "volume": "57", "author": "U Fuhr", "year": "2002", "unstructured": "Fuhr U, Jetter A. Rabeprazole: pharmacokinetics and pharmacokinetic drug interactions. Pharmazie. 2002;57:595\u2013601.", "journal-title": "Pharmazie"}, {"key": "1560_CR199", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.4158/EP.13.4.345", "volume": "13", "author": "I Sachmechi", "year": "2007", "unstructured": "Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism. Endocr Pract. 2007;13:345\u2013349.", "journal-title": "Endocr Pract"}, {"key": "1560_CR200", "doi-asserted-by": "crossref", "first-page": "1211", "DOI": "10.1038/ajg.2009.722", "volume": "105", "author": "AA Alkhatib", "year": "2010", "unstructured": "Alkhatib AA, Elkhatib FA, Khatib OF. Gastric acid-reducing medications and clopidogrel: what are the latest FDA recommendations? Am J Gastroenterol. 2010;105:1211.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR201", "unstructured": "Bhatt DL, Cryer B, Contant CF, et al. COGENT. COGENT: a prospective, randomized, placebo-controlled trial of omeprazole in patients receiving aspirin and clopidogrel [abstract]. Transvascular Cardiovascular Therapeutics Annual Meeting; September 24, 2009; San Francisco, CA. http://www.slideshare.net/flaviog/bhnt ."}, {"key": "1560_CR202", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1001/jama.2009.261", "volume": "301", "author": "PM Ho", "year": "2009", "unstructured": "Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301:937\u2013944.", "journal-title": "JAMA"}, {"key": "1560_CR203", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1016/S0140-6736(09)61525-7", "volume": "374", "author": "ML O\u2019Donoghue", "year": "2009", "unstructured": "O\u2019Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009;374:989\u2013997.", "journal-title": "Lancet"}, {"key": "1560_CR204", "doi-asserted-by": "crossref", "first-page": "2322", "DOI": "10.1161/CIRCULATIONAHA.109.873497", "volume": "120", "author": "JA Rassen", "year": "2009", "unstructured": "Rassen JA, Choudhry NK, Avorn J, Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009;120:2322\u20132329.", "journal-title": "Circulation"}, {"key": "1560_CR205", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.7326/0003-4819-152-6-201003160-00003", "volume": "152", "author": "WA Ray", "year": "2010", "unstructured": "Ray WA, Murray KT, Griffin MR, et al. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ann Intern Med. 2010;152:337\u2013345.", "journal-title": "Ann Intern Med"}, {"key": "1560_CR206", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1001/archinternmed.2010.34", "volume": "170", "author": "KM Stockl", "year": "2010", "unstructured": "Stockl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med. 2010;170:704\u2013710.", "journal-title": "Arch Intern Med"}, {"key": "1560_CR207", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1056/NEJMoa0809171", "volume": "360", "author": "JL Mega", "year": "2009", "unstructured": "Mega JL, Close SL, Wiviott SD, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354\u2013362.", "journal-title": "N Engl J Med"}, {"key": "1560_CR208", "doi-asserted-by": "crossref", "first-page": "1508", "DOI": "10.1001/archinternmed.2010.300", "volume": "170", "author": "StocklKM HA", "year": "2010", "unstructured": "HA StocklKM, Solow BK, Addiego JE, Ramsey S. Conflicting evidence surrounding the clopidogrel and proton pump inhibitor drug interaction\u2014reply. Arch Intern Med. 2010;170:1508.", "journal-title": "Arch Intern Med"}, {"key": "1560_CR209", "doi-asserted-by": "crossref", "first-page": "2395", "DOI": "10.1111/j.1572-0241.2007.01452.x", "volume": "102", "author": "E Rey", "year": "2007", "unstructured": "Rey E, Rodriguez-Artalejo F, Herraiz MA, et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol. 2007;102:2395\u20132400.", "journal-title": "Am J Gastroenterol"}, {"key": "1560_CR210", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1111/j.1365-2036.2005.02306.x", "volume": "21", "author": "O Diav-Citrin", "year": "2005", "unstructured": "Diav-Citrin O, Arnon J, Shechtman S, et al. The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther. 2005;21:269\u2013275.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR211", "doi-asserted-by": "crossref", "first-page": "877", "DOI": "10.1111/j.1471-0528.1998.tb10233.x", "volume": "105", "author": "B Kallen", "year": "1998", "unstructured": "Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special reference to omeprazole. Br J Obstet Gynaecol. 1998;105:877\u2013881.", "journal-title": "Br J Obstet Gynaecol"}, {"key": "1560_CR212", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S0301-2115(00)00388-2", "volume": "96", "author": "BA Kallen", "year": "2001", "unstructured": "Kallen BA. Use of omeprazole during pregnancy\u2013no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2001;96:63\u201368.", "journal-title": "Eur J Obstet Gynecol Reprod Biol"}, {"key": "1560_CR213", "doi-asserted-by": "crossref", "first-page": "727", "DOI": "10.1016/S0002-9378(98)70072-9", "volume": "179", "author": "A Lalkin", "year": "1998", "unstructured": "Lalkin A, Loebstein R, Addis A, et al. The safety of omeprazole during pregnancy: a multicenter prospective controlled study. Am J Obstet Gynecol. 1998;179:727\u2013730.", "journal-title": "Am J Obstet Gynecol"}, {"key": "1560_CR214", "doi-asserted-by": "crossref", "first-page": "1085", "DOI": "10.1046/j.1365-2036.1999.00578.x", "volume": "13", "author": "GL Nielsen", "year": "1999", "unstructured": "Nielsen GL, Sorensen HT, Thulstrup AM, Tage-Jensen U, Olesen C, Ekbom A. The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther. 1999;13:1085\u20131089.", "journal-title": "Aliment Pharmacol Ther"}, {"key": "1560_CR215", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1023/A:1015863018105", "volume": "47", "author": "S Nikfar", "year": "2002", "unstructured": "Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G. Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci. 2002;47:1526\u20131529.", "journal-title": "Dig Dis Sci"}, {"key": "1560_CR216", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1093/oxfordjournals.aje.a010036", "volume": "150", "author": "A Ruigomez", "year": "1999", "unstructured": "Ruigomez A, Garcia Rodriguez LA, Cattaruzzi C, et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol. 1999;150:476\u2013481.", "journal-title": "Am J Epidemiol"}, {"key": "1560_CR217", "unstructured": "Gill SK, O\u2019Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol. 2009;104:1541\u20131545 (quiz 1540, 1546)."}, {"key": "1560_CR218", "doi-asserted-by": "crossref", "first-page": "2114", "DOI": "10.1056/NEJMoa1002689", "volume": "363", "author": "B Pasternak", "year": "2010", "unstructured": "Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363:2114\u20132123.", "journal-title": "N Engl J Med"}, {"key": "1560_CR219", "unstructured": "Mitchell AA. Studies of drug-induced birth defects, chapter 32. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. New York: Wiley; 2005:501\u2013515.", "DOI": "10.1002/9780470059876.ch32", "doi-asserted-by": "crossref"}, {"key": "1560_CR220", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1111/j.1365-2222.2008.03125.x", "volume": "39", "author": "E Dehlink", "year": "2009", "unstructured": "Dehlink E, Yen E, Leichtner AM, Hait EJ, Fiebiger E. First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study. Clin Exp Allergy. 2009;39:246\u2013253.", "journal-title": "Clin Exp Allergy"}], "container-title": ["Digestive Diseases and Sciences"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s10620-010-1560-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s10620-010-1560-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s10620-010-1560-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 8]], "date-time": "2019-06-08T23:26:50Z", "timestamp": 1560036410000}, "score": 54.960274, "issued": {"date-parts": [[2011, 3, 2]]}, "references-count": 220, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "4"}, "alternative-id": ["1560"], "URL": "http://dx.doi.org/10.1007/s10620-010-1560-3", "relation": {"cites": []}, "ISSN": ["0163-2116", "1573-2568"], "issn-type": [{"value": "0163-2116", "type": "print"}, {"value": "1573-2568", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:23:34Z", "timestamp": 1574108614669}, "reference-count": 0, "publisher": "BMJ", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "published-print": {"date-parts": [[2004, 1, 1]]}, "DOI": "10.1136/gut.53.1.5", "type": "journal-article", "created": {"date-parts": [[2003, 12, 18]], "date-time": "2003-12-18T23:23:28Z", "timestamp": 1071789808000}, "page": "5-7", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Helicobacter pylori infection and long term proton pump inhibitor therapy"], "prefix": "10.1136", "volume": "53", "author": [{"given": "K E L", "family": "McColl", "sequence": "first", "affiliation": []}], "member": "239", "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.53.1.5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T21:21:00Z", "timestamp": 1482528060000}, "score": 41.11911, "issued": {"date-parts": [[2004, 1, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 1, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1136/gut.53.1.5", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:50:47Z", "timestamp": 1574398247036}, "publisher-location": "Dordrecht", "reference-count": 67, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9789401057530", "type": "print"}, {"value": "9789401139274", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2000]]}, "DOI": "10.1007/978-94-011-3927-4_28", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 13]], "date-time": "2011-09-13T17:03:36Z", "timestamp": 1315933416000}, "page": "255-267", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Long-term proton pump inhibitor therapy accelerates the onset of atrophic gastritis in Helicobacter pylori -positive patients"], "prefix": "10.1007", "author": [{"given": "E. J.", "family": "Kuipers", "sequence": "first", "affiliation": []}, {"given": "S. G. M.", "family": "Meuwissen", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "28_CR1", "author": "SE Sj\u00f6strand", "first-page": "3", "year": "1999", "unstructured": "Sj\u00f6strand SE, Olbe L, Fellenius E. The discovery and development of the proton pump inhibitor. In: Olbe L, editor. Proton Pump Inhibitors. Basel: Birkh\u00e4user Verlag; 1999:3\u201320.", "volume-title": "Proton Pump Inhibitors", "DOI": "10.1007/978-3-0348-8795-3_1", "doi-asserted-by": "publisher"}, {"key": "28_CR2", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1080/00365521.1984.12005824", "volume": "19", "author": "O Bonnevie", "year": "1984", "unstructured": "Bonnevie O, Nielsen AM, Matzen P et al. Gastric acid secretion and duodenal ulcer healing duringjreatment with omeprazole. Scand J Gastroenterol. 1984;19:882\u2013884.", "journal-title": "Scand J Gastroenterol."}, {"issue": "3", "key": "28_CR3", "first-page": "101", "volume": "59", "author": "GJB Hurenkamp", "year": "1998", "unstructured": "Hurenkamp GJB, Grundmeyer HGLM, Bindels PJE, Tytgat GNJ, van der Hulst RWM. A population-based inventarisation oflongterm acid suppressant use in 24 general practices in the Netherlands. Digestion. 1998;59(Suppl. 3):101.", "journal-title": "Digestion"}, {"issue": "1", "key": "28_CR4", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1159/000200921", "volume": "51", "author": "E Solcia", "year": "1992", "unstructured": "Solcia E, Fiocca R, Havu N, Dalv\u00e4g A, Carlsson R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion. 1992;51(Suppl. 1):82\u201392.", "journal-title": "Digestion"}, {"key": "28_CR5", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.1016/0016-5085(93)90344-C", "volume": "104", "author": "R Lamberts", "year": "1993", "unstructured": "Lamberts R, Creutzfeld W, Stoiber HG, Brunner G, Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 1993;104:1356\u20131370.", "journal-title": "Gastroenterology."}, {"key": "28_CR6", "first-page": "308", "volume": "89", "author": "IM Modlin", "year": "1994", "unstructured": "Modlin IM, Goldenring JR, Lawton GP, Hunt R. Aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol. 1994;89:308\u2013318.", "journal-title": "Am J Gastroenterol."}, {"key": "28_CR7", "doi-asserted-by": "publisher", "first-page": "1217", "DOI": "10.1016/S0016-5085(99)70025-9", "volume": "116", "author": "SOJ Veldhuyzen van Zanten", "year": "1999", "unstructured": "Veldhuyzen van Zanten SOJ, Dixon MF, Lee A. The gastric transitional zones: neglected links between gastroduodenal pathology and Helicobacter ecology. Gastroenterology. 1999;116:1217\u20131229.", "journal-title": "Gastroenterology."}, {"issue": "201", "key": "28_CR8", "doi-asserted-by": "publisher", "first-page": "28", "DOI": "10.3109/00365529409105357", "volume": "29", "author": "E Solcia", "year": "1994", "unstructured": "Solcia E, Villani L, Fiocca R et al Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol. 1994;29(Suppl. 201):28\u201334.", "journal-title": "Scand J Gastroenterol"}, {"key": "28_CR9", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1136/gut.36.1.12", "volume": "36", "author": "RPH Logan", "year": "1995", "unstructured": "Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995;36:12\u201316.", "journal-title": "Gut."}, {"key": "28_CR10", "first-page": "1401", "volume": "90", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, Uyterlinde AM, Pena AS et al. Increase of Helicobacter pylori associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90:1401\u20131406.", "journal-title": "Am J Gastroenterol."}, {"key": "28_CR11", "first-page": "181", "volume": "10", "author": "M Roland", "year": "1975", "unstructured": "Roland M, Berstad A, Liavag I. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol. 1975;10:181\u2013186.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR12", "first-page": "297", "volume": "153", "author": "R Jorde", "year": "1987", "unstructured": "Jorde R, Johnson JA, Bostad LH, Burhol PG. An endoscopic study of ulcer recurrence and mucosal changes following vagotomy and excision of gastric ulcer. Acta Chir Scand. 1987;153:297\u2013302.", "journal-title": "Acta Chir Scand."}, {"key": "28_CR13", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1080/00365521.1984.12005809", "volume": "19", "author": "M \u00c4\u00e4rimaa", "year": "1984", "unstructured": "\u00c4\u00e4rimaa M, S\u00f6derstr\u00f6m KO, Kalimo H, Inberg M. Morphology and function of the parietal cells after proximal selective vagotomy in duodenal ulcer patients. Scand J Gastroenterol. 1984;19:787\u2013797.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR14", "doi-asserted-by": "publisher", "first-page": "947", "DOI": "10.3109/00365527809181374", "volume": "13", "author": "O Hart Hansen", "year": "1978", "unstructured": "Hart Hansen O, Larsen JK, Svendsen LB. Changes in gastric mucosal cell proliferation after antrectomy or vagotomy in man. Scand J Gastroenterol. 1978;13:947\u2013952.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR15", "doi-asserted-by": "publisher", "first-page": "628", "DOI": "10.1016/S0016-5085(98)70142-8", "volume": "115", "author": "M Rektorschek", "year": "1998", "unstructured": "Rektorschek M, Weeks D, Sachs G, Melchers K. Influence of pH on metabolism and urease activity of Helicobacter pylori. Gastroenterology. 1998;115:628\u2013641.", "journal-title": "Gastroenterology."}, {"key": "28_CR16", "doi-asserted-by": "publisher", "first-page": "735", "DOI": "10.1046/j.1365-2036.1998.00370.x", "volume": "12", "author": "A Meining", "year": "1998", "unstructured": "Meining A, Kiel G, Stolte M. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease. Aliment Pharmacol Ther. 1998;12:735\u2013740.", "journal-title": "Aliment Pharmacol Ther."}, {"key": "28_CR17", "first-page": "A127", "volume": "110", "author": "A Hackelsberger", "year": "1996", "unstructured": "Hackelsberger A, Miehlke S, Len N et al. Helicobacter pylori eradication vs short term acid suppression: long term consequences for gastric body mucosa. Gastroenterology. 1996; 110:A127 (abstract).", "journal-title": "Gastroenterology"}, {"key": "28_CR18", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1016/S0016-5085(99)70118-6", "volume": "116", "author": "D Gillen", "year": "1999", "unstructured": "Gillen D, Wirz AA, Ardill JE, McColl KEL. Rebound hypers\u00e9cr\u00e9tion post-omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology. 1999;116:239\u2013247.", "journal-title": "Gastroenterology."}, {"key": "28_CR19", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1016/S0140-6736(75)90498-5", "volume": "2", "author": "P Correa", "year": "1975", "unstructured": "Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet. 1975;2:58\u201359.", "journal-title": "Lancet."}, {"key": "28_CR20", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.3109/00365528209181065", "volume": "17", "author": "K Villako", "year": "1982", "unstructured": "Villako K, Kekki M, Tamm A et al. Epidemiology and dynamics of gastritis in a random sample of an Estonian urban population. Scand J Gastroenterol. 1982;17:601\u2013607.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR21", "first-page": "4737", "volume": "50", "author": "P Correa", "year": "1990", "unstructured": "Correa P, Haenszel W, Cuello C et al. Gastric precancerous process in a high-risk population: cohort follow-up. Cancer Res. 1990;50:4737\u20134740.", "journal-title": "Cancer Res."}, {"key": "28_CR22", "doi-asserted-by": "publisher", "first-page": "1525", "DOI": "10.1016/S0140-6736(95)91084-0", "volume": "345", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, Uyterlinde AM, Pena AS et al. Long term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345:1525\u20131528.", "journal-title": "Lancet."}, {"key": "28_CR23", "unstructured": "McFarlane GA, Wyatt J, Forman D, Lachlan GW. Trends over time in H. pylori gastritis in Kenya. Eur J Gastroenterol Hepatol. 1999;12 (In press).", "DOI": "10.1097/00042737-200012060-00007", "doi-asserted-by": "crossref"}, {"key": "28_CR24", "doi-asserted-by": "publisher", "first-page": "1777", "DOI": "10.1093/jnci/87.23.1777", "volume": "87", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, P\u00e9rez-P\u00e9rez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777\u20131780.", "journal-title": "J Natl Cancer Inst."}, {"key": "28_CR25", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1093/jnci/88.7.465", "volume": "88", "author": "A Ponzetto", "year": "1996", "unstructured": "Ponzetto A, DeGiuli M, Sanseverino P, Soldati T, Bazzoli F. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1996;88:465\u2013466.", "journal-title": "J Natl Cancer Inst."}, {"key": "28_CR26", "doi-asserted-by": "publisher", "first-page": "864", "DOI": "10.1080/003655299750025318", "volume": "34", "author": "HI Maaroos", "year": "1999", "unstructured": "Maaroos HI, Vorobjova T, Sipponen P et al. An 18-year follow-up study of chronic gastritis and Helicobacter pylori: association of CagA positivity with development of atrophy and activity of gastritis. Scand J Gastroenterol. 1999;34:864\u2013869.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR27", "first-page": "645", "volume": "8", "author": "ILP Beales", "year": "1996", "unstructured": "Beales ILP, Crabtree JE, Scunes D, Covacci A, Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1996;8:645\u2013649.", "journal-title": "Eur J Gastroenterol Hepatol."}, {"key": "28_CR28", "doi-asserted-by": "publisher", "first-page": "375", "DOI": "10.1111/j.1572-0241.1998.00375.x", "volume": "93", "author": "M Sozzi", "year": "1998", "unstructured": "Sozzi M, Valentini M, Figura N et al. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Am J Gastroenterol. 1998;93:375\u2013379.", "journal-title": "Am J Gastroenterol."}, {"key": "28_CR29", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1136/gut.41.4.442", "volume": "41", "author": "Y Yamaoka", "year": "1997", "unstructured": "Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut. 1997;41:442\u2013451.", "journal-title": "Gut."}, {"key": "28_CR30", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1136/jcp.51.1.55", "volume": "51", "author": "VJ Warburton", "year": "1998", "unstructured": "Warburton VJ, Everett S, Mapstone NP, Axon AT, Hawkey P, Dixon MF. Clinical and histological association of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol. 1998;51:55\u201361.", "journal-title": "J Clin Pathol"}, {"issue": "1", "key": "28_CR31", "doi-asserted-by": "publisher", "first-page": "64", "DOI": "10.1159/000200520", "volume": "47", "author": "GHG Brunner", "year": "1990", "unstructured": "Brunner GHG, Lamberts R, Creutzfeldt W. Efficacy and safety of omeprazole in long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. Digestion. 1990; 47(Suppl. 1):64\u201368.", "journal-title": "Digestion"}, {"key": "28_CR32", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.7326/0003-4819-121-3-199408010-00001", "volume": "121", "author": "EC Klinkenberg-Knol", "year": "1994", "unstructured": "Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ et al. Eflicacy and safety of long-term treatment with omeprazole for refractory reflux esophagitis. Ann Intern Med. 1994;121:161\u2013167.", "journal-title": "Ann Intern Med."}, {"key": "28_CR33", "doi-asserted-by": "publisher", "first-page": "232", "DOI": "10.7326/0003-4819-121-3-199408010-00012", "volume": "121", "author": "JW Freston", "year": "1994", "unstructured": "Freston JW. Omeprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med. 1994;121:232\u2013233.", "journal-title": "Ann Intern Med."}, {"key": "28_CR34", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.3109/00365528809093891", "volume": "23", "author": "K J\u00f6nsson", "year": "1988", "unstructured": "J\u00f6nsson K\u00c5, Str\u00f6m M, Bodemar G, Norrby K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol. 1988;23:433\u2013441.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR35", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1111/j.1365-2036.1995.tb00391.x", "volume": "9", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, Lee A, Klinkenberg-Knol EC, Meuwissen SGM. Review article: The development of atrophic gastritis \u2014 Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther. 1995;9:331\u2013340.", "journal-title": "Aliment Pharmacol Ther."}, {"key": "28_CR36", "doi-asserted-by": "publisher", "first-page": "1018", "DOI": "10.1056/NEJM199604183341603", "volume": "334", "author": "EJ Kuipers", "year": "1996", "unstructured": "Kuipers EJ, Lundell L, Klinkenberg-Knol EC et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018\u20131022.", "journal-title": "N Engl J Med."}, {"key": "28_CR37", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1053/gast.1997.v112.pm9041231", "volume": "112", "author": "R Eissele", "year": "1997", "unstructured": "Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil-cell hyperplasia. Gastroenterology. 1997;112:707\u2013717.", "journal-title": "Gastroenterology."}, {"key": "28_CR38", "doi-asserted-by": "publisher", "first-page": "740", "DOI": "10.1136/gut.41.6.740", "volume": "41", "author": "AE Berstad", "year": "1997", "unstructured": "Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut. 1997;41:740\u2013747.", "journal-title": "Gut."}, {"key": "28_CR39", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1016/S0016-5085(00)70135-1", "volume": "118", "author": "EC Klinkenberg-Knol", "year": "2000", "unstructured": "Klinkenberg-Knol EC, Nelis F, Dent J et al. Experience with omeprazole in the treatment of resistant gastroesophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology. 2000;118:661\u2013669.", "journal-title": "Gastroenterology."}, {"key": "28_CR40", "first-page": "A185", "volume": "112", "author": "EJ Kuipers", "year": "1997", "unstructured": "Kuipers EJ, Schenk BE, P\u00e9rez-P\u00e9rez GI, Roosendaal R, Meuwissen SGM, Blaser MJ. The relation of H. pylori CagA and HspA serum antibodies with age and development of atrophic gastritis during profound acid suppressive maintenance therapy. Gastroenterology. 1997;112:A185 (abstract).", "journal-title": "Gastroenterology"}, {"key": "28_CR41", "first-page": "1629", "volume": "43", "author": "M-D Diebold", "year": "1998", "unstructured": "Diebold M-D, Richardson S, Duchateau A et al. Factors influencing corpus argyrophil cell density and hyperplasia in reflux esophagitis patients treated with antisecretory drugs. Dig Dis Sci. 1998;43:1629\u20131635.", "journal-title": "Dig Dis Sci."}, {"key": "28_CR42", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1046/j.1365-2036.1998.00310.x", "volume": "12", "author": "M Stolte", "year": "1998", "unstructured": "Stolte M, Meining A, Schmitz JM, Alexandridis T, Seifert E. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998;12:247\u2013253.", "journal-title": "Aliment Pharmacol Ther."}, {"key": "28_CR43", "doi-asserted-by": "publisher", "first-page": "830", "DOI": "10.1002/bjs.1800830633", "volume": "83", "author": "L Lundell", "year": "1996", "unstructured": "Lundell L, Abrahamsson H, Ruth M, Rydberg L, L\u00f6nroth H, Olbe L. Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundo-plication (Toupet) for gastro-oesophageal reflux. Br J Surg. 1996;83:830\u2013835.", "journal-title": "Br J Surg."}, {"key": "28_CR44", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1053/gast.1999.0029900319", "volume": "117", "author": "L Lundell", "year": "1999", "unstructured": "Lundell L, Miettinen P, Myrvol HE et al. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology. 1999;117:319\u2013326.", "journal-title": "Gastroenterology."}, {"key": "28_CR45", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1016/S0016-5085(00)70443-4", "volume": "118", "author": "RE Pounder", "year": "2000", "unstructured": "Pounder RE, Williams MP. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology. 2000;118:238\u2013239.", "journal-title": "Gastroenterology."}, {"key": "28_CR46", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1016/S0016-5085(00)70444-6", "volume": "118", "author": "KEL McColl", "year": "2000", "unstructured": "McColl KEL, Murray LS, Gillen D. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology. 2000;118:239.", "journal-title": "Gastroenterology"}, {"key": "28_CR47", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1016/S0016-5085(00)70445-8", "volume": "118", "author": "EJ Kuipers", "year": "2000", "unstructured": "Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SGM. Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology. 2000;118:239\u2013240.", "journal-title": "Gastroenterology."}, {"key": "28_CR48", "doi-asserted-by": "publisher", "first-page": "242", "DOI": "10.1016/S0016-5085(00)70447-1", "volume": "118", "author": "M Stolte", "year": "2000", "unstructured": "Stolte M, Meining A. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology. 2000;118:242\u2013243.", "journal-title": "Gastroenterology."}, {"key": "28_CR49", "first-page": "A771", "volume": "112", "author": "L Lundell", "year": "1997", "unstructured": "Lundell L, Havu N, Andersson A et al. Gastritis development and acid suppression therapy revisited. Results of a randomized clinical study with long-term follow-up. Gastroenterology. 1997;112:A771.", "journal-title": "Gastroenterology"}, {"key": "28_CR50", "first-page": "A214", "volume": "118", "author": "L Lundell", "year": "2000", "unstructured": "Lundell L, Havu N, Miettinen P et al. No effect of acid suppression therapy over five years on gastric glandular atrophy. Results of a randomised clinical study. Gut. 2000; 118:A214.", "journal-title": "Gut"}, {"issue": "1", "key": "28_CR51", "doi-asserted-by": "publisher", "first-page": "S35", "DOI": "10.1136/gut.43.2008.S35", "volume": "43", "author": "RM Genta", "year": "1998", "unstructured": "Genta RM. Acid suppression and gastric atrophy: sifting fact from fiction. Gut. 1998; 43(Suppl. 1):S35\u20138.", "journal-title": "Gut"}, {"key": "28_CR52", "doi-asserted-by": "publisher", "first-page": "716", "DOI": "10.1093/ije/26.4.716", "volume": "26", "author": "M Plummer", "year": "1997", "unstructured": "Plummer M, Buiatti E, Lopez G et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol. 1997;26:716\u2013720.", "journal-title": "Int J Epidemiol."}, {"key": "28_CR53", "doi-asserted-by": "publisher", "first-page": "320", "DOI": "10.1046/j.1365-2559.1999.00635.x", "volume": "34", "author": "GJA Offerhaus", "year": "1999", "unstructured": "Offerhaus GJA, Price AB, Haot J et al. Observer agreement on the grading of gastric atrophy. Histopathology. 1999;34:320\u2013325.", "journal-title": "Histopathology."}, {"key": "28_CR54", "doi-asserted-by": "publisher", "first-page": "1431", "DOI": "10.1016/S0046-8177(99)90164-8", "volume": "30", "author": "J Guarner", "year": "1999", "unstructured": "Guarner J, Herrera-Goepfert R, Mohar A et al. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol. 1999;30:1431\u20131434.", "journal-title": "Hum Pathol."}, {"key": "28_CR55", "unstructured": "van Grieken NCT, Weiss MM, Meijer GA et al Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol. 2000 (in press)."}, {"key": "28_CR56", "doi-asserted-by": "publisher", "first-page": "1343", "DOI": "10.1046/j.1365-2036.1999.00616.x", "volume": "13", "author": "BE Schenk", "year": "1999", "unstructured": "Schenk BE, Kuipers EJ, Klinkenberg-Knol EC et al. Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels. Aliment Pharmacol Ther. 1999;13:1343\u20131346.", "journal-title": "Aliment Pharmacol Ther."}, {"key": "28_CR57", "doi-asserted-by": "publisher", "first-page": "546", "DOI": "10.3109/00365529609009126", "volume": "31", "author": "J Valle", "year": "1996", "unstructured": "Valle J, Kekki M, Sipponen P, Iham\u00e4ki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Scand J Gastroenterol. 1996;31:546\u2013550.", "journal-title": "Scand J Gastroenterol."}, {"key": "28_CR58", "doi-asserted-by": "publisher", "first-page": "36", "DOI": "10.1016/S0016-5085(00)70412-4", "volume": "118", "author": "TC Wang", "year": "2000", "unstructured": "Wang TC, Dangler CA, Chen D et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 2000;118:36\u201347.", "journal-title": "Gastroenterology."}, {"key": "28_CR59", "first-page": "217", "volume": "88", "author": "P Sipponen", "year": "1980", "unstructured": "Sipponen P, Sepp\u00e4l\u00e4 K, Varis K et al. Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa; its association with gastric carcinoma. Acta Pathol Microbiol Scand. 1980;88:217\u2013224.", "journal-title": "Acta Pathol Microbiol Scand."}, {"key": "28_CR60", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1002/ijc.2910570306", "volume": "57", "author": "MI Filipe", "year": "1994", "unstructured": "Filipe MI, Munoz N, Matko I et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 1994;57:324\u2013329.", "journal-title": "Int J Cancer."}, {"key": "28_CR61", "author": "MF Dixon", "first-page": "336", "year": "1998", "unstructured": "Dixon MF. Atrophy, metaplasia and dysplasia \u2014 a risk for gastric cancer: are they reversible? In: Hunt RH, Tytgat GNJ, editors. Helicobacter pylori. Basic Mechanisms to Clinical Cure. Dordrecht: Kluwer; 1998:336\u2013353.", "volume-title": "Helicobacter pylori. Basic Mechanisms to Clinical Cure", "DOI": "10.1007/978-94-011-4882-5_36", "doi-asserted-by": "crossref"}, {"key": "28_CR62", "doi-asserted-by": "publisher", "first-page": "1271", "DOI": "10.1111/j.1365-2559.1986.tb02570.x", "volume": "10", "author": "N Ectors", "year": "1986", "unstructured": "Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology. 1986;10:1271\u20131277.", "journal-title": "Histopathology."}, {"key": "28_CR63", "doi-asserted-by": "publisher", "first-page": "311", "DOI": "10.1007/s004280050171", "volume": "432", "author": "A Meining", "year": "1998", "unstructured": "Meining A, Bayerd\u00f6rffer E, M\u00fcller P et al. Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virch Arch. 1998;432:311\u2013314.", "journal-title": "Virch Arch."}, {"key": "28_CR64", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1016/S0016-5085(97)70075-1", "volume": "113", "author": "EM El-Omar", "year": "1997", "unstructured": "El-Omar EM, Oien K, El-Nujumi A et al. Helicobacter pylori infection and chronic acid hyposecretion. Gastroenterology. 1997;113:15\u201324.", "journal-title": "Gastroenterology."}, {"key": "28_CR65", "doi-asserted-by": "publisher", "first-page": "8", "DOI": "10.1136/gut.41.1.8", "volume": "41", "author": "P Malfertheiner", "year": "1997", "unstructured": "Malfertheiner P. Current European concepts in the management of Helicobacter pylori infection: the Maastricht consensus report. Gut. 1997;41:8\u201313.", "journal-title": "Gut."}, {"key": "28_CR66", "first-page": "A117", "volume": "116", "author": "ATR Axon", "year": "1999", "unstructured": "Axon ATR, Bardhan K, Moayeddi P, Dixon MF. Does eradication of H. pylori influence the recurrence of symptoms in patients with symptomatic gastro-oesophageal reflux disease? \u2014 A randomised double blind study. Gastroenterology. 1999;116:A117 (abstract).", "journal-title": "Gastroenterology"}, {"key": "28_CR67", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1136/gut.46.5.615", "volume": "46", "author": "BE Schenk", "year": "2000", "unstructured": "Schenk BE, Kuipers EJ, Nelis GF et al. Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut. 2000;46:615\u2013621.", "journal-title": "Gut."}], "container-title": ["Helicobacter pylori"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-94-011-3927-4_28", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 15]], "date-time": "2019-06-15T12:42:50Z", "timestamp": 1560602570000}, "score": 35.13134, "issued": {"date-parts": [[2000]]}, "ISBN": ["9789401057530", "9789401139274"], "references-count": 67, "URL": "http://dx.doi.org/10.1007/978-94-011-3927-4_28", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T04:46:33Z", "timestamp": 1575434793614}, "reference-count": 150, "publisher": "Springer Science and Business Media LLC", "issue": "7", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2019, 4, 10]], "date-time": "2019-04-10T00:00:00Z", "timestamp": 1554854400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Drugs"], "published-print": {"date-parts": [[2019, 5]]}, "DOI": "10.1007/s40265-019-01110-3", "type": "journal-article", "created": {"date-parts": [[2019, 4, 10]], "date-time": "2019-04-10T19:14:41Z", "timestamp": 1554923681000}, "page": "715-731", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["The Clinician\u2019s Guide to Proton Pump Inhibitor Related Adverse Events"], "prefix": "10.1007", "volume": "79", "author": [{"given": "Evan", "family": "Elias", "sequence": "first", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0002-4366-9076", "authenticated-orcid": false, "given": "Laura E.", "family": "Targownik", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 4, 10]]}, "reference": [{"key": "1110_CR1", "unstructured": "IMS Institute for Healthcare Informatics. Declining medicine use and costs: For better or worse? A review of the use of medicines in the United States in 2012. Burlington, MA."}, {"issue": "9", "key": "1110_CR2", "first-page": "717", "volume": "72", "author": "GT Schumock", "year": "2015", "unstructured": "Schumock GT, Li EC, Suda KJ, Wiest MD, Stubbings J, Matusiak LM, et al. National trends in prescription drug expenditures and projections for 2015. AJHP. 2015;72(9):717\u201336.", "journal-title": "AJHP"}, {"issue": "6", "key": "1110_CR3", "first-page": "F812", "volume": "276", "author": "F Jaisser", "year": "1999", "unstructured": "Jaisser F, Beggah AT. The nongastric H+-K+-ATPases: molecular and functional properties. Am J Physiol. 1999;276(6):F812\u201324.", "journal-title": "Am J Physiol"}, {"issue": "1", "key": "1110_CR4", "doi-asserted-by": "publisher", "first-page": "280", "DOI": "10.1074/jbc.M110.136382", "volume": "286", "author": "I Novak", "year": "2011", "unstructured": "Novak I, Wang J, Henriksen KL, Haanes KA, Krabbe S, Nitschke R, et al. Pancreatic bicarbonate secretion involves two proton pumps. J Biol Chem. 2011;286(1):280\u20139.", "journal-title": "J Biol Chem"}, {"issue": "5", "key": "1110_CR5", "doi-asserted-by": "publisher", "first-page": "e0126432", "DOI": "10.1371/journal.pone.0126432", "volume": "10", "author": "J Wang", "year": "2015", "unstructured": "Wang J, Barbuskaite D, Tozzi M, Giannuzzo A, Sorensen CE, Novak I. Proton pump inhibitors inhibit pancreatic secretion: role of gastric and non-gastric H+/K+-ATPases. PLoS One. 2015;10(5):e0126432.", "journal-title": "PLoS One"}, {"issue": "2", "key": "1110_CR6", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1111/j.1365-2036.1990.tb00457.x", "volume": "4", "author": "H Koop", "year": "1990", "unstructured": "Koop H, Klein M, Arnold R. Serum gastrin levels during long-term omeprazole treatment. Aliment Pharmacol Ther. 1990;4(2):131\u20138.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "6", "key": "1110_CR7", "doi-asserted-by": "publisher", "first-page": "649", "DOI": "10.1111/apt.13324", "volume": "42", "author": "L Lundell", "year": "2015", "unstructured": "Lundell L, Vieth M, Gibson F, Nagy P, Kahrilas PJ. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther. 2015;42(6):649\u201363.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "1110_CR8", "doi-asserted-by": "publisher", "first-page": "379", "DOI": "10.1046/j.1365-2036.2001.00888.x", "volume": "15", "author": "S Sanduleanu", "year": "2001", "unstructured": "Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW. Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001;15(3):379\u201388.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "6447", "key": "1110_CR9", "doi-asserted-by": "publisher", "first-page": "717", "DOI": "10.1136/bmj.289.6447.717", "volume": "289", "author": "BK Sharma", "year": "1984", "unstructured": "Sharma BK, Santana IA, Wood EC, Walt RP, Pereira M, Noone P, et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. BMJ. 1984;289(6447):717\u20139.", "journal-title": "BMJ"}, {"issue": "Suppl", "key": "1110_CR10", "doi-asserted-by": "publisher", "first-page": "S18", "DOI": "10.1097/MCG.0b013e318267b55d", "volume": "46", "author": "M Piano Del", "year": "2012", "unstructured": "Del Piano M, Anderloni A, Balzarini M, Ballare M, Carmagnola S, Montino F, et al. The innovative potential of Lactobacillus rhamnosus LR06, Lactobacillus pentosus LPS01, Lactobacillus plantarum LP01, and Lactobacillus delbrueckii Subsp. delbrueckii LDD01 to restore the \u201cgastric barrier effect\u201d in patients chronically treated with PPI: a pilot study. J Clin Gastroenterol. 2012;46(Suppl):S18\u201326.", "journal-title": "J Clin Gastroenterol."}, {"issue": "1", "key": "1110_CR11", "doi-asserted-by": "publisher", "first-page": "84", "DOI": "10.2174/138920009787048392", "volume": "10", "author": "BJ Vesper", "year": "2009", "unstructured": "Vesper BJ, Jawdi A, Altman KW, Haines GK 3rd, Tao L, Radosevich JA. The effect of proton pump inhibitors on the human microbiota. Curr Drug Metab. 2009;10(1):84\u20139.", "journal-title": "Curr Drug Metab"}, {"issue": "4", "key": "1110_CR12", "doi-asserted-by": "publisher", "first-page": "599", "DOI": "10.1097/MLG.0b013e318161f9bf", "volume": "118", "author": "KW Altman", "year": "2008", "unstructured": "Altman KW, Chhaya V, Hammer ND, Pavlova S, Vesper BJ, Tao L, et al. Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains. Laryngoscope. 2008;118(4):599\u2013604.", "journal-title": "Laryngoscope"}, {"issue": "11", "key": "1110_CR13", "doi-asserted-by": "publisher", "first-page": "e1006653", "DOI": "10.1371/journal.ppat.1006653", "volume": "13", "author": "BN Parsons", "year": "2017", "unstructured": "Parsons BN, Ijaz UZ, D\u2019Amore R, Burkitt MD, Eccles R, Lenzi L, et al. Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use. PLoS Pathog. 2017;13(11):e1006653.", "journal-title": "PLoS Pathog"}, {"issue": "10", "key": "1110_CR14", "doi-asserted-by": "publisher", "first-page": "1331", "DOI": "10.1136/gut.33.10.1331", "volume": "33", "author": "E Husebye", "year": "1992", "unstructured": "Husebye E, Skar V, Hoverstad T, Melby K. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992;33(10):1331\u20137.", "journal-title": "Gut"}, {"issue": "9", "key": "1110_CR15", "doi-asserted-by": "publisher", "first-page": "875", "DOI": "10.3109/00365529609051995", "volume": "31", "author": "PO Stotzer", "year": "1996", "unstructured": "Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31(9):875\u201380.", "journal-title": "Scand J Gastroenterol"}, {"issue": "1", "key": "1110_CR16", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1097/00004836-200007000-00015", "volume": "31", "author": "F Castiglione", "year": "2000", "unstructured": "Castiglione F, Del Vecchio Blanco G, Rispo A, Petrelli G, Amalfi G, Cozzolino A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn\u2019s disease. J Clin Gastroenterol. 2000;31(1):63\u20136.", "journal-title": "J Clin Gastroenterol"}, {"issue": "6", "key": "1110_CR17", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1002/bjs.1800650619", "volume": "65", "author": "GA McLoughlin", "year": "1978", "unstructured": "McLoughlin GA, Hede JE, Temple JG, Bradley J, Chapman DM, McFarland J. The role of IgA in the prevention of bacterial colonization of the jejunum in the vagotomized subject. Br J Surg. 1978;65(6):435\u20137.", "journal-title": "Br J Surg."}, {"issue": "5", "key": "1110_CR18", "doi-asserted-by": "publisher", "first-page": "483", "DOI": "10.1016/j.cgh.2012.12.011", "volume": "11", "author": "WK Lo", "year": "2013", "unstructured": "Lo WK, Chan WW. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(5):483\u201390.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "1", "key": "1110_CR19", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1007/s00535-017-1371-9", "volume": "53", "author": "T Su", "year": "2018", "unstructured": "Su T, Lai S, Lee A, He X, Chen S. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth. J Gastroenterol. 2018;53(1):27\u201336.", "journal-title": "J Gastroenterol"}, {"issue": "13", "key": "1110_CR20", "doi-asserted-by": "publisher", "first-page": "1198", "DOI": "10.1056/NEJMoa1306801", "volume": "370", "author": "SS Magill", "year": "2014", "unstructured": "Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198\u2013208.", "journal-title": "N Engl J Med."}, {"issue": "11", "key": "1110_CR21", "doi-asserted-by": "publisher", "first-page": "3901", "DOI": "10.1128/AAC.01506-05", "volume": "50", "author": "A Rao", "year": "2006", "unstructured": "Rao A, Jump RL, Pultz NJ, Pultz MJ, Donskey CJ. In vitro killing of nosocomial pathogens by acid and acidified nitrite. Antimicrob Agents Chemother. 2006;50(11):3901\u20134.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "9", "key": "1110_CR22", "doi-asserted-by": "publisher", "first-page": "974", "DOI": "10.1111/apt.13568", "volume": "43", "author": "AG Clooney", "year": "2016", "unstructured": "Clooney AG, Bernstein CN, Leslie WD, Vagianos K, Sargent M, Laserna-Mendieta EJ, et al. A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors. Aliment Pharmacol Ther. 2016;43(9):974\u201384.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "11", "key": "1110_CR23", "doi-asserted-by": "publisher", "first-page": "5588", "DOI": "10.1128/JCM.43.11.5588-5592.2005", "volume": "43", "author": "MF Cochetiere De La", "year": "2005", "unstructured": "De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Dore J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol. 2005;43(11):5588\u201392.", "journal-title": "J Clin Microbiol"}, {"issue": "4", "key": "1110_CR24", "first-page": "883 e9", "volume": "149", "author": "DE Freedberg", "year": "2015", "unstructured": "Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015;149(4):883 e9\u2013885 e9.", "journal-title": "Gastroenterology."}, {"issue": "18", "key": "1110_CR25", "doi-asserted-by": "publisher", "first-page": "1693", "DOI": "10.1056/NEJMoa1012413", "volume": "365", "author": "VG Loo", "year": "2011", "unstructured": "Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693\u2013703.", "journal-title": "N Engl J Med."}, {"issue": "7", "key": "1110_CR26", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1038/ajg.2012.108", "volume": "107", "author": "CS Kwok", "year": "2012", "unstructured": "Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011\u20139.", "journal-title": "Am J Gastroenterol"}, {"issue": "6", "key": "1110_CR27", "doi-asserted-by": "publisher", "first-page": "784", "DOI": "10.1001/jamainternmed.2017.0212", "volume": "177", "author": "R Tariq", "year": "2017", "unstructured": "Tariq R, Singh S, Gupta A, Pardi DS, Khanna S. Association of gastric acid suppression with recurrent Clostridium difficile infection: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(6):784\u201391.", "journal-title": "JAMA Intern Med."}, {"issue": "9", "key": "1110_CR28", "doi-asserted-by": "publisher", "first-page": "2047", "DOI": "10.1111/j.1572-0241.2007.01275.x", "volume": "102", "author": "J Leonard", "year": "2007", "unstructured": "Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol. 2007;102(9):2047\u201356 (quiz 57).", "journal-title": "Am J Gastroenterol."}, {"issue": "10", "key": "1110_CR29", "doi-asserted-by": "publisher", "first-page": "1057", "DOI": "10.1007/s10654-016-0136-8", "volume": "31", "author": "RJ Hassing", "year": "2016", "unstructured": "Hassing RJ, Verbon A, de Visser H, Hofman A, Stricker BH. Proton pump inhibitors and gastroenteritis. Eur J Epidemiol. 2016;31(10):1057\u201363.", "journal-title": "Eur J Epidemiol"}, {"issue": "3", "key": "1110_CR30", "doi-asserted-by": "publisher", "first-page": "7490", "DOI": "10.4238/2015.July.3.25", "volume": "14", "author": "HB Xu", "year": "2015", "unstructured": "Xu HB, Wang HD, Li CH, Ye S, Dong MS, Xia QJ, et al. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis. GMR. 2015;14(3):7490\u2013501.", "journal-title": "GMR"}, {"issue": "4", "key": "1110_CR31", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1002/hep.28737", "volume": "64", "author": "G Dam", "year": "2016", "unstructured": "Dam G, Vilstrup H, Watson H, Jepsen P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology. 2016;64(4):1265\u201372.", "journal-title": "Hepatology"}, {"issue": "5", "key": "1110_CR32", "doi-asserted-by": "publisher", "first-page": "1056", "DOI": "10.1016/j.jhep.2014.11.036", "volume": "62", "author": "R Terg", "year": "2015", "unstructured": "Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, et al. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study. J Hepatol. 2015;62(5):1056\u201360.", "journal-title": "J Hepatol"}, {"issue": "9", "key": "1110_CR33", "doi-asserted-by": "publisher", "first-page": "1602", "DOI": "10.1111/liv.13862", "volume": "38", "author": "TL Tergast", "year": "2018", "unstructured": "Tergast TL, Wranke A, Laser H, Gerbel S, Manns MP, Cornberg M, et al. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis. Liver Int. 2018;38(9):1602\u201313.", "journal-title": "Liver Int"}, {"key": "1110_CR34", "doi-asserted-by": "publisher", "first-page": "h3867", "DOI": "10.1136/bmj.h3867", "volume": "351", "author": "H Song", "year": "2015", "unstructured": "Song H, Ekheden IG, Zheng Z, Ericsson J, Nyren O, Ye W. Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ. 2015;351:h3867.", "journal-title": "BMJ"}, {"issue": "10", "key": "1110_CR35", "first-page": "1801", "volume": "88", "author": "F Mauch", "year": "1993", "unstructured": "Mauch F, Bode G, Malfertheiner P. Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am J Gastroenterol. 1993;88(10):1801\u20132.", "journal-title": "Am J Gastroenterol."}, {"issue": "8", "key": "1110_CR36", "first-page": "811", "volume": "8", "author": "B Stoschus", "year": "1996", "unstructured": "Stoschus B, Dominguez-Munoz JE, Kalhori N, Sauerbruch T, Malfertheiner P. Effect of omeprazole on Helicobacter pylori urease activity in vivo. Eur J Gastroenterol Hepatol. 1996;8(8):811\u20133.", "journal-title": "Eur J Gastroenterol Hepatol"}, {"issue": "1", "key": "1110_CR37", "doi-asserted-by": "publisher", "first-page": "12", "DOI": "10.1136/gut.36.1.12", "volume": "36", "author": "RP Logan", "year": "1995", "unstructured": "Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut. 1995;36(1):12\u20136.", "journal-title": "Gut"}, {"issue": "9", "key": "1110_CR38", "first-page": "1401", "volume": "90", "author": "EJ Kuipers", "year": "1995", "unstructured": "Kuipers EJ, Uyterlinde AM, Pena AS, Hazenberg HJ, Bloemena E, Lindeman J, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol. 1995;90(9):1401\u20136.", "journal-title": "Am J Gastroenterol."}, {"issue": "3", "key": "1110_CR39", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1046/j.1365-2036.1998.00310.x", "volume": "12", "author": "M Stolte", "year": "1998", "unstructured": "Stolte M, Meining A, Schmitz JM, Alexandridis T, Seifert E. Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during 12\u00a0months of treatment with omeprazole and lansoprazole in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1998;12(3):247\u201353.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "Suppl 1", "key": "1110_CR40", "doi-asserted-by": "publisher", "first-page": "82", "DOI": "10.1159/000200921", "volume": "51", "author": "E Solcia", "year": "1992", "unstructured": "Solcia E, Fiocca R, Havu N, Dalvag A, Carlsson R. Gastric endocrine cells and gastritis in patients receiving long-term omeprazole treatment. Digestion. 1992;51(Suppl 1):82\u201392.", "journal-title": "Digestion."}, {"issue": "Suppl 1", "key": "1110_CR41", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1159/000200920", "volume": "51", "author": "W Creutzfeldt", "year": "1992", "unstructured": "Creutzfeldt W, Lamberts R. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth. Digestion. 1992;51(Suppl 1):76\u201381.", "journal-title": "Digestion"}, {"issue": "3", "key": "1110_CR42", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1053/gast.1997.v112.pm9041231", "volume": "112", "author": "R Eissele", "year": "1997", "unstructured": "Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology. 1997;112(3):707\u201317.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "1110_CR43", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1046/j.1523-5378.2000.00032.x", "volume": "5", "author": "P Moayyedi", "year": "2000", "unstructured": "Moayyedi P, Wason C, Peacock R, Walan A, Bardhan K, Axon AT, et al. Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter. 2000;5(4):206\u201314.", "journal-title": "Helicobacter"}, {"issue": "16", "key": "1110_CR44", "doi-asserted-by": "publisher", "first-page": "1018", "DOI": "10.1056/NEJM199604183341603", "volume": "334", "author": "EJ Kuipers", "year": "1996", "unstructured": "Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334(16):1018\u201322.", "journal-title": "N Engl J Med."}, {"issue": "10", "key": "1110_CR45", "doi-asserted-by": "publisher", "first-page": "e017739", "DOI": "10.1136/bmjopen-2017-017739", "volume": "7", "author": "N Brusselaers", "year": "2017", "unstructured": "Brusselaers N, Wahlin K, Engstrand L, Lagergren J. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. 2017;7(10):e017739.", "journal-title": "BMJ Open"}, {"issue": "16", "key": "1110_CR46", "doi-asserted-by": "publisher", "first-page": "2560", "DOI": "10.3748/wjg.v19.i16.2560", "volume": "19", "author": "JS Ahn", "year": "2013", "unstructured": "Ahn JS, Eom CS, Jeon CY, Park SM. Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19(16):2560\u20138.", "journal-title": "World J Gastroenterol"}, {"issue": "12", "key": "1110_CR47", "doi-asserted-by": "publisher", "first-page": "1706 e5", "DOI": "10.1016/j.cgh.2016.05.018", "volume": "14", "author": "A Tran-Duy", "year": "2016", "unstructured": "Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(12):1706 e5\u20131719 e5.", "journal-title": "Clin Gastroenterol Hepatol."}, {"issue": "9", "key": "1110_CR48", "doi-asserted-by": "publisher", "first-page": "915", "DOI": "10.1111/apt.13800", "volume": "44", "author": "FC Martin", "year": "2016", "unstructured": "Martin FC, Chenevix-Trench G, Yeomans ND. Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors. Aliment Pharmacol Ther. 2016;44(9):915\u201325.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "1110_CR49", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1016/S0016-5107(93)70057-7", "volume": "39", "author": "Y Kinoshita", "year": "1993", "unstructured": "Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39(2):161\u20133.", "journal-title": "Gastrointest Endosc"}, {"issue": "3", "key": "1110_CR50", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1097/00000478-199803000-00003", "volume": "22", "author": "TT Wu", "year": "1998", "unstructured": "Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22(3):293\u20138.", "journal-title": "Am J Surg Pathol."}, {"issue": "9", "key": "1110_CR51", "doi-asserted-by": "publisher", "first-page": "1124", "DOI": "10.1111/j.1365-2036.2010.04453.x", "volume": "32", "author": "D Keszthelyi", "year": "2010", "unstructured": "Keszthelyi D, Jansen SV, Schouten GA, de Kort S, Scholtes B, Engels LG, et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2010;32(9):1124\u20138.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "1110_CR52", "first-page": "11", "volume": "2010", "author": "MF Pascua", "year": "2010", "unstructured": "Pascua MF, Kedia P, Weiner MG, Holmes J, Ellenberg J, Lewis JD. Microscopic colitis and medication use. Clin Med Insights Gastroenterol. 2010;2010(3):11\u20139.", "journal-title": "Clin Med Insights Gastroenterol."}, {"issue": "2", "key": "1110_CR53", "first-page": "411", "volume": "19", "author": "F Fernandez-Banares", "year": "2013", "unstructured": "Fernandez-Banares F, de Sousa MR, Salas A, Beltran B, Piqueras M, Iglesias E, et al. Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis. 2013;19(2):411\u20137.", "journal-title": "Inflamm Bowel Dis"}, {"issue": "5", "key": "1110_CR54", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1038/ajg.2015.119", "volume": "110", "author": "GM Masclee", "year": "2015", "unstructured": "Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015;110(5):749\u201359.", "journal-title": "Am J Gastroenterol."}, {"issue": "10", "key": "1110_CR55", "doi-asserted-by": "publisher", "first-page": "1702", "DOI": "10.1097/MIB.0000000000000143", "volume": "20", "author": "OK Bonderup", "year": "2014", "unstructured": "Bonderup OK, Fenger-Gron M, Wigh T, Pedersen L, Nielsen GL. Drug exposure and risk of microscopic colitis: a nationwide Danish case-control study with 5751 cases. Inflamm Bowel Dis. 2014;20(10):1702\u20137.", "journal-title": "Inflamm Bowel Dis"}, {"issue": "9", "key": "1110_CR56", "doi-asserted-by": "publisher", "first-page": "1004", "DOI": "10.1111/apt.13583", "volume": "43", "author": "BP Verhaegh", "year": "2016", "unstructured": "Verhaegh BP, de Vries F, Masclee AA, Keshavarzian A, de Boer A, Souverein PC, et al. High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther. 2016;43(9):1004\u201313.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "3", "key": "1110_CR57", "first-page": "375", "volume": "88", "author": "T Andersen", "year": "1993", "unstructured": "Andersen T, Andersen JR, Tvede M, Franzmann MB. Collagenous colitis: are bacterial cytotoxins responsible? Am J Gastroenterol. 1993;88(3):375\u20137.", "journal-title": "Am J Gastroenterol."}, {"issue": "4", "key": "1110_CR58", "doi-asserted-by": "publisher", "first-page": "351", "DOI": "10.1080/19490976.2017.1284732", "volume": "8", "author": "F Imhann", "year": "2017", "unstructured": "Imhann F, Vich Vila A, Bonder MJ, Lopez Manosalva AG, Koonen DPY, Fu J, et al. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut microbes. 2017;8(4):351\u20138.", "journal-title": "Gut microbes."}, {"issue": "19", "key": "1110_CR59", "first-page": "13740", "volume": "267", "author": "MS Crowson", "year": "1992", "unstructured": "Crowson MS, Shull GE. Isolation and characterization of a cDNA encoding the putative distal colon H+, K(+)-ATPase. Similarity of deduced amino acid sequence to gastric H+, K(+)-ATPase and Na+, K(+)-ATPase and mRNA expression in distal colon, kidney, and uterus. J Biol Chem. 1992;267(19):13740\u20138.", "journal-title": "J Biol Chem."}, {"issue": "6", "key": "1110_CR60", "doi-asserted-by": "publisher", "first-page": "e0128004", "DOI": "10.1371/journal.pone.0128004", "volume": "10", "author": "AA Lambert", "year": "2015", "unstructured": "Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015;10(6):e0128004.", "journal-title": "PLoS One"}, {"key": "1110_CR61", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1146/annurev-physiol-021115-105238", "volume": "78", "author": "RP Dickson", "year": "2016", "unstructured": "Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB. The microbiome and the respiratory tract. Annu Rev Physiol. 2016;78:481\u2013504.", "journal-title": "Annu Rev Physiol"}, {"issue": "3", "key": "1110_CR62", "doi-asserted-by": "publisher", "first-page": "755", "DOI": "10.1016/S0016-5085(97)70168-9", "volume": "113", "author": "HB El-Serag", "year": "1997", "unstructured": "El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113(3):755\u201360.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "1110_CR63", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1136/gutjnl-2013-304738", "volume": "63", "author": "KB Filion", "year": "2014", "unstructured": "Filion KB, Chateau D, Targownik LE, Gershon A, Durand M, Tamim H, et al. Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut. 2014;63(4):552\u20138.", "journal-title": "Gut"}, {"issue": "1", "key": "1110_CR64", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1186/s13054-016-1305-6", "volume": "20", "author": "F Alshamsi", "year": "2016", "unstructured": "Alshamsi F, Belley-Cote E, Cook D, Almenawer SA, Alqahtani Z, Perri D, et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials. Crit Care. 2016;20(1):120.", "journal-title": "Crit Care"}, {"issue": "22", "key": "1110_CR65", "doi-asserted-by": "publisher", "first-page": "2435", "DOI": "10.1001/jama.2013.280490", "volume": "310", "author": "JR Lam", "year": "2013", "unstructured": "Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435\u201342.", "journal-title": "JAMA"}, {"issue": "3", "key": "1110_CR66", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.3889/oamjms.2018.142", "volume": "6", "author": "H Qorraj-Bytyqi", "year": "2018", "unstructured": "Qorraj-Bytyqi H, Hoxha R, Sadiku S, Bajraktari IH, Sopjani M, Thaci K, et al. Proton pump inhibitors intake and iron and vitamin B12 status: a prospective comparative study with a follow up of 12 months. Open Access Maced. J Med Sci. 2018;6(3):442\u20136.", "journal-title": "Open Access Maced. J Med Sci."}, {"issue": "4", "key": "1110_CR67", "doi-asserted-by": "publisher", "first-page": "821 e1", "DOI": "10.1053/j.gastro.2016.11.023", "volume": "152", "author": "JR Lam", "year": "2017", "unstructured": "Lam JR, Schneider JL, Quesenberry CP, Corley DA. Proton pump inhibitor and histamine-2 receptor antagonist use and iron deficiency. Gastroenterology. 2017;152(4):821 e1\u2013829 e1.", "journal-title": "Gastroenterology."}, {"issue": "13", "key": "1110_CR68", "doi-asserted-by": "publisher", "first-page": "672", "DOI": "10.1056/NEJM196809262791302", "volume": "279", "author": "SG Schade", "year": "1968", "unstructured": "Schade SG, Cohen RJ, Conrad ME. Effect of hydrochloric acid on iron absorption. N Engl J Med. 1968;279(13):672\u20134.", "journal-title": "N Engl J Med."}, {"issue": "4", "key": "1110_CR69", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1007/BF01298866", "volume": "36", "author": "J Golubov", "year": "1991", "unstructured": "Golubov J, Flanagan P, Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig Dis Sci. 1991;36(4):405\u20138.", "journal-title": "Dig Dis Sci"}, {"issue": "4", "key": "1110_CR70", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1097/00004836-199206000-00005", "volume": "14", "author": "H Koop", "year": "1992", "unstructured": "Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14(4):288\u201392.", "journal-title": "J Clin Gastroenterol"}, {"issue": "1", "key": "1110_CR71", "doi-asserted-by": "publisher", "first-page": "83", "DOI": "10.1046/j.1365-2036.1998.00274.x", "volume": "12", "author": "CA Stewart", "year": "1998", "unstructured": "Stewart CA, Termanini B, Sutliff VE, Serrano J, Yu F, Gibril F, et al. Iron absorption in patients with Zollinger\u2013Ellison syndrome treated with long-term gastric acid antisecretory therapy. Aliment Pharmacol Ther. 1998;12(1):83\u201398.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "9", "key": "1110_CR72", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1136/gut.2006.108613", "volume": "56", "author": "C Hutchinson", "year": "2007", "unstructured": "Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007;56(9):1291\u20135.", "journal-title": "Gut"}, {"issue": "8", "key": "1110_CR73", "doi-asserted-by": "publisher", "first-page": "2349", "DOI": "10.1007/s10620-011-1589-y", "volume": "56", "author": "E Sarzynski", "year": "2011", "unstructured": "Sarzynski E, Puttarajappa C, Xie Y, Grover M, Laird-Fick H. Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sci. 2011;56(8):2349\u201353.", "journal-title": "Dig Dis Sci"}, {"issue": "2", "key": "1110_CR74", "doi-asserted-by": "publisher", "first-page": "152", "DOI": "10.5527/wjn.v5.i2.152", "volume": "5", "author": "JH William", "year": "2016", "unstructured": "William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms. World J Nephrol. 2016;5(2):152\u20137.", "journal-title": "World J Nephrol."}, {"issue": "9", "key": "1110_CR75", "doi-asserted-by": "publisher", "first-page": "e1001736", "DOI": "10.1371/journal.pmed.1001736", "volume": "11", "author": "J Zipursky", "year": "2014", "unstructured": "Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, et al. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case\u2013control study. PLoS Med. 2014;11(9):e1001736.", "journal-title": "PLoS Med."}, {"issue": "2", "key": "1110_CR76", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/j.cgh.2015.10.012", "volume": "14", "author": "AI Sharara", "year": "2016", "unstructured": "Sharara AI, Chalhoub JM, Hammoud N, Harb AH, Sarkis FS, Hamadeh G. Low prevalence of hypomagnesemia in long-term recipients of proton pump inhibitors in a managed care cohort. Clin Gastroenterol Hepatol. 2016;14(2):317\u201321.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "5", "key": "1110_CR77", "doi-asserted-by": "publisher", "first-page": "405", "DOI": "10.1111/j.1365-2036.2012.05201.x", "volume": "36", "author": "MW Hess", "year": "2012", "unstructured": "Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther. 2012;36(5):405\u201313.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "1110_CR78", "doi-asserted-by": "publisher", "first-page": "70", "DOI": "10.1056/NEJM198507113130202", "volume": "313", "author": "RR Recker", "year": "1985", "unstructured": "Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985;313(2):70\u20133.", "journal-title": "N Engl J Med"}, {"issue": "10", "key": "1110_CR79", "doi-asserted-by": "publisher", "first-page": "2205", "DOI": "10.1002/jbmr.108", "volume": "25", "author": "MJ Wright", "year": "2010", "unstructured": "Wright MJ, Sullivan RR, Gaffney-Stomberg E, Caseria DM, O\u2019Brien KO, Proctor DD, et al. Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: a randomized, crossover, controlled clinical trial. J Bone Miner Res. 2010;25(10):2205\u201311.", "journal-title": "J Bone Miner Res"}, {"issue": "12", "key": "1110_CR80", "doi-asserted-by": "publisher", "first-page": "2786", "DOI": "10.1002/jbmr.166", "volume": "25", "author": "KE Hansen", "year": "2010", "unstructured": "Hansen KE, Jones AN, Lindstrom MJ, Davis LA, Ziegler TE, Penniston KL, et al. Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res. 2010;25(12):2786\u201395.", "journal-title": "J Bone Miner Res"}, {"issue": "11", "key": "1110_CR81", "doi-asserted-by": "publisher", "first-page": "1162", "DOI": "10.1111/apt.13194", "volume": "41", "author": "SE Attwood", "year": "2015", "unstructured": "Attwood SE, Ell C, Galmiche JP, Fiocca R, Hatlebakk JG, Hasselgren B, et al. Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015;41(11):1162\u201374.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "2", "key": "1110_CR82", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1007/s00223-006-0021-7", "volume": "79", "author": "P Vestergaard", "year": "2006", "unstructured": "Vestergaard P, Rejnmark L, Mosekilde L. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int. 2006;79(2):76\u201383.", "journal-title": "Calcif Tissue Int"}, {"issue": "24", "key": "1110_CR83", "doi-asserted-by": "publisher", "first-page": "2947", "DOI": "10.1001/jama.296.24.2947", "volume": "296", "author": "YX Yang", "year": "2006", "unstructured": "Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006;296(24):2947\u201353.", "journal-title": "JAMA"}, {"issue": "4", "key": "1110_CR84", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1503/cmaj.071330", "volume": "179", "author": "LE Targownik", "year": "2008", "unstructured": "Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ. 2008;179(4):319\u201326.", "journal-title": "CMAJ"}, {"issue": "1", "key": "1110_CR85", "doi-asserted-by": "publisher", "first-page": "339", "DOI": "10.1007/s00198-015-3365-x", "volume": "27", "author": "B Zhou", "year": "2016", "unstructured": "Zhou B, Huang Y, Li H, Sun W, Liu J. Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int. 2016;27(1):339\u201347.", "journal-title": "Osteoporos Int"}, {"issue": "9", "key": "1110_CR86", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1038/ajg.2012.200", "volume": "107", "author": "LE Targownik", "year": "2012", "unstructured": "Targownik LE, Leslie WD, Davison KS, Goltzman D, Jamal SA, Kreiger N, et al. The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol. 2012;107(9):1361\u20139.", "journal-title": "Am J Gastroenterol"}, {"issue": "1", "key": "1110_CR87", "doi-asserted-by": "publisher", "first-page": "95", "DOI": "10.1038/ajg.2016.481", "volume": "112", "author": "LE Targownik", "year": "2017", "unstructured": "Targownik LE, Goertzen AL, Luo Y, Leslie WD. Long-term proton pump inhibitor use is not associated with changes in bone strength and structure. Am J Gastroenterol. 2017;112(1):95\u2013101.", "journal-title": "Am J Gastroenterol."}, {"issue": "6", "key": "1110_CR88", "doi-asserted-by": "publisher", "first-page": "473", "DOI": "10.1007/s00228-006-0131-1", "volume": "62", "author": "DW Clark", "year": "2006", "unstructured": "Clark DW, Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Eur J Clin Pharmacol. 2006;62(6):473\u20139.", "journal-title": "Eur J Clin Pharmacol"}, {"issue": "1", "key": "1110_CR89", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1177/1060028016665641", "volume": "51", "author": "EW Colmenares", "year": "2017", "unstructured": "Colmenares EW, Pappas AL. Proton pump inhibitors: risk for myopathy? Ann Pharmacother. 2017;51(1):66\u201371.", "journal-title": "Ann Pharmacother."}, {"issue": "4", "key": "1110_CR90", "doi-asserted-by": "publisher", "first-page": "410", "DOI": "10.1001/jamaneurol.2015.4791", "volume": "73", "author": "W Gomm", "year": "2016", "unstructured": "Gomm W, von Holt K, Thome F, Broich K, Maier W, Fink A, et al. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol. 2016;73(4):410\u20136.", "journal-title": "JAMA Neurol."}, {"issue": "2", "key": "1110_CR91", "doi-asserted-by": "publisher", "first-page": "e0171006", "DOI": "10.1371/journal.pone.0171006", "volume": "12", "author": "SY Tai", "year": "2017", "unstructured": "Tai SY, Chien CY, Wu DC, Lin KD, Ho BL, Chang YH, et al. Risk of dementia from proton pump inhibitor use in Asian population: a nationwide cohort study in Taiwan. PLoS One. 2017;12(2):e0171006.", "journal-title": "PLoS One"}, {"issue": "4", "key": "1110_CR92", "doi-asserted-by": "publisher", "first-page": "971 e4", "DOI": "10.1053/j.gastro.2017.06.061", "volume": "153", "author": "P Lochhead", "year": "2017", "unstructured": "Lochhead P, Hagan K, Joshi AD, Khalili H, Nguyen LH, Grodstein F, et al. Association between proton pump inhibitor use and cognitive function in women. Gastroenterology. 2017;153(4):971 e4\u2013979 e4.", "journal-title": "Gastroenterology."}, {"issue": "12", "key": "1110_CR93", "doi-asserted-by": "publisher", "first-page": "1802", "DOI": "10.1038/ajg.2017.196", "volume": "112", "author": "H Taipale", "year": "2017", "unstructured": "Taipale H, Tolppanen AM, Tiihonen M, Tanskanen A, Tiihonen J, Hartikainen S. No association between proton pump inhibitor use and risk of Alzheimer\u2019s disease. Am J Gastroenterol. 2017;112(12):1802\u20138.", "journal-title": "Am J Gastroenterol."}, {"issue": "5", "key": "1110_CR94", "doi-asserted-by": "publisher", "first-page": "681", "DOI": "10.1016/j.cgh.2018.01.034", "volume": "16", "author": "M Wod", "year": "2018", "unstructured": "Wod M, Hallas J, Andersen K, Garcia Rodriguez LA, Christensen K, Gaist D. Lack of association between proton pump inhibitor use and cognitive decline. Clin Gastroenterol Hepatol. 2018;16(5):681\u20139.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "7", "key": "1110_CR95", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1017/S1041610215002082", "volume": "28", "author": "A Booker", "year": "2016", "unstructured": "Booker A, Jacob LE, Rapp M, Bohlken J, Kostev K. Risk factors for dementia diagnosis in German primary care practices. Int Psychogeriatr. 2016;28(7):1059\u201365.", "journal-title": "Int Psychogeriatr"}, {"issue": "9", "key": "1110_CR96", "doi-asserted-by": "publisher", "first-page": "1969", "DOI": "10.1111/jgs.14956", "volume": "65", "author": "FC Goldstein", "year": "2017", "unstructured": "Goldstein FC, Steenland K, Zhao L, Wharton W, Levey AI, Hajjar I. Proton pump inhibitors and risk of mild cognitive impairment and dementia. J Am Geriatr Soc. 2017;65(9):1969\u201374.", "journal-title": "J Am Geriatr Soc"}, {"issue": "3", "key": "1110_CR97", "doi-asserted-by": "publisher", "first-page": "e58837", "DOI": "10.1371/journal.pone.0058837", "volume": "8", "author": "N Badiola", "year": "2013", "unstructured": "Badiola N, Alcalde V, Pujol A, Munter LM, Multhaup G, Lleo A, et al. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS One. 2013;8(3):e58837.", "journal-title": "PLoS One"}, {"issue": "4", "key": "1110_CR98", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1038/ki.2014.74", "volume": "86", "author": "ML Blank", "year": "2014", "unstructured": "Blank ML, Parkin L, Paul C, Herbison P. A nationwide nested case\u2013control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use. Kidney Int. 2014;86(4):837\u201344.", "journal-title": "Kidney Int"}, {"issue": "5", "key": "1110_CR99", "doi-asserted-by": "publisher", "first-page": "597", "DOI": "10.1016/j.cgh.2005.11.004", "volume": "4", "author": "N Geevasinga", "year": "2006", "unstructured": "Geevasinga N, Coleman PL, Webster AC, Roger SD. Proton pump inhibitors and acute interstitial nephritis. Clin Gastroenterol Hepatol. 2006;4(5):597\u2013604.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "6", "key": "1110_CR100", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1038/ncpneph0802", "volume": "4", "author": "SG Coca", "year": "2008", "unstructured": "Coca SG, Perazella MA. Early steroid treatment for drug-induced acute interstitial nephritis. Nat Clin Pract Nephrol. 2008;4(6):298\u20139.", "journal-title": "Nat Clin Pract Nephrol."}, {"key": "1110_CR101", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.2147/DDDT.S130568", "volume": "11", "author": "Y Yang", "year": "2017", "unstructured": "Yang Y, George KC, Shang WF, Zeng R, Ge SW, Xu G. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Drug Des Dev Ther. 2017;11:1291\u20139.", "journal-title": "Drug Des Dev Ther."}, {"issue": "10", "key": "1110_CR102", "doi-asserted-by": "publisher", "first-page": "2821", "DOI": "10.1007/s10620-017-4725-5", "volume": "62", "author": "K Wijarnpreecha", "year": "2017", "unstructured": "Wijarnpreecha K, Thongprayoon C, Chesdachai S, Panjawatanana P, Ungprasert P, Cheungpasitporn W. Associations of proton-pump inhibitors and H2 receptor antagonists with chronic kidney disease: a meta-analysis. Dig Dis Sci. 2017;62(10):2821\u20137.", "journal-title": "Dig Dis Sci"}, {"issue": "10", "key": "1110_CR103", "doi-asserted-by": "publisher", "first-page": "3153", "DOI": "10.1681/ASN.2015121377", "volume": "27", "author": "Y Xie", "year": "2016", "unstructured": "Xie Y, Bowe B, Li T, Xian H, Balasubramanian S, Al-Aly Z. Proton pump inhibitors and risk of incident CKD and progression to ESRD. JASN. 2016;27(10):3153\u201363.", "journal-title": "JASN"}, {"issue": "2", "key": "1110_CR104", "doi-asserted-by": "publisher", "first-page": "238", "DOI": "10.1001/jamainternmed.2015.7193", "volume": "176", "author": "B Lazarus", "year": "2016", "unstructured": "Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238\u201346.", "journal-title": "JAMA Intern Med."}, {"issue": "6", "key": "1110_CR105", "doi-asserted-by": "publisher", "first-page": "1482", "DOI": "10.1016/j.kint.2016.12.021", "volume": "91", "author": "Y Xie", "year": "2017", "unstructured": "Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int. 2017;91(6):1482\u201394.", "journal-title": "Kidney Int"}, {"issue": "4", "key": "1110_CR106", "doi-asserted-by": "publisher", "first-page": "820", "DOI": "10.1038/ki.2014.331", "volume": "87", "author": "A Tin", "year": "2015", "unstructured": "Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, et al. Results from the atherosclerosis risk in communities study suggest that low serum magnesium is associated with incident kidney disease. Kidney Int. 2015;87(4):820\u20137.", "journal-title": "Kidney Int"}, {"issue": "8", "key": "1110_CR107", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1161/CIRCULATIONAHA.113.003602", "volume": "128", "author": "YT Ghebremariam", "year": "2013", "unstructured": "Ghebremariam YT, LePendu P, Lee JC, Erlanson DA, Slaviero A, Shah NH, et al. Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine. Circulation. 2013;128(8):845\u201353.", "journal-title": "Circulation"}, {"issue": "1", "key": "1110_CR108", "doi-asserted-by": "publisher", "first-page": "50", "DOI": "10.1159/000355776", "volume": "39", "author": "J Eiselt", "year": "2014", "unstructured": "Eiselt J, Rajdl D, Racek J, Vostry M, Rulcova K, Wirth J. Asymmetric dimethylarginine and progression of chronic kidney disease: a one-year follow-up study. Kidney Blood Pressure Res. 2014;39(1):50\u20137.", "journal-title": "Kidney Blood Pressure Res."}, {"issue": "4", "key": "1110_CR109", "doi-asserted-by": "publisher", "first-page": "657", "DOI": "10.1681/ASN.2013080905", "volume": "25", "author": "A Ramezani", "year": "2014", "unstructured": "Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. JASN. 2014;25(4):657\u201370.", "journal-title": "JASN"}, {"issue": "3", "key": "1110_CR110", "doi-asserted-by": "publisher", "first-page": "702", "DOI": "10.1053/j.gastro.2017.05.046", "volume": "153", "author": "DCF Klatte", "year": "2017", "unstructured": "Klatte DCF, Gasparini A, Xu H, de Deco P, Trevisan M, Johansson ALV, et al. Association between proton pump inhibitor use and risk of progression of chronic kidney disease. Gastroenterology. 2017;153(3):702\u201310.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "1110_CR111", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1124/dmd.109.029132", "volume": "38", "author": "M Kazui", "year": "2010", "unstructured": "Kazui M, Nishiya Y, Ishizuka T, Hagihara K, Farid NA, Okazaki O, et al. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite. Drug Metab Dispos Biol Fate Chem. 2010;38(1):92\u20139.", "journal-title": "Drug Metab Dispos Biol Fate Chem."}, {"issue": "3", "key": "1110_CR112", "doi-asserted-by": "publisher", "first-page": "256", "DOI": "10.1016/j.jacc.2007.06.064", "volume": "51", "author": "M Gilard", "year": "2008", "unstructured": "Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51(3):256\u201360.", "journal-title": "J Am Coll Cardiol"}, {"issue": "9", "key": "1110_CR113", "doi-asserted-by": "publisher", "first-page": "937", "DOI": "10.1001/jama.2009.261", "volume": "301", "author": "PM Ho", "year": "2009", "unstructured": "Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301(9):937\u201344.", "journal-title": "JAMA"}, {"issue": "7", "key": "1110_CR114", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1503/cmaj.082001", "volume": "180", "author": "DN Juurlink", "year": "2009", "unstructured": "Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180(7):713\u20138.", "journal-title": "CMAJ"}, {"key": "1110_CR115", "unstructured": "prilosec IfhputtlocbmaPtahpaadiwomapa. United States Food and Drug Administration. \n                    https://wayback.archive-it.org/7993/20170406044850/\n                    \n                  . \n                    https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm190787.htm\n                    \n                  ."}, {"issue": "9694", "key": "1110_CR116", "doi-asserted-by": "publisher", "first-page": "989", "DOI": "10.1016/S0140-6736(09)61525-7", "volume": "374", "author": "ML O\u2019Donoghue", "year": "2009", "unstructured": "O\u2019Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet. 2009;374(9694):989\u201397.", "journal-title": "Lancet"}, {"issue": "5", "key": "1110_CR117", "doi-asserted-by": "publisher", "first-page": "474", "DOI": "10.1161/CIRCULATIONAHA.110.965640", "volume": "123", "author": "T Simon", "year": "2011", "unstructured": "Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, et al. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation. 2011;123(5):474\u201382.", "journal-title": "Circulation"}, {"issue": "20", "key": "1110_CR118", "doi-asserted-by": "publisher", "first-page": "1909", "DOI": "10.1056/NEJMoa1007964", "volume": "363", "author": "DL Bhatt", "year": "2010", "unstructured": "Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363(20):1909\u201317.", "journal-title": "N Engl J Med."}, {"issue": "9", "key": "1110_CR119", "doi-asserted-by": "publisher", "first-page": "1002", "DOI": "10.1016/j.amjmed.2016.03.042", "volume": "129", "author": "M Vaduganathan", "year": "2016", "unstructured": "Vaduganathan M, Cannon CP, Cryer BL, Liu Y, Hsieh WH, Doros G, et al. Efficacy and safety of proton-pump inhibitors in high-risk cardiovascular subsets of the COGENT trial. Am J Med. 2016;129(9):1002\u20135.", "journal-title": "Am J Med."}, {"issue": "3", "key": "1110_CR120", "doi-asserted-by": "publisher", "first-page": "521", "DOI": "10.1016/0002-8703(82)90222-8", "volume": "104", "author": "WE Shell", "year": "1982", "unstructured": "Shell WE, DeWood MA, Peter T, Mickle D, Prause JA, Forrester JS, et al. Comparison of clinical signs and hemodynamic state in the early hours of transmural myocardial infarction. Am Heart J. 1982;104(3):521\u20138.", "journal-title": "Am Heart J"}, {"issue": "4", "key": "1110_CR121", "doi-asserted-by": "publisher", "first-page": "475", "DOI": "10.1177/0091270008315310", "volume": "48", "author": "DS Small", "year": "2008", "unstructured": "Small DS, Farid NA, Payne CD, Weerakkody GJ, Li YG, Brandt JT, et al. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol. 2008;48(4):475\u201384.", "journal-title": "J Clin Pharmacol"}, {"issue": "1", "key": "1110_CR122", "doi-asserted-by": "publisher", "first-page": "148 e1\u20135", "DOI": "10.1016/j.ahj.2008.09.017", "volume": "157", "author": "JM Siller-Matula", "year": "2009", "unstructured": "Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009;157(1):148 e1\u20135.", "journal-title": "Am Heart J."}, {"issue": "3", "key": "1110_CR123", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1177/1078155214527145", "volume": "21", "author": "VH Ha", "year": "2015", "unstructured": "Ha VH, Ngo M, Chu MP, Ghosh S, Sawyer MB, Chambers CR. Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer? J Oncol Pharm Pract. 2015;21(3):194\u2013200.", "journal-title": "J Oncol Pharm Pract"}, {"issue": "1", "key": "1110_CR124", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1016/j.cllc.2014.07.005", "volume": "16", "author": "MP Chu", "year": "2015", "unstructured": "Chu MP, Ghosh S, Chambers CR, Basappa N, Butts CA, Chu Q, et al. Gastric acid suppression is associated with decreased erlotinib efficacy in non-small-cell lung cancer. Clin Lung Cancer. 2015;16(1):33\u20139.", "journal-title": "Clin Lung Cancer."}, {"issue": "3", "key": "1110_CR125", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1016/j.clcc.2015.12.008", "volume": "15", "author": "J Sun", "year": "2016", "unstructured": "Sun J, Ilich AI, Kim CA, Chu MP, Wong GG, Ghosh S, et al. Concomitant administration of proton pump inhibitors and capecitabine is associated with increased recurrence risk in early stage colorectal cancer patients. Clin Colorectal Cancer. 2016;15(3):257\u201363.", "journal-title": "Clin Colorectal Cancer."}, {"issue": "6", "key": "1110_CR126", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.1001/jamaoncol.2016.3358", "volume": "3", "author": "MP Chu", "year": "2017", "unstructured": "Chu MP, Hecht JR, Slamon D, Wainberg ZA, Bang YJ, Hoff PM, et al. Association of proton pump inhibitors and capecitabine efficacy in advanced gastroesophageal cancer: secondary analysis of the TRIO-013/logic randomized clinical trial. JAMA Oncol. 2017;3(6):767\u201373.", "journal-title": "JAMA Oncol."}, {"issue": "18", "key": "1110_CR127", "doi-asserted-by": "publisher", "first-page": "1137", "DOI": "10.1056/NEJM198405033101801", "volume": "310", "author": "MJ Davies", "year": "1984", "unstructured": "Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310(18):1137\u201340.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "1110_CR128", "doi-asserted-by": "publisher", "first-page": "1893", "DOI": "10.1002/hep.28782", "volume": "64", "author": "EB Tapper", "year": "2016", "unstructured": "Tapper EB, Bacon BR, Curry MP, Dieterich DT, Flamm SL, Guest LE, et al. Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study. Hepatology. 2016;64(6):1893\u20139.", "journal-title": "Hepatology"}, {"issue": "8", "key": "1110_CR129", "doi-asserted-by": "publisher", "first-page": "1671", "DOI": "10.1128/AAC.39.8.1671", "volume": "39", "author": "TW Chin", "year": "1995", "unstructured": "Chin TW, Loeb M, Fong IW. Effects of an acidic beverage (Coca\u2013Cola) on absorption of ketoconazole. Antimicrob Agents Chemother. 1995;39(8):1671\u20135.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "1110_CR130", "doi-asserted-by": "publisher", "first-page": "958", "DOI": "10.1128/AAC.01034-08", "volume": "53", "author": "G Krishna", "year": "2009", "unstructured": "Krishna G, Moton A, Ma L, Medlock MM, McLeod J. Pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers. Antimicrob Agents Chemother. 2009;53(3):958\u201366.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "1110_CR131", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1592/phco.26.3.341", "volume": "26", "author": "DL Tomilo", "year": "2006", "unstructured": "Tomilo DL, Smith PF, Ogundele AB, Difrancesco R, Berenson CS, Eberhardt E, et al. Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers. Pharmacotherapy. 2006;26(3):341\u20136.", "journal-title": "Pharmacotherapy."}, {"issue": "1", "key": "1110_CR132", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1097/FTD.0000000000000101", "volume": "37", "author": "C Gjestad", "year": "2015", "unstructured": "Gjestad C, Westin AA, Skogvoll E, Spigset O. Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline. Ther Drug Monit. 2015;37(1):90\u20137.", "journal-title": "Ther Drug Monit"}, {"issue": "3", "key": "1110_CR133", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1007/BF00266355", "volume": "42", "author": "PA Soons", "year": "1992", "unstructured": "Soons PA, van den Berg G, Danhof M, van Brummelen P, Jansen JB, Lamers CB, et al. Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects. Eur J Clin Pharmacol. 1992;42(3):319\u201324.", "journal-title": "Eur J Clin Pharmacol"}, {"issue": "1 Suppl", "key": "1110_CR134", "first-page": "S81", "volume": "34", "author": "H Bliesath", "year": "1996", "unstructured": "Bliesath H, Huber R, Steinijans VW, Koch HJ, Kunz K, Wurst W. Pantoprazole does not interact with nifedipine in man under steady-state conditions. Int J Clin Pharmacol Ther. 1996;34(1 Suppl):S81\u20135.", "journal-title": "Int J Clin Pharmacol Ther"}, {"issue": "5", "key": "1110_CR135", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1111/j.1365-2125.1991.tb03953.x", "volume": "32", "author": "B Oosterhuis", "year": "1991", "unstructured": "Oosterhuis B, Jonkman JH, Andersson T, Zuiderwijk PB, Jedema JN. Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose. Br J Clin Pharmacol. 1991;32(5):569\u201372.", "journal-title": "Br J Clin Pharmacol"}, {"issue": "7", "key": "1110_CR136", "doi-asserted-by": "publisher", "first-page": "540", "DOI": "10.7326/0003-4819-115-7-540", "volume": "115", "author": "AF Cohen", "year": "1991", "unstructured": "Cohen AF, Kroon R, Schoemaker R, Hoogkamer H, van Vliet A. Influence of gastric acidity on the bioavailability of digoxin. Ann Intern Med. 1991;115(7):540\u20135.", "journal-title": "Ann Intern Med"}, {"issue": "1 Suppl", "key": "1110_CR137", "first-page": "S67", "volume": "34", "author": "M Hartmann", "year": "1996", "unstructured": "Hartmann M, Huber R, Bliesath H, Steinijans VW, Koch HJ, Wurst W, et al. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. Int J Clin Pharmacol Ther. 1996;34(1 Suppl):S67\u201371.", "journal-title": "Int J Clin Pharmacol Ther"}, {"issue": "1", "key": "1110_CR138", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.2165/0044011-200929010-00004", "volume": "29", "author": "M Vakily", "year": "2009", "unstructured": "Vakily M, Lee RD, Wu J, Gunawardhana L, Mulford D. Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies. Clin Drug Investig. 2009;29(1):35\u201350.", "journal-title": "Clin Drug Investig."}, {"issue": "6", "key": "1110_CR139", "doi-asserted-by": "publisher", "first-page": "674", "DOI": "10.1038/clpt.1989.204", "volume": "46", "author": "GS Hughes", "year": "1989", "unstructured": "Hughes GS, Heald DL, Barker KB, Patel RK, Spillers CR, Watts KC, et al. The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil. Clin Pharmacol Ther. 1989;46(6):674\u201385.", "journal-title": "Clin Pharmacol Ther"}, {"issue": "5", "key": "1110_CR140", "doi-asserted-by": "publisher", "first-page": "615", "DOI": "10.1128/AAC.33.5.615", "volume": "33", "author": "TH Grasela Jr", "year": "1989", "unstructured": "Grasela TH Jr, Schentag JJ, Sedman AJ, Wilton JH, Thomas DJ, Schultz RW, et al. Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrob Agents Chemother. 1989;33(5):615\u20137.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "7", "key": "1110_CR141", "doi-asserted-by": "publisher", "first-page": "845", "DOI": "10.1177/0091270005276738", "volume": "45", "author": "H Derendorf", "year": "2005", "unstructured": "Derendorf H, VanderMaelen CP, Brickl RS, MacGregor TR, Eisert W. Dipyridamole bioavailability in subjects with reduced gastric acidity. J Clin Pharmacol. 2005;45(7):845\u201350.", "journal-title": "J Clin Pharmacol"}, {"issue": "3", "key": "1110_CR142", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1016/0009-9236(95)90245-7", "volume": "58", "author": "BJ Gertz", "year": "1995", "unstructured": "Gertz BJ, Holland SD, Kline WF, Matuszewski BK, Freeman A, Quan H, et al. Studies of the oral bioavailability of alendronate. Clin Pharmacol Ther. 1995;58(3):288\u201398.", "journal-title": "Clin Pharmacol Ther"}, {"issue": "17", "key": "1110_CR143", "first-page": "1604", "volume": "170", "author": "JS Bell", "year": "2010", "unstructured": "Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010;170(17):1604\u20135.", "journal-title": "Arch Intern Med"}, {"issue": "9", "key": "1110_CR144", "doi-asserted-by": "publisher", "first-page": "866", "DOI": "10.1001/archinternmed.2011.164", "volume": "171", "author": "N Wilson", "year": "2011", "unstructured": "Wilson N, Gnjidic D, March L, Sambrook P, Hilmer SN. Use of PPIs are not associated with mortality in institutionalized older people. Arch Intern Med. 2011;171(9):866 (author reply-7).", "journal-title": "Arch Intern Med."}, {"issue": "5", "key": "1110_CR145", "doi-asserted-by": "publisher", "first-page": "488 e9", "DOI": "10.1016/j.jamda.2012.03.003", "volume": "13", "author": "M Teramura-Gronblad", "year": "2012", "unstructured": "Teramura-Gronblad M, Bell JS, Poysti MM, Strandberg TE, Laurila JV, Tilvis RS, et al. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Direct Assoc. 2012;13(5):488 e9\u2013513 e9.", "journal-title": "J Am Med Direct Assoc."}, {"issue": "7", "key": "1110_CR146", "doi-asserted-by": "publisher", "first-page": "518", "DOI": "10.1001/jamainternmed.2013.2851", "volume": "173", "author": "M Maggio", "year": "2013", "unstructured": "Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Butto V, et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013;173(7):518\u201323.", "journal-title": "JAMA Intern Med."}, {"issue": "2", "key": "1110_CR147", "doi-asserted-by": "publisher", "first-page": "374", "DOI": "10.1016/j.ekir.2017.11.001", "volume": "3", "author": "ALM Francisco de", "year": "2018", "unstructured": "de Francisco ALM, Varas J, Ramos R, Merello JI, Canaud B, Stuard S, et al. Proton pump inhibitor usage and the risk of mortality in hemodialysis patients. Kidney Int Rep. 2018;3(2):374\u201384.", "journal-title": "Kidney Int Rep."}, {"issue": "4", "key": "1110_CR148", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1177/2042098616679814", "volume": "8", "author": "MA Pegoli", "year": "2017", "unstructured": "Pegoli MA, Dedigama M, Mangoni AA, Russell PT, Grzeskowiak LE, Thynne T. Proton pump inhibitors and risk of readmission and mortality in older patients discharged from a tertiary hospital to residential aged care facilities. Ther Adv Drug Saf. 2017;8(4):137\u20139.", "journal-title": "Ther Adv Drug Saf."}, {"issue": "1", "key": "1110_CR149", "doi-asserted-by": "publisher", "first-page": "e0169826", "DOI": "10.1371/journal.pone.0169826", "volume": "12", "author": "AM Pello Lazaro", "year": "2017", "unstructured": "Pello Lazaro AM, Cristobal C, Franco-Pelaez JA, Tarin N, Acena A, Carda R, et al. Use of proton-pump inhibitors predicts heart failure and death in patients with coronary artery disease. PLoS One. 2017;12(1):e0169826.", "journal-title": "PLoS One"}, {"issue": "9", "key": "1110_CR150", "first-page": "e228", "volume": "16", "author": "JJ Heidelbaugh", "year": "2010", "unstructured": "Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care. 2010;16(9):e228\u201334.", "journal-title": "Am J Manag Care"}], "container-title": ["Drugs"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s40265-019-01110-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s40265-019-01110-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s40265-019-01110-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 17]], "date-time": "2019-09-17T18:28:15Z", "timestamp": 1568744895000}, "score": 32.594948, "issued": {"date-parts": [[2019, 4, 10]]}, "references-count": 150, "journal-issue": {"published-print": {"date-parts": [[2019, 5]]}, "issue": "7"}, "alternative-id": ["1110"], "URL": "http://dx.doi.org/10.1007/s40265-019-01110-3", "relation": {"cites": []}, "ISSN": ["0012-6667", "1179-1950"], "issn-type": [{"value": "0012-6667", "type": "print"}, {"value": "1179-1950", "type": "electronic"}], "subject": ["Pharmacology (medical)"], "assertion": [{"value": "10 April 2019", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Compliance with Ethical Standards"}}, {"value": "No funding was received for the preparation of this manuscript", "order": 2, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Funding"}}, {"value": "Evan Elias has no conflicts of interest to declare. Laura E. Targownik has no conflicts of interest to declare that directly relate to this manuscript.", "order": 3, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Conflicts of Interest"}}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T17:16:49Z", "timestamp": 1574875009986}, "reference-count": 0, "publisher": "American Society of Consultant Pharmacists", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["consult pharm"], "published-print": {"date-parts": [[2018, 9, 1]]}, "DOI": "10.4140/tcp.n.2018.497", "type": "journal-article", "created": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T04:35:48Z", "timestamp": 1536208548000}, "page": "497-503", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Proton Pump Inhibitor Use in Older Adults: Long-Term Risks and Steps for Deprescribing"], "prefix": "10.4140", "volume": "33", "author": [{"given": "Sara", "family": "Pezeshkian", "sequence": "first", "affiliation": [{"name": "University of Oklahoma College of Pharmacy, Oklahoma City, Oklahoma."}]}, {"given": "Susan E.", "family": "Conway", "sequence": "additional", "affiliation": [{"name": "Department of Pharmacy: Clinical and Administrative Sciences, University of Oklahoma College of Pharmacy."}]}], "member": "2625", "container-title": ["The Consultant Pharmacist"], "language": "en", "link": [{"URL": "http://www.ingentaconnect.com/content/ascp/tcp/2018/00000033/00000009/art00004", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 6]], "date-time": "2018-09-06T04:35:50Z", "timestamp": 1536208550000}, "score": 31.24104, "issued": {"date-parts": [[2018, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2018, 9, 1]]}, "issue": "9"}, "alternative-id": ["0888-5109(20180901)33:9L.497;1-"], "URL": "http://dx.doi.org/10.4140/tcp.n.2018.497", "ISSN": ["0888-5109"], "issn-type": [{"value": "0888-5109", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T07:46:20Z", "timestamp": 1574495180279}, "reference-count": 0, "publisher": "BMJ", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "published-print": {"date-parts": [[2011, 5, 1]]}, "DOI": "10.1136/gut.2010.229286", "type": "journal-article", "created": {"date-parts": [[2011, 2, 18]], "date-time": "2011-02-18T03:53:31Z", "timestamp": 1298001211000}, "page": "567-568", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil"], "prefix": "10.1136", "volume": "60", "author": [{"given": "J. G.", "family": "Fox", "sequence": "first", "affiliation": []}, {"given": "E. J.", "family": "Kuipers", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2011, 2, 17]]}, "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.2010.229286", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T22:22:48Z", "timestamp": 1482531768000}, "score": 30.910603, "issued": {"date-parts": [[2011, 2, 17]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2011, 4, 4]]}, "published-print": {"date-parts": [[2011, 5, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1136/gut.2010.229286", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T10:12:37Z", "timestamp": 1574763157976}, "reference-count": 9, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ACG Case Reports Journal"], "published-print": {"date-parts": [[2016, 1]]}, "DOI": "10.14309/crj.2016.11", "type": "journal-article", "created": {"date-parts": [[2016, 2, 4]], "date-time": "2016-02-04T20:45:06Z", "timestamp": 1454618706000}, "page": "95-97", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Esophageal Eosinophilia Treated With Long-Duration Proton Pump Inhibitor Therapy"], "prefix": "10.14309", "volume": "3", "author": [{"given": "Ernest L.", "family": "DiGiovanni", "sequence": "first", "affiliation": []}, {"given": "Anne L.", "family": "Champeaux", "sequence": "additional", "affiliation": []}, {"given": "May R.", "family": "Arroyo", "sequence": "additional", "affiliation": []}, {"given": "Joel E.", "family": "Richter", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["ACG Case Reports Journal"], "language": "en", "link": [{"URL": "http://journals.lww.com/acgcr/Fulltext/10.14309/crj.2016.11", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 2]], "date-time": "2019-09-02T04:47:39Z", "timestamp": 1567399659000}, "score": 29.263577, "subtitle": [""], "issued": {"date-parts": [[2016, 1]]}, "references-count": 9, "journal-issue": {"issue": "2"}, "URL": "http://dx.doi.org/10.14309/crj.2016.11", "ISSN": ["2326-3253"], "issn-type": [{"value": "2326-3253", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T23:02:51Z", "timestamp": 1574550171132}, "reference-count": 0, "publisher": "BMJ", "issue": "oct01 1", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "short-container-title": ["Case Reports"], "published-print": {"date-parts": [[2014, 10, 1]]}, "DOI": "10.1136/bcr-2014-205165", "type": "journal-article", "created": {"date-parts": [[2014, 10, 1]], "date-time": "2014-10-01T11:14:38Z", "timestamp": 1412162078000}, "page": "bcr2014205165-bcr2014205165", "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["From hypomagnesaemia to Zollinger-Ellison syndrome: an adverse effect of a proton pump inhibitor"], "prefix": "10.1136", "volume": "2014", "author": [{"given": "A.", "family": "Eyal", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Sueissa", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Braun", "sequence": "additional", "affiliation": []}, {"given": "M. E.", "family": "Naffaa", "sequence": "additional", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2014, 10, 1]]}, "container-title": ["Case Reports"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/bcr-2014-205165", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T08:04:45Z", "timestamp": 1482480285000}, "score": 28.684582, "issued": {"date-parts": [[2014, 10, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 10, 1]]}, "published-print": {"date-parts": [[2014, 10, 1]]}, "issue": "oct01 1"}, "URL": "http://dx.doi.org/10.1136/bcr-2014-205165", "ISSN": ["1757-790X"], "issn-type": [{"value": "1757-790X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T17:53:16Z", "timestamp": 1574531596856}, "reference-count": 19, "publisher": "S. Karger AG", "issue": "2", "license": [{"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "vor"}, {"URL": "https://www.karger.com/Services/SiteLicenses", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Digestion"], "published-print": {"date-parts": [[2013]]}, "DOI": "10.1159/000345144", "type": "journal-article", "created": {"date-parts": [[2013, 1, 25]], "date-time": "2013-01-25T07:09:39Z", "timestamp": 1359097779000}, "page": "85-90", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Patient Selection for Therapy Reduction after Long-Term Daily Proton Pump Inhibitor Treatment for Gastro-Oesophageal Reflux Disease: Trial and Error"], "prefix": "10.1159", "volume": "87", "author": [{"given": "Alike W.", "family": "van der Velden", "sequence": "first", "affiliation": []}, {"given": "Niek J.", "family": "de Wit", "sequence": "additional", "affiliation": []}, {"given": "A. Otto", "family": "Quartero", "sequence": "additional", "affiliation": []}, {"given": "Diederick E.", "family": "Grobbee", "sequence": "additional", "affiliation": []}, {"given": "Mattijs E.", "family": "Numans", "sequence": "additional", "affiliation": []}], "member": "127", "reference": [{"key": "sref_1", "DOI": "10.1111/j.1365-2036.2004.02093.x", "doi-asserted-by": "publisher"}, {"key": "sref_2", "author": "Heidelbaugh JJ", "volume": "68", "first-page": "1311", "year": "2003", "journal-title": "Am Fam Physician"}, {"key": "sref_3", "DOI": "10.1111/j.1365-2036.2005.02611.x", "doi-asserted-by": "publisher"}, {"key": "sref_4", "DOI": "10.1111/j.1572-0241.2006.00998.x", "doi-asserted-by": "publisher"}, {"key": "sref_5", "DOI": "10.1111/j.1365-2036.2007.03381.x", "doi-asserted-by": "publisher"}, {"key": "sref_6", "DOI": "10.1111/j.1572-0241.2000.01759.x", "doi-asserted-by": "publisher"}, {"key": "sref_7", "DOI": "10.1111/j.1365-2036.2004.02289.x", "doi-asserted-by": "publisher"}, {"key": "sref_8", "DOI": "10.1136/bmj.39406.449456.BE", "doi-asserted-by": "publisher"}, {"key": "sref_9", "author": "Meineche-Schmidt V", "volume": "24", "first-page": "1117", "year": "2006", "journal-title": "Aliment Pharmacol Ther", "DOI": "10.1111/j.1365-2036.2006.03046.x", "doi-asserted-by": "crossref"}, {"key": "sref_10", "DOI": "10.1111/j.1365-2036.2007.03249.x", "doi-asserted-by": "publisher"}, {"key": "sref_11", "DOI": "10.1136/pgmj.2006.051151", "doi-asserted-by": "publisher"}, {"key": "sref_12", "DOI": "10.1159/000236025", "doi-asserted-by": "publisher"}, {"key": "sref_13", "DOI": "10.1016/S0002-9270(01)02495-9", "doi-asserted-by": "publisher"}, {"key": "sref_14", "DOI": "10.1192/bjp.128.3.280", "doi-asserted-by": "publisher"}, {"key": "sref_15", "DOI": "10.1016/S0895-4356(98)00097-3", "doi-asserted-by": "publisher"}, {"key": "sref_16", "author": "Cote GA", "volume": "25", "first-page": "709", "year": "2007", "journal-title": "Aliment Pharmacol Ther", "DOI": "10.1111/j.1365-2036.2007.03248.x", "doi-asserted-by": "crossref"}, {"key": "sref_17", "author": "Sheu BS", "volume": "102", "first-page": "2387", "year": "2007", "journal-title": "Am J Gastroenterol", "DOI": "10.1111/j.1572-0241.2007.01468.x", "doi-asserted-by": "crossref"}, {"key": "sref_18", "author": "Gorgels WJ", "volume": "78", "first-page": "49", "year": "2005", "journal-title": "Drugs Alcohol Depend", "DOI": "10.1016/j.drugalcdep.2004.09.001", "doi-asserted-by": "crossref"}, {"key": "sref_19", "author": "Grime J", "volume": "51", "first-page": "703", "year": "2001", "journal-title": "Br J Gen Pract"}], "container-title": ["Digestion"], "language": "en", "link": [{"URL": "https://www.karger.com/Article/Pdf/345144", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.karger.com/Article/Pdf/345144", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 22]], "date-time": "2018-08-22T15:47:44Z", "timestamp": 1534952864000}, "score": 28.110456, "issued": {"date-parts": [[2013]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2013]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.1159/000345144", "relation": {"cites": []}, "ISSN": ["1421-9867", "0012-2823"], "issn-type": [{"value": "0012-2823", "type": "print"}, {"value": "1421-9867", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T19:07:39Z", "timestamp": 1574795259525}, "reference-count": 59, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T00:00:00Z", "timestamp": 1497484800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc/4.0/", "start": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T00:00:00Z", "timestamp": 1497484800000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical And Translational Science"], "published-print": {"date-parts": [[2017, 9]]}, "DOI": "10.1111/cts.12475", "type": "journal-article", "created": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T22:17:07Z", "timestamp": 1497565027000}, "page": "387-394", "source": "Crossref", "is-referenced-by-count": 2, "title": ["A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long-Term Safety"], "prefix": "10.1111", "volume": "10", "author": [{"given": "E", "family": "Dubcenco", "sequence": "first", "affiliation": [{"name": "Robarts Clinical Trials Inc.; University of Western Ontario; London Ontario Canada"}, {"name": "Rutgers; State University of New Jersey; The Biopharma Educational Initiative; Newark New Jersey USA"}, {"name": "Oak Ridge Institute for Science and Education; Oak Ridge Tennessee USA"}, {"name": "U.S. Food and Drug Administration; Silver Spring Maryland USA"}]}, {"given": "PM", "family": "Beers-Block", "sequence": "additional", "affiliation": [{"name": "Rutgers; State University of New Jersey; The Biopharma Educational Initiative; Newark New Jersey USA"}]}, {"given": "LP", "family": "Kim", "sequence": "additional", "affiliation": [{"name": "Rutgers; State University of New Jersey; The Biopharma Educational Initiative; Newark New Jersey USA"}]}, {"given": "P", "family": "Schotland", "sequence": "additional", "affiliation": [{"name": "Oak Ridge Institute for Science and Education; Oak Ridge Tennessee USA"}, {"name": "U.S. Food and Drug Administration; Silver Spring Maryland USA"}]}, {"given": "JG", "family": "Levine", "sequence": "additional", "affiliation": [{"name": "U.S. Food and Drug Administration; Silver Spring Maryland USA"}]}, {"given": "CA", "family": "McCloskey", "sequence": "additional", "affiliation": [{"name": "U.S. Food and Drug Administration; Silver Spring Maryland USA"}]}, {"given": "ED", "family": "Bashaw", "sequence": "additional", "affiliation": [{"name": "U.S. Food and Drug Administration; Silver Spring Maryland USA"}]}], "member": "311", "published-online": {"date-parts": [[2017, 6, 15]]}, "reference": [{"key": "10.1111/cts.12475-BIB0001|cts12475-cit-0001", "unstructured": "U.S. Food and Drug Administration http://www.fda.gov/downloads/Drugs/Guidances/ucm070244.pdff"}, {"key": "10.1111/cts.12475-BIB0002|cts12475-cit-0002", "unstructured": "U.S. Food and Drug administration Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs - General Considerations. Guidance for Industry http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm389370.pdf"}, {"key": "10.1111/cts.12475-BIB0003|cts12475-cit-0003", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1023/A:1018932430733", "article-title": "Bioequivalence: Performance of several measures of extent of absorption", "volume": "11", "author": "Bois", "year": "1994)", "journal-title": "Pharm. Res"}, {"key": "10.1111/cts.12475-BIB0004|cts12475-cit-0004", "unstructured": "European Medicines Agency Committee for medicinal products for human use http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf"}, {"key": "10.1111/cts.12475-BIB0005|cts12475-cit-0005", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1016/j.cgh.2012.11.031", "article-title": "Perspectives in clinical gastroenterology and hepatology", "volume": "11", "author": "Johnson", "year": "2013", "journal-title": "Clin. Gastroent. Hepatol"}, {"key": "10.1111/cts.12475-BIB0006|cts12475-cit-0006", "unstructured": "Open FDA Dynamic PRR http://54.201.82.167/dynprr/"}, {"key": "10.1111/cts.12475-BIB0007|cts12475-cit-0007", "unstructured": "EMEA Eudravigilance Expert Working Group (EV-EWG) Guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system. 2008 http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011437.pdf"}, {"key": "10.1111/cts.12475-BIB0008|cts12475-cit-0008", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.1002/pds.677", "article-title": "Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports", "volume": "10", "author": "Evans", "year": "2001", "journal-title": "Pharmacoepidemiol. Drug Saf"}, {"key": "10.1111/cts.12475-BIB0009|cts12475-cit-0009", "unstructured": "U.S. Food and Drug Administration Code of Federal Regulations. 21CFR320.23 (b) http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=320.23"}, {"key": "10.1111/cts.12475-BIB0010|cts12475-cit-0010", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.3177/jnsv.44.473", "article-title": "Effect of L-lactic acid on calcium absorption in rats fed omeprazole", "volume": "44", "author": "Chonan", "year": "1998", "journal-title": "J. Nutr. Sci. Vitaminol"}, {"key": "10.1111/cts.12475-BIB0011|cts12475-cit-0011", "doi-asserted-by": "crossref", "first-page": "507", "DOI": "10.1007/s00223-012-9601-x", "article-title": "Pantoprazole, a proton pump inhibitor, delays fracture healing in mice", "volume": "90", "author": "Histing", "year": "2012", "journal-title": "Calcif. Tissue Int"}, {"key": "10.1111/cts.12475-BIB0012|cts12475-cit-0012", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.3892/mmr.2013.1327", "article-title": "The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats", "volume": "7", "author": "Joo", "year": "2013", "journal-title": "Mol. Med. Rep"}, {"key": "10.1111/cts.12475-BIB0013|cts12475-cit-0013", "first-page": "877", "article-title": "Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts", "volume": "26", "author": "Hyun", "year": "2010", "journal-title": "Int. J. Mol. Med"}, {"key": "10.1111/cts.12475-BIB0014|cts12475-cit-0014", "doi-asserted-by": "crossref", "first-page": "413097", "DOI": "10.1155/2015/413097", "article-title": "Pantoprazole decreases cell viability and function of human osteoclasts in vitro", "volume": "2015", "author": "Prause", "year": "2015", "journal-title": "Mediat. Inflamm"}, {"key": "10.1111/cts.12475-BIB0015|cts12475-cit-0015", "first-page": "1948", "article-title": "Impact of omeprazole on bone remodeling in normal and ovariectomized Wistar rats", "volume": "18", "author": "Hasanin", "year": "2014", "journal-title": "Eur. Rev. Med. Pharmacol. Sci"}, {"key": "10.1111/cts.12475-BIB0016|cts12475-cit-0016", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1002/jcb.23337", "article-title": "Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice", "volume": "113", "author": "Fossmark", "year": "2012", "journal-title": "J. Cell Biochem"}, {"key": "10.1111/cts.12475-BIB0017|cts12475-cit-0017", "doi-asserted-by": "crossref", "first-page": "556", "DOI": "10.1016/j.nut.2012.07.014", "article-title": "Can 2-oxoglutarate prevent changes in bone evoked by omeprazole?", "volume": "29", "author": "Dobrowolski", "year": "2013", "journal-title": "Nutrition"}, {"key": "10.1111/cts.12475-BIB0018|cts12475-cit-0018", "doi-asserted-by": "crossref", "first-page": "778", "DOI": "10.1016/j.amjmed.2005.02.007", "article-title": "Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial", "volume": "118", "author": "O'Connell", "year": "2005", "journal-title": "Am. J. Med"}, {"key": "10.1111/cts.12475-BIB0019|cts12475-cit-0019", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1016/j.metabol.2012.09.011", "article-title": "Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: A prospective matched controlled study", "volume": "62", "author": "Sharara", "year": "2013", "journal-title": "Metabolism"}, {"key": "10.1111/cts.12475-BIB0020|cts12475-cit-0020", "doi-asserted-by": "crossref", "first-page": "2255", "DOI": "10.1007/s00296-013-2709-0", "article-title": "Bone density in proton pump inhibitors users: a prospective study", "volume": "33", "author": "Ozdil", "year": "2013", "journal-title": "Rheumatol. Int"}, {"key": "10.1111/cts.12475-BIB0021|cts12475-cit-0021", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1053/j.gastro.2009.11.014", "article-title": "Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss", "volume": "138", "author": "Targownik", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1111/cts.12475-BIB0022|cts12475-cit-0022", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1038/ajg.2012.200", "article-title": "The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study (corrected) from the Canadian Multicentre Osteoporosis Study (CaMos)", "volume": "107", "author": "Targownik", "year": "2012", "journal-title": "Am. J. Gastroenterol"}, {"key": "10.1111/cts.12475-BIB0023|cts12475-cit-0023", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.1016/j.bone.2013.09.014", "article-title": "Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals", "volume": "57", "author": "Maggio", "year": "2013", "journal-title": "Bone"}, {"key": "10.1111/cts.12475-BIB0024|cts12475-cit-0024", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1111/j.1742-1241.2008.01883.x", "article-title": "Proton pump inhibitor omeprazole use is associated with low bone mineral density in maintenance haemodialysis patients", "volume": "63", "author": "Kirkpantur", "year": "2009", "journal-title": "Int. J. Clin. Pract"}, {"key": "10.1111/cts.12475-BIB0025|cts12475-cit-0025", "doi-asserted-by": "crossref", "first-page": "e372", "DOI": "10.1136/bmj.e372", "article-title": "Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study", "volume": "344", "author": "Khalili", "year": "2012", "journal-title": "BMJ"}, {"key": "10.1111/cts.12475-BIB0026|cts12475-cit-0026", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1002/phar.1410", "article-title": "Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting", "volume": "34", "author": "Cea Soriano", "year": "2014", "journal-title": "Pharmacotherapy"}, {"key": "10.1111/cts.12475-BIB0027|cts12475-cit-0027", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1016/j.bone.2013.08.013", "article-title": "Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data", "volume": "57", "author": "Abrahamsen", "year": "2013", "journal-title": "Bone"}, {"key": "10.1111/cts.12475-BIB0028|cts12475-cit-0028", "doi-asserted-by": "crossref", "first-page": "1161", "DOI": "10.1007/s00198-012-2112-9", "article-title": "The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study", "volume": "24", "author": "Fraser", "year": "2013", "journal-title": "Osteoporos. Int"}, {"key": "10.1111/cts.12475-BIB0029|cts12475-cit-0029", "doi-asserted-by": "crossref", "first-page": "2489", "DOI": "10.1002/jbmr.2279", "article-title": "Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study", "volume": "29", "author": "Lewis", "year": "2014", "journal-title": "J. Bone Miner. Res"}, {"key": "10.1111/cts.12475-BIB0030|cts12475-cit-0030", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1007/s00223-006-0021-7", "article-title": "Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture", "volume": "79", "author": "Vestergaard", "year": "2006", "journal-title": "Calcif. Tissue Int"}, {"key": "10.1111/cts.12475-BIB0031|cts12475-cit-0031", "doi-asserted-by": "crossref", "first-page": "2947", "DOI": "10.1001/jama.296.24.2947", "article-title": "Long-term proton pump inhibitor therapy and risk of hip fracture", "volume": "296", "author": "Yang", "year": "2006", "journal-title": "JAMA"}, {"key": "10.1111/cts.12475-BIB0032|cts12475-cit-0032", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1007/s00223-008-9170-1", "article-title": "Acid-suppressive medications and risk of bone loss and fracture in older adults", "volume": "83", "author": "Yu", "year": "2008", "journal-title": "Calcif. Tissue Int"}, {"key": "10.1111/cts.12475-BIB0033|cts12475-cit-0033", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1503/cmaj.071330", "article-title": "Use of proton pump inhibitors and risk of osteoporosis-related fractures", "volume": "179", "author": "Targownik", "year": "2008", "journal-title": "CMAJ"}, {"key": "10.1111/cts.12475-BIB0034|cts12475-cit-0034", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1592/phco.28.8.951", "article-title": "Proton pump inhibitor use and risk of hip fractures in patients without major risk factors", "volume": "28", "author": "Kaye", "year": "2008", "journal-title": "Pharmacotherapy"}, {"key": "10.1111/cts.12475-BIB0035|cts12475-cit-0035", "doi-asserted-by": "crossref", "first-page": "1989", "DOI": "10.1007/s00198-009-0891-4", "article-title": "Fracture risk in patients receiving acid- suppressant medication alone and in combination with bisphosphonates", "volume": "20", "author": "Vries", "year": "2009", "journal-title": "Osteoporos. Int"}, {"key": "10.1111/cts.12475-BIB0036|cts12475-cit-0036", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1007/s00223-008-9188-4", "article-title": "Increase in vertebral fracture risk in postmenopausal women using omeprazole", "volume": "84", "author": "Roux", "year": "2009", "journal-title": "Calcif. Tissue Int"}, {"key": "10.1111/cts.12475-BIB0037|cts12475-cit-0037", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1053/j.gastro.2010.03.055", "article-title": "Proton Pump Inhibitors and Histamine-2 Receptor Antagonists are Associated with Hip Fractures among At-Risk Patients", "volume": "139", "author": "Corley", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1111/cts.12475-BIB0038|cts12475-cit-0038", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1001/archinternmed.2010.94", "article-title": "Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women", "volume": "170", "author": "Gray", "year": "2010", "journal-title": "Arch. Intern. Med"}, {"key": "10.1111/cts.12475-BIB0039|cts12475-cit-0039", "doi-asserted-by": "crossref", "first-page": "1131", "DOI": "10.1002/pds.2026", "article-title": "Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study", "volume": "19", "author": "Chiu", "year": "2010", "journal-title": "Pharmacoepidemiol. Drug Saf"}, {"key": "10.1111/cts.12475-BIB0040|cts12475-cit-0040", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1007/s00198-010-1337-8", "article-title": "Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study", "volume": "22", "author": "Pouwels", "year": "2011", "journal-title": "Osteoporos. Int"}, {"key": "10.1111/cts.12475-BIB0041|cts12475-cit-0041", "doi-asserted-by": "crossref", "first-page": "998", "DOI": "10.1001/archinternmed.2011.20", "article-title": "Proton pump inhibitor use and the antifracture efficacy of alendronate", "volume": "171", "author": "Abrahamsen", "year": "2011", "journal-title": "Arch. Intern. Med"}, {"key": "10.1111/cts.12475-BIB0042|cts12475-cit-0042", "doi-asserted-by": "crossref", "first-page": "1016", "DOI": "10.1007/s00535-012-0722-9", "article-title": "A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate", "volume": "48", "author": "Lee", "year": "2013", "journal-title": "Gastroenterology"}, {"key": "10.1111/cts.12475-BIB0043|cts12475-cit-0043", "doi-asserted-by": "crossref", "first-page": "557", "DOI": "10.1016/j.bone.2012.09.028", "article-title": "Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region", "volume": "52", "author": "Reyes", "year": "2013", "journal-title": "Bone"}, {"key": "10.1111/cts.12475-BIB0044|cts12475-cit-0044", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1007/s00223-014-9855-6", "article-title": "The relationship between proton pump inhibitor adherence and fracture risk in the elderly", "volume": "94", "author": "Ding", "year": "2014", "journal-title": "Calcif. Tissue Int"}, {"key": "10.1111/cts.12475-BIB0045|cts12475-cit-0045", "doi-asserted-by": "crossref", "first-page": "286", "DOI": "10.1016/j.annepidem.2014.01.004", "article-title": "Proton-pump inhibitor use and hip fractures in men: a population-based case-control study", "volume": "24", "author": "Adams", "year": "2014", "journal-title": "Ann. Epidemiol"}, {"key": "10.1111/cts.12475-BIB0046|cts12475-cit-0046", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1016/j.maturitas.2014.05.019", "article-title": "Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study", "volume": "78", "author": "Moberg", "year": "2014", "journal-title": "Maturitas"}, {"key": "10.1111/cts.12475-BIB0047|cts12475-cit-0047", "doi-asserted-by": "crossref", "first-page": "268", "DOI": "10.1002/jbmr.2011", "article-title": "Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study", "volume": "29", "author": "Prieto-Alhambra", "year": "2014", "journal-title": "J. Bone Miner. Res"}, {"key": "10.1111/cts.12475-BIB0048|cts12475-cit-0048", "doi-asserted-by": "crossref", "first-page": "2501", "DOI": "10.1007/s00198-015-3168-0", "article-title": "Use of proton pump inhibitors is associated with fractures in young adults: a population-based study", "volume": "26", "author": "Freedberg", "year": "2015", "journal-title": "Osteoporosis Int"}, {"key": "10.1111/cts.12475-BIB0049|cts12475-cit-0049", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1002/jbmr.2344", "article-title": "Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: A SWAN Cohort Study", "volume": "30", "author": "Solomon", "year": "2015", "journal-title": "J. Bone Miner. Res"}, {"key": "10.1111/cts.12475-BIB0050|cts12475-cit-0050", "doi-asserted-by": "crossref", "first-page": "1179", "DOI": "10.1053/j.gastro.2012.08.002", "article-title": "Burden of gastrointestinal disease in the United States", "volume": "143", "author": "Peery", "year": "2012", "journal-title": "Gastroenterology"}, {"key": "10.1111/cts.12475-BIB0051|cts12475-cit-0051", "unstructured": "AstraZeneca Annual Report and Form 20-F Information 2013 http://www.astrazeneca-annualreports.com/2013/_assets/pdfs/Strategic_report.pdf"}, {"key": "10.1111/cts.12475-BIB0052|cts12475-cit-0052", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1111/j.1365-2036.1995.tb00362.x", "article-title": "Prescribing of antacids and ulcer healing drugs in primary care in the north of England", "volume": "9", "author": "Roberts", "year": "1995", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/cts.12475-BIB0053|cts12475-cit-0053", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1111/j.1365-2036.2004.02120.x", "article-title": "Use of antisecretory medication: a population-based cohort study", "volume": "20", "author": "Lassen", "year": "2004", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/cts.12475-BIB0054|cts12475-cit-0054", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1136/bmj.308.6932.827", "article-title": "Long-term acid suppressing treatment in general practice", "volume": "308", "author": "Ryder", "year": "1994", "journal-title": "BMJ"}, {"key": "10.1111/cts.12475-BIB0055|cts12475-cit-0055", "doi-asserted-by": "crossref", "first-page": "813", "DOI": "10.1046/j.1365-2036.1999.00524.x", "article-title": "Survey on repeat prescribing for acid suppression drugs in primary care in Cornwall and the Isles of Scilly", "volume": "13", "author": "Boutet", "year": "1999", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/cts.12475-BIB0056|cts12475-cit-0056", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.3109/13814780309160421", "article-title": "The cost and cost-effectiveness of PPIs - GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centered healthcare", "volume": "9", "author": "Pollock", "year": "2003", "journal-title": "Eur. J. Gen. Pract"}, {"key": "10.1111/cts.12475-BIB0057|cts12475-cit-0057", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.1046/j.1365-2036.1998.00374.x", "article-title": "Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care", "volume": "12", "author": "Martin", "year": "1998", "journal-title": "Aliment. Pharmacol. Ther"}, {"key": "10.1111/cts.12475-BIB0058|cts12475-cit-0058", "first-page": "A1461", "article-title": "Proton Pump inhibitors Understanding the prescribing behaviour of general practitioners", "volume": "49", "author": "Raghunath", "year": "2001", "journal-title": "Gut"}, {"key": "10.1111/cts.12475-BIB0059|cts12475-cit-0059", "doi-asserted-by": "crossref", "first-page": "S21", "DOI": "10.1038/ajg.2009.48", "article-title": "Proton Pump Inhibitors and Bone Fractures?", "volume": "104", "author": "Laine", "year": "2009", "journal-title": "Am. J. Gastroenterol"}], "container-title": ["Clinical and Translational Science"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fcts.12475", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/cts.12475/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 9, 11]], "date-time": "2017-09-11T17:06:06Z", "timestamp": 1505149566000}, "score": 27.954191, "subtitle": ["Reformulation and the Long-Term Safety of PPIs"], "issued": {"date-parts": [[2017, 6, 15]]}, "references-count": 59, "journal-issue": {"published-print": {"date-parts": [[2017, 9]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1111/cts.12475", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1752-8054"], "issn-type": [{"value": "1752-8054", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T13:24:58Z", "timestamp": 1574429098295}, "reference-count": 25, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1939, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2012, 5]]}, "DOI": "10.1111/j.1445-5994.2010.02259.x", "type": "journal-article", "created": {"date-parts": [[2010, 5, 12]], "date-time": "2010-05-12T02:10:43Z", "timestamp": 1273630243000}, "page": "e68-e73", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Initiation and duration of proton pump inhibitors in the Australian veteran population"], "prefix": "10.1111", "volume": "42", "author": [{"given": "S. V.", "family": "Gadzhanova", "sequence": "first", "affiliation": []}, {"given": "E. E.", "family": "Roughead", "sequence": "additional", "affiliation": []}, {"given": "J. M.", "family": "Mackson", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 5, 11]]}, "reference": [{"key": "10.1111/j.1445-5994.2010.02259.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "iv35", "DOI": "10.1136/gut.2003.034314", "article-title": "Quality of life assessment in gastrooesophageal reflux disease", "volume": "53", "author": "Irvine", "year": "2004", "journal-title": "Gut"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB2|cit2", "first-page": "66", "article-title": "Estimating prevalence of common chronic morbidities in Australia", "volume": "189", "author": "Knox", "year": "2008", "journal-title": "Med J Aust"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB3|cit3", "first-page": "841", "article-title": "Systematic review: persistence and severity in gastrooesophageal reflux disease", "volume": "28", "author": "Armstrong", "year": "2008", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB4|cit4", "first-page": "987", "article-title": "Gastrooesophageal reflux disease: current concepts in management", "volume": "33", "author": "Piterman", "year": "2005", "journal-title": "Aust Fam Physician"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB5|cit5", "unstructured": "Medicare Australia Statistics Pharmaceutical Benefits Schedule Item Reports http://www.medicareaustralia.gov.au/provider/pbs/stats.jsp"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB6|cit6", "unstructured": "Gastroenterological Society of Australia Gastrooesophageal reflux disease in adults 2001"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB7|cit7", "author": "Rossi", "year": "2004", "volume-title": "Australian Medicines Handbook"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB8|cit8", "unstructured": "National Prescribing Service Limited Proton pump inhibitors: too much of a good thing?"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB9|cit9", "unstructured": "National Prescribing Service Limited Proton pump inhibitors in primary care"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB10|cit10", "unstructured": "Veterans' MATES PPIs in GORD: reduce the dose - keep the benefits http://www.veteransmates.net.au/VeteransMATES/documents/module_materials/M7_TherBrief.pdf"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "S54", "DOI": "10.1111/j.1440-1746.2004.03590.x", "article-title": "Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: the FAST survey", "volume": "19", "author": "Wong", "year": "2004", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB12|cit12", "unstructured": "National Prescribing Service Limited Optimising use of proton pump inhibitors - pre and post survey of GPs' knowledge and attitudes"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1007/s11096-006-9028-4", "article-title": "Continuation of proton pump inhibitors from hospital to community", "volume": "28", "author": "Grant", "year": "2006", "journal-title": "Pharm World Sci"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "116", "DOI": "10.1023/A:1011278030001", "article-title": "An evaluation of the use of proton pump inhibitors", "volume": "23", "author": "Walker", "year": "2001", "journal-title": "Pharm World Sci"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1111/j.1445-5994.2009.02105.x", "article-title": "Continuity of care: when do patients visit community healthcare providers after leaving hospital?", "volume": "41", "author": "Roughead", "year": "2011", "journal-title": "Int Med J"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1111/j.1753-6405.2009.00357.x", "article-title": "Validity of medication-based co-morbidity indices in the Australian elderly population", "volume": "33", "author": "Vitry", "year": "2009", "journal-title": "Aust N Z J Public Health"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1046/j.1365-2710.2000.00312.x", "article-title": "Overuse of proton pump inhibitors", "volume": "25", "author": "Naunton", "year": "2000", "journal-title": "J Clin Pharm Ther"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "1241", "DOI": "10.1111/j.1365-2036.2004.02289.x", "article-title": "Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?", "volume": "20", "author": "Lee", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1111/j.1365-2036.2005.02611.x", "article-title": "Review article: the long-term use of proton-pump inhibitors", "volume": "22", "author": "Raghunath", "year": "2005", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "377", "DOI": "10.1111/j.1365-2036.2006.02982.x", "article-title": "Persistence and adherence to proton pump inhibitors in daily clinical practice", "volume": "24", "author": "Van Soest", "year": "2006", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1053/j.gastro.2009.03.058", "article-title": "Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy", "volume": "137", "author": "Reimer", "year": "2009", "journal-title": "Gastroenterology"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB22|cit22", "unstructured": "Lloyd J Anderson P Australian Institute of Health and Welfare Veterans' use of health services"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB23|cit23", "unstructured": "Commonwealth Department of Health and Ageing PBS Expenditure and Prescriptions for 12\u2003months to 30 June 2008 http://www.health.gov.au/internet/main/publishing.nsf/Content/pbs-stats-pbexp-jun08"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1016/j.cgh.2005.11.004", "article-title": "Proton pump inhibitors and acute interstitial nephritis", "volume": "4", "author": "Geevasinga", "year": "2006", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1111/j.1445-5994.2010.02259.x-BIB25|cit25", "first-page": "115", "article-title": "Proton-pump inhibitors and the risk of antiobiotic use and hospitalisation for pneumonia", "volume": "190", "author": "Roughead", "year": "2009", "journal-title": "MJA"}], "container-title": ["Internal Medicine Journal"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.2010.02259.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T08:04:21Z", "timestamp": 1497859461000}, "score": 27.390406, "subtitle": ["Proton pump inhibitor duration in Australia"], "issued": {"date-parts": [[2010, 5, 11]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2012, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1111/j.1445-5994.2010.02259.x", "relation": {"cites": []}, "ISSN": ["1444-0903"], "issn-type": [{"value": "1444-0903", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:32:16Z", "timestamp": 1574688736801}, "reference-count": 33, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 144, "content-version": "tdm"}], "funder": [{"name": "Astra Zeneca supported this project", "award": ["1"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aliment Pharmacol Ther"], "published-print": {"date-parts": [[2015, 6]]}, "DOI": "10.1111/apt.13194", "type": "journal-article", "created": {"date-parts": [[2015, 4, 10]], "date-time": "2015-04-10T07:52:26Z", "timestamp": 1428652346000}, "page": "1162-1174", "source": "Crossref", "is-referenced-by-count": 58, "title": ["Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies"], "prefix": "10.1111", "volume": "41", "author": [{"given": "S. E.", "family": "Attwood", "sequence": "first", "affiliation": [{"name": "North Tyneside General Hospital; North Shields UK"}]}, {"given": "C.", "family": "Ell", "sequence": "additional", "affiliation": [{"name": "Sana Klinikum Offenbach; Frankfurt Germany"}]}, {"given": "J. P.", "family": "Galmiche", "sequence": "additional", "affiliation": [{"name": "H\u00f4tel Dieu-CHU de Nantes; Nantes France"}]}, {"given": "R.", "family": "Fiocca", "sequence": "additional", "affiliation": [{"name": "University of Genoa and IRCCS S. Martino; Genoa Italy"}]}, {"given": "J. G.", "family": "Hatlebakk", "sequence": "additional", "affiliation": [{"name": "Haukeland University Hospital; Bergen Norway"}]}, {"given": "B.", "family": "Hasselgren", "sequence": "additional", "affiliation": [{"name": "AstraZeneca R&D; M\u00f6lndal Sweden"}]}, {"given": "G.", "family": "L\u00e5ngstr\u00f6m", "sequence": "additional", "affiliation": [{"name": "AstraZeneca R&D; M\u00f6lndal Sweden"}]}, {"given": "M.", "family": "Jahreskog", "sequence": "additional", "affiliation": [{"name": "AstraZeneca R&D; M\u00f6lndal Sweden"}]}, {"given": "S.", "family": "Eklund", "sequence": "additional", "affiliation": [{"name": "AstraZeneca R&D; M\u00f6lndal Sweden"}]}, {"given": "T.", "family": "Lind", "sequence": "additional", "affiliation": [{"name": "AstraZeneca R&D; M\u00f6lndal Sweden"}]}, {"given": "L.", "family": "Lundell", "sequence": "additional", "affiliation": [{"name": "Department of Surgery; Centre for Digestive Diseases; Karolinska University Hospital; CLINTEC; Karolinska Institutet; Stockholm Sweden"}]}], "member": "311", "published-online": {"date-parts": [[2015, 4, 10]]}, "reference": [{"key": "10.1111/apt.13194-BIB0001|apt13194-cit-0001", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1038/nrgastro.2011.272", "article-title": "The risks of PPI therapy", "volume": "9", "author": "Moayyedi", "year": "2012", "journal-title": "Nat Rev Gastroenterol Hepatol"}, {"key": "10.1111/apt.13194-BIB0002|apt13194-cit-0002", "doi-asserted-by": "crossref", "first-page": "443", "DOI": "10.1016/j.bpg.2013.06.001", "article-title": "Safety of long-term PPI therapy", "volume": "27", "author": "Reimer", "year": "2013", "journal-title": "Best Pract Res Clin Gastroenterol"}, {"key": "10.1111/apt.13194-BIB0003|apt13194-cit-0003", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1016/j.amjmed.2009.04.014", "article-title": "Long-term safety concerns with proton pump inhibitors", "volume": "122", "author": "Ali", "year": "2009", "journal-title": "Am J Med"}, {"key": "10.1111/apt.13194-BIB0004|apt13194-cit-0004", "doi-asserted-by": "crossref", "first-page": "1708", "DOI": "10.1093/eurheartj/eht042", "article-title": "Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy", "volume": "34", "author": "Agewall", "year": "2013", "journal-title": "Eur Heart J"}, {"key": "10.1111/apt.13194-BIB0005|apt13194-cit-0005", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1097/MCG.0b013e3182333820", "article-title": "Recent safety concerns with proton pump inhibitors", "volume": "46", "author": "Chen", "year": "2012", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1111/apt.13194-BIB0006|apt13194-cit-0006", "doi-asserted-by": "crossref", "first-page": "959", "DOI": "10.1111/apt.12052", "article-title": "Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial", "volume": "36", "author": "Fiocca", "year": "2012", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/apt.13194-BIB0007|apt13194-cit-0007", "doi-asserted-by": "crossref", "first-page": "1015", "DOI": "10.1038/ajg.2009.631", "article-title": "Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial", "volume": "105", "author": "Fiocca", "year": "2010", "journal-title": "Am J Gastroenterol"}, {"key": "10.1111/apt.13194-BIB0008|apt13194-cit-0008", "doi-asserted-by": "crossref", "first-page": "1292", "DOI": "10.1016/j.cgh.2009.05.021", "article-title": "Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis", "volume": "7", "author": "Lundell", "year": "2009", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1111/apt.13194-BIB0009|apt13194-cit-0009", "doi-asserted-by": "crossref", "first-page": "1207", "DOI": "10.1136/gut.2008.148833", "article-title": "Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial", "volume": "57", "author": "Lundell", "year": "2008", "journal-title": "Gut"}, {"key": "10.1111/apt.13194-BIB0010|apt13194-cit-0010", "doi-asserted-by": "crossref", "first-page": "1969", "DOI": "10.1001/jama.2011.626", "article-title": "Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial", "volume": "305", "author": "Galmiche", "year": "2011", "journal-title": "JAMA"}, {"key": "10.1111/apt.13194-BIB0011|apt13194-cit-0011", "doi-asserted-by": "crossref", "first-page": "1249", "DOI": "10.1111/j.1365-2036.2009.03998.x", "article-title": "The clinical safety of long-term lansoprazole for the maintenance of healed erosive oesophagitis", "volume": "29", "author": "Freston", "year": "2009", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/apt.13194-BIB0012|apt13194-cit-0012", "doi-asserted-by": "crossref", "first-page": "399", "DOI": "10.1111/j.1365-2036.2004.02079.x", "article-title": "Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study", "volume": "20", "author": "Katz", "year": "2004", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/apt.13194-BIB0013|apt13194-cit-0013", "unstructured": "FDA FDA's Safety Reviews of Prilosec and Nexium Find No Evidence of Increased Rates of Cardiac Events http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109037.htm http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm143258.htm2007"}, {"key": "10.1111/apt.13194-BIB0014|apt13194-cit-0014", "doi-asserted-by": "crossref", "first-page": "1909", "DOI": "10.1056/NEJMoa1007964", "article-title": "Clopidogrel with or without omeprazole in coronary artery disease", "volume": "363", "author": "Bhatt", "year": "2010", "journal-title": "N Engl J Med"}, {"key": "10.1111/apt.13194-BIB0015|apt13194-cit-0015", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1016/S0140-6736(09)61525-7", "article-title": "Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials", "volume": "374", "author": "O'Donoghue", "year": "2009", "journal-title": "Lancet"}, {"key": "10.1111/apt.13194-BIB0016|apt13194-cit-0016", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1016/0016-5085(91)90197-S", "article-title": "Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat", "volume": "100", "author": "Mattsson", "year": "1991", "journal-title": "Gastroenterology"}, {"key": "10.1111/apt.13194-BIB0017|apt13194-cit-0017", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1111/apt.12012", "article-title": "Gastric carcinoids after long-term use of a proton pump inhibitor", "volume": "36", "author": "Jianu", "year": "2012", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/apt.13194-BIB0018|apt13194-cit-0018", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1007/s11894-010-0141-0", "article-title": "Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium", "volume": "12", "author": "Ito", "year": "2010", "journal-title": "Curr Gastroenterol Rep"}, {"key": "10.1111/apt.13194-BIB0019|apt13194-cit-0019", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.7326/0003-4819-120-3-199402010-00006", "article-title": "Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)", "volume": "120", "author": "Marcuard", "year": "1994", "journal-title": "Ann Intern Med"}, {"key": "10.1111/apt.13194-BIB0020|apt13194-cit-0020", "doi-asserted-by": "crossref", "first-page": "422", "DOI": "10.1016/j.jclinepi.2003.08.015", "article-title": "A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults", "volume": "57", "author": "Valuck", "year": "2004", "journal-title": "J Clin Epidemiol"}, {"key": "10.1111/apt.13194-BIB0021|apt13194-cit-0021", "doi-asserted-by": "crossref", "first-page": "2947", "DOI": "10.1001/jama.296.24.2947", "article-title": "Long-term proton pump inhibitor therapy and risk of hip fracture", "volume": "296", "author": "Yang", "year": "2006", "journal-title": "JAMA"}, {"key": "10.1111/apt.13194-BIB0022|apt13194-cit-0022", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1007/s00223-006-0021-7", "article-title": "Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture", "volume": "79", "author": "Vestergaard", "year": "2006", "journal-title": "Calcif Tissue Int"}, {"key": "10.1111/apt.13194-BIB0023|apt13194-cit-0023", "doi-asserted-by": "crossref", "first-page": "896", "DOI": "10.1053/j.gastro.2009.11.014", "article-title": "Proton pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss", "volume": "138", "author": "Targownik", "year": "2010", "journal-title": "Gastroenterology"}, {"key": "10.1111/apt.13194-BIB0024|apt13194-cit-0024", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1592/phco.28.8.951", "article-title": "Proton pump inhibitor use and risk of hip fractures in patients without major risk factors", "volume": "28", "author": "Kaye", "year": "2008", "journal-title": "Pharmacotherapy"}, {"issue": "Suppl. 3", "key": "10.1111/apt.13194-BIB0025|apt13194-cit-0025", "first-page": "A36", "article-title": "A UK primary care study on acid-suppressive drugs and hip fracture: is there a link?", "volume": "60", "author": "Garcia Rodriguez", "year": "2011", "journal-title": "Gut"}, {"key": "10.1111/apt.13194-BIB0026|apt13194-cit-0026", "doi-asserted-by": "crossref", "first-page": "1418", "DOI": "10.1016/j.cgh.2007.09.010", "article-title": "Use of acid-suppressing drugs and the risk of bacterial gastroenteritis", "volume": "5", "author": "Garcia Rodriguez", "year": "2007", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "10.1111/apt.13194-BIB0027|apt13194-cit-0027", "doi-asserted-by": "crossref", "first-page": "414", "DOI": "10.1136/bmj.312.7028.414", "article-title": "Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study", "volume": "312", "author": "Neal", "year": "1996", "journal-title": "BMJ"}, {"key": "10.1111/apt.13194-BIB0028|apt13194-cit-0028", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0195-6701(03)00088-4", "article-title": "Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea", "volume": "54", "author": "Cunningham", "year": "2003", "journal-title": "J Hosp Infect"}, {"key": "10.1111/apt.13194-BIB0029|apt13194-cit-0029", "doi-asserted-by": "crossref", "first-page": "1955", "DOI": "10.1001/jama.292.16.1955", "article-title": "Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs", "volume": "292", "author": "Laheij", "year": "2004", "journal-title": "JAMA"}, {"key": "10.1111/apt.13194-BIB0030|apt13194-cit-0030", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1001/archinte.167.9.950", "article-title": "Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study", "volume": "167", "author": "Gulmez", "year": "2007", "journal-title": "Arch Intern Med"}, {"key": "10.1111/apt.13194-BIB0031|apt13194-cit-0031", "doi-asserted-by": "crossref", "first-page": "391", "DOI": "10.7326/0003-4819-149-6-200809160-00005", "article-title": "Proton-pump inhibitor use and the risk for community-acquired pneumonia", "volume": "149", "author": "Sarkar", "year": "2008", "journal-title": "Ann Intern Med"}, {"key": "10.1111/apt.13194-BIB0032|apt13194-cit-0032", "doi-asserted-by": "crossref", "first-page": "792", "DOI": "10.1002/pds.1978", "article-title": "Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study", "volume": "19", "author": "Dublin", "year": "2010", "journal-title": "Pharmacoepidemiol Drug Saf"}, {"key": "10.1111/apt.13194-BIB0033|apt13194-cit-0033", "unstructured": "Estborn L Joelson S Frequency and time to onset of respiratory tract infections in esomeprazole and placebo treated patients in 24 randomized controlled trials (UEGW 2013 poster P1617) 2013"}], "container-title": ["Alimentary Pharmacology & Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fapt.13194", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T09:05:20Z", "timestamp": 1498208720000}, "score": 26.83847, "issued": {"date-parts": [[2015, 4, 10]]}, "references-count": 33, "journal-issue": {"published-print": {"date-parts": [[2015, 6]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1111/apt.13194", "relation": {"cites": []}, "ISSN": ["0269-2813"], "issn-type": [{"value": "0269-2813", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T18:09:38Z", "timestamp": 1575310178232}, "reference-count": 153, "publisher": "Wiley", "issue": "10", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2018, 7, 20]], "date-time": "2018-07-20T00:00:00Z", "timestamp": 1532044800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2018, 7, 20]], "date-time": "2018-07-20T00:00:00Z", "timestamp": 1532044800000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Br J Clin Pharmacol"], "published-print": {"date-parts": [[2018, 10]]}, "DOI": "10.1111/bcp.13656", "type": "journal-article", "created": {"date-parts": [[2018, 6, 4]], "date-time": "2018-06-04T15:49:49Z", "timestamp": 1528127389000}, "page": "2218-2230", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Long-term adverse effects of paracetamol - a review"], "prefix": "10.1111", "volume": "84", "author": [{"ORCID": "http://orcid.org/0000-0002-1009-0404", "authenticated-orcid": false, "given": "J. C.", "family": "McCrae", "sequence": "first", "affiliation": [{"name": "BHF Centre of Research Excellence (CoRE); Queen's Medical Research Institute, Pharmacology, Toxicology & Therapeutics; Edinburgh UK"}]}, {"ORCID": "http://orcid.org/0000-0003-4478-1550", "authenticated-orcid": false, "given": "E. E.", "family": "Morrison", "sequence": "additional", "affiliation": [{"name": "BHF Centre of Research Excellence (CoRE); Queen's Medical Research Institute, Pharmacology, Toxicology & Therapeutics; Edinburgh UK"}]}, {"ORCID": "http://orcid.org/0000-0003-4420-3822", "authenticated-orcid": false, "given": "I. M.", "family": "MacIntyre", "sequence": "additional", "affiliation": [{"name": "BHF Centre of Research Excellence (CoRE); Queen's Medical Research Institute, Pharmacology, Toxicology & Therapeutics; Edinburgh UK"}]}, {"ORCID": "http://orcid.org/0000-0002-8630-8625", "authenticated-orcid": false, "given": "J. W.", "family": "Dear", "sequence": "additional", "affiliation": [{"name": "BHF Centre of Research Excellence (CoRE); Queen's Medical Research Institute, Pharmacology, Toxicology & Therapeutics; Edinburgh UK"}]}, {"ORCID": "http://orcid.org/0000-0003-0755-1756", "authenticated-orcid": false, "given": "D. J.", "family": "Webb", "sequence": "additional", "affiliation": [{"name": "BHF Centre of Research Excellence (CoRE); Queen's Medical Research Institute, Pharmacology, Toxicology & Therapeutics; Edinburgh UK"}]}], "member": "311", "published-online": {"date-parts": [[2018, 7, 20]]}, "reference": [{"key": "10.1111/bcp.13656-BIB0001|bcp13656-cit-0002", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1002/cber.18780110151", "article-title": "Ueber eine neue darstellungsmethode der acetylamidophenole", "volume": "11", "author": "Morse", "year": "1878", "journal-title": "Ber Dtsch Chem Ges"}, {"key": "10.1111/bcp.13656-BIB0002|bcp13656-cit-0003", "first-page": "74", "article-title": "Paracetamol in critical illness: a review", "volume": "14", "author": "Jefferies", "year": "2012", "journal-title": "Crit Care Resusc"}, {"key": "10.1111/bcp.13656-BIB0003|bcp13656-cit-0004", "first-page": "577", "article-title": "Beitrage zur Kenntniss der antipyretica", "volume": "7", "author": "Von Mering", "year": "1893", "journal-title": "Ther Monatsch"}, {"key": "10.1111/bcp.13656-BIB0004|bcp13656-cit-0005", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1111/1753-6405.12252", "article-title": "The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia", "volume": "38", "author": "Antoni", "year": "2014", "journal-title": "Aust N Z J Public Health"}, {"key": "10.1111/bcp.13656-BIB0005|bcp13656-cit-0006", "doi-asserted-by": "crossref", "first-page": "250", "DOI": "10.1111/j.1527-3458.2006.00250.x", "article-title": "Paracetamol: new vistas of an old drug", "volume": "12", "author": "Bertolini", "year": "2006", "journal-title": "CNS Drug Rev"}, {"key": "10.1111/bcp.13656-BIB0006|bcp13656-cit-0007", "doi-asserted-by": "crossref", "first-page": "552", "DOI": "10.1136/annrheumdis-2014-206914", "article-title": "Paracetamol: not as safe as we thought? A systematic literature review of observational studies", "volume": "75", "author": "Roberts", "year": "2015", "journal-title": "Ann Rheum Dis"}, {"key": "10.1111/bcp.13656-BIB0007|bcp13656-cit-0008", "unstructured": "World Health Organization Cancer pain relief: with a guide to opioid availability http://www.who.int/iris/handle/10665/37896"}, {"key": "10.1111/bcp.13656-BIB0008|bcp13656-cit-0009", "unstructured": "Paracetamol 500\u00a0mg tablets - summary of product characteristics (SmPC) - (eMC) [online] http://medicines.org.uk https://www.medicines.org.uk/emc/product/4195"}, {"key": "10.1111/bcp.13656-BIB0009|bcp13656-cit-0010", "unstructured": "Saragiotto BT Machado GC Ferreira ML Pinheiro MB Abdel Shaheed C Maher CG Paracetamol for low back pain http://doi.wiley.com/10.1002/14651858.CD012230"}, {"key": "10.1111/bcp.13656-BIB0010|bcp13656-cit-0011", "unstructured": "Towheed T Maxwell L Judd M Catton M Hochberg MC Wells GA Acetaminophen for osteoarthritis http://doi.wiley.com/10.1002/14651858.CD004257.pub2"}, {"key": "10.1111/bcp.13656-BIB0011|bcp13656-cit-0012", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1016/j.joca.2010.01.013", "article-title": "OARSI recommendations for the management of hip and knee osteoarthritis", "volume": "18", "author": "Zhang", "year": "2010", "journal-title": "Osteoarthritis Cartilage"}, {"key": "10.1111/bcp.13656-BIB0012|bcp13656-cit-0013", "doi-asserted-by": "crossref", "first-page": "901", "DOI": "10.1136/ard.2003.018531", "article-title": "Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials", "volume": "63", "author": "Zhang", "year": "2004", "journal-title": "Ann Rheum Dis"}, {"key": "10.1111/bcp.13656-BIB0013|bcp13656-cit-0014", "unstructured": "National Institute for Health and Care Excellence Osteoarthritis: care and management https://www.nice.org.uk/guidance/cg177?unlid=124915017201652233315"}, {"key": "10.1111/bcp.13656-BIB0014|bcp13656-cit-0015", "unstructured": "Price C NICE forced into U-turn on advice to avoid paracetamol in osteoarthritis [online] http://www.pulsetoday.co.uk/clinical/more-clinical-areas/musculoskeletal/nice-forced-into-u-turn-on-advice-to-avoid-paracetamol-in-osteoarthritis/20005837.article"}, {"key": "10.1111/bcp.13656-BIB0015|bcp13656-cit-0016", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.3109/15360288.2015.1037521", "article-title": "The epidemic of prescription opioid abuse, the subsequent rising prevalence of heroin use, and the federal response", "volume": "29", "author": "Kanouse", "year": "2015", "journal-title": "J Pain Palliat Care Pharmacother"}, {"key": "10.1111/bcp.13656-BIB0016|bcp13656-cit-0017", "doi-asserted-by": "crossref", "first-page": "j790", "DOI": "10.1136/bmj.j790", "article-title": "Could we see a prescription opioid epidemic in the UK?", "volume": "356", "author": "Basler", "year": "2017", "journal-title": "BMJ"}, {"key": "10.1111/bcp.13656-BIB0017|bcp13656-cit-0018", "doi-asserted-by": "crossref", "first-page": "1343", "DOI": "10.1002/j.1532-2149.2014.496.x", "article-title": "Changes in trends and pattern of strong opioid prescribing in primary care", "volume": "18", "author": "Zin", "year": "2014", "journal-title": "Eur J Pain"}, {"key": "10.1111/bcp.13656-BIB0018|bcp13656-cit-0019", "doi-asserted-by": "crossref", "first-page": "d2218", "DOI": "10.1136/bmj.d2218", "article-title": "Management of paracetamol poisoning", "volume": "342", "author": "Ferner", "year": "2011", "journal-title": "BMJ"}, {"key": "10.1111/bcp.13656-BIB0019|bcp13656-cit-0020", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1007/s10787-013-0172-x", "article-title": "The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings", "volume": "21", "author": "Graham", "year": "2013", "journal-title": "Inflammopharmacology"}, {"key": "10.1111/bcp.13656-BIB0020|bcp13656-cit-0021", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1016/j.joen.2015.01.024", "article-title": "Acetaminophen: old drug, new issues", "volume": "41", "author": "Aminoshariae", "year": "2015", "journal-title": "J Endod"}, {"key": "10.1111/bcp.13656-BIB0021|bcp13656-cit-0022", "doi-asserted-by": "crossref", "first-page": "46", "DOI": "10.1097/00045391-200501000-00008", "article-title": "Mechanism of action of paracetamol", "volume": "12", "author": "Graham", "year": "2005", "journal-title": "Am J Ther"}, {"key": "10.1111/bcp.13656-BIB0022|bcp13656-cit-0023", "doi-asserted-by": "crossref", "first-page": "31405", "DOI": "10.1074/jbc.M501489200", "article-title": "Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system", "volume": "280", "author": "H\u00f6gest\u00e4tt", "year": "2005", "journal-title": "J Biol Chem"}, {"key": "10.1111/bcp.13656-BIB0023|bcp13656-cit-0024", "doi-asserted-by": "crossref", "first-page": "e12748", "DOI": "10.1371/journal.pone.0012748", "article-title": "TRPV1 in brain is involved in acetaminophen-induced antinociception", "volume": "5", "author": "Mallet", "year": "2010", "journal-title": "PLOS ONE"}, {"key": "10.1111/bcp.13656-BIB0024|bcp13656-cit-0025", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1038/ncomms1559", "article-title": "TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid \u03949-tetrahydrocannabiorcol", "volume": "2", "author": "Andersson", "year": "2011", "journal-title": "Nat Commun"}, {"key": "10.1111/bcp.13656-BIB0025|bcp13656-cit-0026", "doi-asserted-by": "crossref", "first-page": "e113841", "DOI": "10.1371/journal.pone.0113841", "article-title": "Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1", "volume": "9", "author": "Fresno", "year": "2014", "journal-title": "PLoS One"}, {"key": "10.1111/bcp.13656-BIB0026|bcp13656-cit-0027", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1097/FPC.0000000000000150", "article-title": "PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses", "volume": "25", "author": "Mazaleuskaya", "year": "2015", "journal-title": "Pharmacogenet Genomics"}, {"key": "10.1111/bcp.13656-BIB0027|bcp13656-cit-0028", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1161/CIRCULATIONAHA.105.595793", "article-title": "Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events", "volume": "113", "author": "Chan", "year": "2006", "journal-title": "Circulation"}, {"key": "10.1111/bcp.13656-BIB0028|bcp13656-cit-0029", "doi-asserted-by": "crossref", "first-page": "1396", "DOI": "10.1111/bcp.12032", "article-title": "A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects", "volume": "75", "author": "Turtle", "year": "2013", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0029|bcp13656-cit-0030", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1016/S0002-9343(98)00091-6", "article-title": "Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs", "volume": "104", "author": "Cryer", "year": "1998", "journal-title": "Am J Med"}, {"key": "10.1111/bcp.13656-BIB0030|bcp13656-cit-0031", "first-page": "1077", "article-title": "Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients", "volume": "6", "author": "Chalmers", "year": "1984", "journal-title": "Clin Exp Hypertens"}, {"key": "10.1111/bcp.13656-BIB0031|bcp13656-cit-0032", "unstructured": "National Institute for Health and Care Excellence Hypertension in adults: diagnosis and management https://www.nice.org.uk/guidance/CG127"}, {"key": "10.1111/bcp.13656-BIB0032|bcp13656-cit-0033", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1161/01.HYP.0000035856.77718.DA", "article-title": "Nonnarcotic analgesic use and the risk of hypertension in US women", "volume": "40", "author": "Dedier", "year": "2002", "journal-title": "Hypertension"}, {"key": "10.1111/bcp.13656-BIB0033|bcp13656-cit-0034", "doi-asserted-by": "crossref", "first-page": "2204", "DOI": "10.1001/archinte.162.19.2204", "article-title": "Frequency of analgesic use and risk of hypertension in younger women", "volume": "162", "author": "Curhan", "year": "2002", "journal-title": "Arch Intern Med"}, {"key": "10.1111/bcp.13656-BIB0034|bcp13656-cit-0035", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1001/archinte.167.4.394", "article-title": "Frequency of analgesic use and risk of hypertension among men", "volume": "167", "author": "Forman", "year": "2007", "journal-title": "Arch Intern Med"}, {"key": "10.1111/bcp.13656-BIB0035|bcp13656-cit-0036", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.1001/archinte.165.16.1903", "article-title": "Analgesic use and risk of subsequent hypertension in apparently healthy men", "volume": "165", "author": "Kurth", "year": "2005", "journal-title": "Arch Intern Med"}, {"key": "10.1111/bcp.13656-BIB0036|bcp13656-cit-0037", "doi-asserted-by": "crossref", "first-page": "1485", "DOI": "10.1097/HJH.0b013e328360f6f8", "article-title": "Acetaminophen use and change in blood pressure in a hypertensive population", "volume": "31", "author": "Dawson", "year": "2013", "journal-title": "J Hypertens"}, {"key": "10.1111/bcp.13656-BIB0037|bcp13656-cit-0038", "doi-asserted-by": "crossref", "first-page": "500", "DOI": "10.1161/01.HYP.0000177437.07240.70", "article-title": "Non-narcotic analgesic dose and risk of incident hypertension in US women", "volume": "46", "author": "Forman", "year": "2005", "journal-title": "Hypertension"}, {"key": "10.1111/bcp.13656-BIB0038|bcp13656-cit-0039", "doi-asserted-by": "crossref", "first-page": "1789", "DOI": "10.1161/CIRCULATIONAHA.110.956490", "article-title": "Acetaminophen increases blood pressure in patients with coronary artery disease", "volume": "122", "author": "Sudano", "year": "2010", "journal-title": "Circulation"}, {"key": "10.1111/bcp.13656-BIB0039|bcp13656-cit-0040", "doi-asserted-by": "crossref", "first-page": "1008", "DOI": "10.1161/HYPERTENSIONAHA.114.04945", "article-title": "Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort", "volume": "65", "author": "Fulton", "year": "2015", "journal-title": "Hypertension"}, {"key": "10.1111/bcp.13656-BIB0040|bcp13656-cit-0041", "doi-asserted-by": "crossref", "first-page": "826", "DOI": "10.1136/adc.65.8.826", "article-title": "Trends in the incidence of Reye's syndrome and the use of aspirin", "volume": "65", "author": "Porter", "year": "1990", "journal-title": "Arch Dis Child"}, {"key": "10.1111/bcp.13656-BIB0041|bcp13656-cit-0042", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1136/bmj.322.7302.1591", "article-title": "Reye's syndrome and aspirin: lest we forget", "volume": "322", "author": "McGovern", "year": "2001", "journal-title": "BMJ"}, {"key": "10.1111/bcp.13656-BIB0042|bcp13656-cit-0043", "unstructured": "Global Asthma Network The global asthma report [online] http://www.globalasthmareport.org/resources/Global_Asthma_Report_2014.pdf"}, {"key": "10.1111/bcp.13656-BIB0043|bcp13656-cit-0044", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1016/S1081-1206(10)63127-4", "article-title": "Hypothesis: decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma", "volume": "81", "author": "Varner", "year": "1998", "journal-title": "Ann Allergy Asthma Immunol"}, {"key": "10.1111/bcp.13656-BIB0044|bcp13656-cit-0045", "doi-asserted-by": "crossref", "first-page": "1316", "DOI": "10.1378/chest.09-0865", "article-title": "Acetaminophen use and the risk of asthma in children and adults: a systematic review and meta analysis", "volume": "136", "author": "Etminan", "year": "2009", "journal-title": "Chest"}, {"key": "10.1111/bcp.13656-BIB0045|bcp13656-cit-0046", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.aller.2012.07.012", "article-title": "Asthma and paracetamol: could we really know what happens between them?", "volume": "41", "author": "Moral", "year": "2013", "journal-title": "Allergol Immunopathol"}, {"key": "10.1111/bcp.13656-BIB0046|bcp13656-cit-0047", "first-page": "32", "article-title": "The role of paracetamol in the pathogenesis of asthma", "volume": "40", "author": "Farquhar", "year": "2010", "journal-title": "Clin Exp Allergy"}, {"key": "10.1111/bcp.13656-BIB0047|bcp13656-cit-0048", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1080/02770900802165998", "article-title": "Intake of paracetamol and risk of asthma in adults", "volume": "45", "author": "Thomsen", "year": "2008", "journal-title": "J Asthma"}, {"key": "10.1111/bcp.13656-BIB0048|bcp13656-cit-0049", "doi-asserted-by": "crossref", "first-page": "836", "DOI": "10.1164/rccm.200304-596OC", "article-title": "Prospective study of acetaminophen use and newly diagnosed asthma among women", "volume": "169", "author": "Barr", "year": "2004", "journal-title": "Am J Respir Crit Care Med"}, {"key": "10.1111/bcp.13656-BIB0049|bcp13656-cit-0050", "doi-asserted-by": "crossref", "first-page": "966", "DOI": "10.1164/rccm.200409-1269OC", "article-title": "The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function", "volume": "171", "author": "McKeever", "year": "2005", "journal-title": "Am J Respir Crit Care Med"}, {"key": "10.1111/bcp.13656-BIB0050|bcp13656-cit-0051", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1183/09031936.00.16581700", "article-title": "Paracetamol sales and atopic disease in children and adults: an ecological analysis", "volume": "16", "author": "Newson", "year": "2000", "journal-title": "Eur Respir J"}, {"key": "10.1111/bcp.13656-BIB0051|bcp13656-cit-0052", "doi-asserted-by": "crossref", "first-page": "266", "DOI": "10.1136/thorax.55.4.266", "article-title": "Frequent paracetamol use and asthma in adults", "volume": "55", "author": "Shaheen", "year": "2000", "journal-title": "Thorax"}, {"key": "10.1111/bcp.13656-BIB0052|bcp13656-cit-0053", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1136/archdischild-2012-303043", "article-title": "Paracetamol exposure in pregnancy and early childhood and development of childhood asthma: a systematic review and meta-analysis", "volume": "100", "author": "Cheelo", "year": "2015", "journal-title": "Arch Dis Child"}, {"key": "10.1111/bcp.13656-BIB0053|bcp13656-cit-0054", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1164/rccm.200802-309OC", "article-title": "Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children", "volume": "178", "author": "Jackson", "year": "2008", "journal-title": "Am J Respir Crit Care Med"}, {"key": "10.1111/bcp.13656-BIB0054|bcp13656-cit-0055", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1016/j.jaci.2009.11.039", "article-title": "Adolescents with asthma or atopic eczema have more febrile days in early childhood: a possible explanation for the connection between paracetamol and asthma?", "volume": "125", "author": "Tapiainen", "year": "2010", "journal-title": "J Allergy Clin Immunol"}, {"key": "10.1111/bcp.13656-BIB0055|bcp13656-cit-0056", "doi-asserted-by": "crossref", "first-page": "c4616", "DOI": "10.1136/bmj.c4616", "article-title": "Paracetamol use in early life and asthma: prospective birth cohort study", "volume": "341", "author": "Lowe", "year": "2010", "journal-title": "BMJ"}, {"key": "10.1111/bcp.13656-BIB0056|bcp13656-cit-0057", "doi-asserted-by": "crossref", "first-page": "165", "DOI": "10.1164/rccm.201006-0989OC", "article-title": "The role of acetaminophen and geohelminth infection on the incidence of wheeze and eczema: a longitudinal birth-cohort study", "volume": "183", "author": "Amberbir", "year": "2011", "journal-title": "Am J Respir Crit Care Med"}, {"key": "10.1111/bcp.13656-BIB0057|bcp13656-cit-0058", "doi-asserted-by": "crossref", "first-page": "1197", "DOI": "10.1007/s00228-012-1463-7", "article-title": "The case of drug causation of childhood asthma: antibiotics and paracetamol", "volume": "69", "author": "Heintze", "year": "2013", "journal-title": "Eur J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0058|bcp13656-cit-0059", "doi-asserted-by": "crossref", "first-page": "413", "DOI": "10.1038/clpt.1987.50", "article-title": "Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans", "volume": "41", "author": "Slattery", "year": "1987", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1111/bcp.13656-BIB0059|bcp13656-cit-0060", "doi-asserted-by": "crossref", "first-page": "1141", "DOI": "10.1002/hep.1840190511", "article-title": "Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency", "volume": "19", "author": "Bonkovsky", "year": "1994", "journal-title": "Hepatology"}, {"key": "10.1111/bcp.13656-BIB0060|bcp13656-cit-0061", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/j.prrv.2012.04.004", "article-title": "Acetaminophen and asthma", "volume": "14", "author": "Henderson", "year": "2013", "journal-title": "Paediatr Respir Rev"}, {"key": "10.1111/bcp.13656-BIB0061|bcp13656-cit-0062", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1007/s11882-009-0024-3", "article-title": "Acetaminophen use: a risk for asthma?", "volume": "9", "author": "Allmers", "year": "2009", "journal-title": "Curr Allergy Asthma Rep"}, {"key": "10.1111/bcp.13656-BIB0062|bcp13656-cit-0063", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1378/chest.127.2.604", "article-title": "Acetaminophen and the risk of asthma: the epidemiologic and pathophysiologic evidence", "volume": "127", "author": "Eneli", "year": "2005", "journal-title": "Chest"}, {"key": "10.1111/bcp.13656-BIB0063|bcp13656-cit-0064", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1007/s004320000228", "article-title": "The glutathione-related detoxification system is increased in human breast cancer in correlation with clinical and histopathological features", "volume": "127", "author": "Perquin", "year": "2001", "journal-title": "J Cancer Res Clin Oncol"}, {"key": "10.1111/bcp.13656-BIB0064|bcp13656-cit-0065", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1046/j.1365-2710.2003.00492.x", "article-title": "Does paracetamol cause asthma?", "volume": "28", "author": "Nuttall", "year": "2003", "journal-title": "J Clin Pharm Ther"}, {"key": "10.1111/bcp.13656-BIB0065|bcp13656-cit-0066", "doi-asserted-by": "crossref", "first-page": "1470", "DOI": "10.1378/chest.118.5.1470", "article-title": "Aspirin and asthma", "volume": "118", "author": "Babu", "year": "2000", "journal-title": "Chest"}, {"key": "10.1111/bcp.13656-BIB0066|bcp13656-cit-0067", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1016/0091-6749(89)90174-7", "article-title": "Cross sensitivity with acetaminophen in aspirin-sensitive subjects with asthma", "volume": "84", "author": "Settipane", "year": "1989", "journal-title": "J Allergy Clin Immunol"}, {"key": "10.1111/bcp.13656-BIB0067|bcp13656-cit-0068", "doi-asserted-by": "crossref", "first-page": "480", "DOI": "10.1016/S0091-6749(95)70290-3", "article-title": "Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects", "volume": "96", "author": "Settipane", "year": "1995", "journal-title": "J Allergy Clin Immunol"}, {"key": "10.1111/bcp.13656-BIB0068|bcp13656-cit-0069", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1016/j.iac.2004.03.001", "article-title": "Aspirin and NSAID sensitivity", "volume": "24", "author": "Stevenson", "year": "2004", "journal-title": "Immunol Allergy Clin North Am"}, {"key": "10.1111/bcp.13656-BIB0069|bcp13656-cit-0070", "doi-asserted-by": "crossref", "first-page": "17", "DOI": "10.1007/s11882-004-0037-x", "article-title": "Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs", "volume": "4", "author": "Simon", "year": "2004", "journal-title": "Curr Allergy Asthma Rep"}, {"key": "10.1111/bcp.13656-BIB0070|bcp13656-cit-0071", "doi-asserted-by": "crossref", "first-page": "e004324", "DOI": "10.1136/bmjopen-2013-004324", "article-title": "Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults", "volume": "4", "author": "Ioannides", "year": "2014", "journal-title": "BMJ Open"}, {"key": "10.1111/bcp.13656-BIB0071|bcp13656-cit-0072", "doi-asserted-by": "crossref", "first-page": "619", "DOI": "10.1056/NEJMoa1515990", "article-title": "Acetaminophen versus ibuprofen in young children with mild persistent asthma", "volume": "375", "author": "Sheehan", "year": "2016", "journal-title": "N Engl J Med"}, {"key": "10.1111/bcp.13656-BIB0072|bcp13656-cit-0073", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1136/adc.74.2.164", "article-title": "Comparing efficacy and tolerability of ibuprofen and paracetamol in fever", "volume": "74", "author": "McIntyre", "year": "1996", "journal-title": "Arch Dis Child"}, {"key": "10.1111/bcp.13656-BIB0073|bcp13656-cit-0074", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1177/014107688007301004", "article-title": "Long-term ingestion of paracetamol and liver disease", "volume": "73", "author": "Neuberger", "year": "1980", "journal-title": "J R Soc Med"}, {"key": "10.1111/bcp.13656-BIB0074|bcp13656-cit-0075", "doi-asserted-by": "crossref", "first-page": "h3705", "DOI": "10.1136/bmj.h3705", "article-title": "Where are we now with paracetamol?", "volume": "351", "author": "Dear", "year": "2015", "journal-title": "BMJ"}, {"key": "10.1111/bcp.13656-BIB0075|bcp13656-cit-0076", "author": "Hinson", "first-page": "369", "year": "2010", "article-title": "Mechanisms of acetaminophen-induced liver necrosis", "journal-title": "Handb Exp Pharmacol", "DOI": "10.1007/978-3-642-00663-0_12", "doi-asserted-by": "crossref"}, {"key": "10.1111/bcp.13656-BIB0076|bcp13656-cit-0077", "doi-asserted-by": "crossref", "first-page": "1534", "DOI": "10.1136/ard.2011.154047", "article-title": "A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain", "volume": "70", "author": "Doherty", "year": "2011", "journal-title": "Ann Rheum Dis"}, {"key": "10.1111/bcp.13656-BIB0077|bcp13656-cit-0078", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1007/s11096-004-9008-5", "article-title": "Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol", "volume": "26", "author": "Blot", "year": "2004", "journal-title": "Pharm World Sci"}, {"key": "10.1111/bcp.13656-BIB0078|bcp13656-cit-0079", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1517/14740338.3.4.269", "article-title": "Gastrointestinal safety of paracetamol: is there any cause for concern?", "volume": "3", "author": "Bannwarth", "year": "2004", "journal-title": "Expert Opin Drug Saf"}, {"key": "10.1111/bcp.13656-BIB0079|bcp13656-cit-0080", "doi-asserted-by": "crossref", "first-page": "255", "DOI": "10.1016/0895-4356(95)00539-0", "article-title": "Aspirin or acetaminophen? A comparison from data collected by the Spanish drug monitoring system", "volume": "49", "author": "Carvajal", "year": "1996", "journal-title": "J Clin Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0080|bcp13656-cit-0081", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1046/j.1365-2125.2002.01636.x", "article-title": "Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data", "volume": "54", "author": "Lewis", "year": "2002", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0081|bcp13656-cit-0082", "doi-asserted-by": "crossref", "first-page": "570", "DOI": "10.1097/00001648-200109000-00018", "article-title": "Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs", "volume": "12", "author": "Rodr\u00edguez", "year": "2001", "journal-title": "Epidemiology"}, {"key": "10.1111/bcp.13656-BIB0082|bcp13656-cit-0083", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1111/j.1742-7843.2006.pto_248.x", "article-title": "Upper gastrointestinal complications among users of paracetamol", "volume": "98", "author": "Gonz\u00e1lez-P\u00e9rez", "year": "2006", "journal-title": "Basic Clin Pharmacol Toxicol"}, {"key": "10.1111/bcp.13656-BIB0083|bcp13656-cit-0084", "doi-asserted-by": "crossref", "first-page": "872", "DOI": "10.1111/j.1572-0241.2008.01811.x", "article-title": "Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada", "volume": "103", "author": "Rahme", "year": "2008", "journal-title": "Am J Gastroenterol"}, {"key": "10.1111/bcp.13656-BIB0084|bcp13656-cit-0085", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1111/j.1572-0241.1998.00327.x", "article-title": "An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen", "volume": "93", "author": "Lanza", "year": "1998", "journal-title": "Am J Gastroenterol"}, {"key": "10.1111/bcp.13656-BIB0085|bcp13656-cit-0086", "doi-asserted-by": "crossref", "first-page": "1045", "DOI": "10.1161/STROKEAHA.115.012091", "article-title": "Paracetamol, ibuprofen, and recurrent major cardiovascular and major bleeding events in 19\u2009120 patients with recent ischemic stroke", "volume": "47", "author": "Gonzalez-Valcarcel", "year": "2016", "journal-title": "Stroke"}, {"key": "10.1111/bcp.13656-BIB0086|bcp13656-cit-0087", "doi-asserted-by": "crossref", "first-page": "291", "DOI": "10.1046/j.1365-2125.2000.00167.x", "article-title": "Paracetamol, alcohol and the liver", "volume": "49", "author": "Prescott", "year": "2000", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0087|bcp13656-cit-0088", "doi-asserted-by": "crossref", "first-page": "e1430", "DOI": "10.1542/peds.2009-3352", "article-title": "Therapeutic acetaminophen is not associated with liver injury in children: a systematic review", "volume": "126", "author": "Lavonas", "year": "2010", "journal-title": "Pediatrics"}, {"key": "10.1111/bcp.13656-BIB0088|bcp13656-cit-0089", "first-page": "1105", "article-title": "Mildly elevated liver transaminase levels in the asymptomatic patient", "volume": "71", "author": "Giboney", "year": "2016", "journal-title": "Am Fam Physician"}, {"key": "10.1111/bcp.13656-BIB0089|bcp13656-cit-0090", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1186/2050-6511-15-39", "article-title": "A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration", "volume": "15", "author": "Heard", "year": "2014", "journal-title": "BMC Pharmacol Toxicol"}, {"key": "10.1111/bcp.13656-BIB0090|bcp13656-cit-0091", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1592/phco.27.9.1219", "article-title": "Does therapeutic use of acetaminophen cause acute liver failure?", "volume": "27", "author": "Dart", "year": "2007", "journal-title": "Pharmacotherapy"}, {"key": "10.1111/bcp.13656-BIB0091|bcp13656-cit-0092", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1111/bcp.12802", "article-title": "Can paracetamol (acetaminophen) be administered to patients with liver impairment?", "volume": "81", "author": "Hayward", "year": "2016", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0092|bcp13656-cit-0093", "first-page": "1189", "article-title": "Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples", "volume": "256", "author": "Guengerich", "year": "1991", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1111/bcp.13656-BIB0093|bcp13656-cit-0094", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1038/clpt.1983.14", "article-title": "Acetaminophen in chronic liver disease", "volume": "33", "author": "Benson", "year": "1983", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1111/bcp.13656-BIB0094|bcp13656-cit-0095", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1111/j.1365-2125.1981.tb01193.x", "article-title": "Effects of microsomal enzyme induction on paracetamol metabolism in man", "volume": "12", "author": "Prescott", "year": "1981", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0095|bcp13656-cit-0096", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1097/01.mjt.0000140216.40700.95", "article-title": "The therapeutic use of acetaminophen in patients with liver disease", "volume": "12", "author": "Benson", "year": "2005", "journal-title": "Am J Ther"}, {"key": "10.1111/bcp.13656-BIB0096|bcp13656-cit-0097", "first-page": "1621", "article-title": "Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study", "volume": "91", "author": "Mahe", "year": "2006", "journal-title": "Haematologica"}, {"key": "10.1111/bcp.13656-BIB0097|bcp13656-cit-0098", "first-page": "673", "article-title": "Clinical inquiries. Alcoholic liver disease: is acetaminophen safe?", "volume": "56", "author": "Worriax", "year": "2007", "journal-title": "J Fam Pract"}, {"key": "10.1111/bcp.13656-BIB0098|bcp13656-cit-0099", "doi-asserted-by": "crossref", "first-page": "1543", "DOI": "10.1111/j.1365-2036.2007.03503.x", "article-title": "Toxicity of chronic paracetamol ingestion", "volume": "26", "author": "Watelet", "year": "2007", "journal-title": "Aliment Pharmacol Ther"}, {"key": "10.1111/bcp.13656-BIB0099|bcp13656-cit-0100", "doi-asserted-by": "crossref", "first-page": "945", "DOI": "10.1093/qjmed/hcr098", "article-title": "Acute liver failure in Scotland between 1992 and 2009; incidence, aetiology and outcome", "volume": "104", "author": "Bretherick", "year": "2011", "journal-title": "QJM"}, {"key": "10.1111/bcp.13656-BIB0100|bcp13656-cit-0101", "doi-asserted-by": "crossref", "first-page": "149", "DOI": "10.1097/00045391-200203000-00009", "article-title": "Important role of prodromal viral infections responsible for inhibition of xenobiotic metabolizing enzymes in the pathomechanism of idiopathic Reye's syndrome, Stevens-Johnson syndrome, autoimmune hepatitis, and hepatotoxicity of the therapeutic doses of acetaminophen used in genetically predisposed persons", "volume": "9", "author": "Prandota", "year": "2002", "journal-title": "Am J Ther"}, {"key": "10.1111/bcp.13656-BIB0101|bcp13656-cit-0102", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1007/BF03160941", "article-title": "Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management", "volume": "4", "author": "Mazer", "year": "2008", "journal-title": "J Med Toxicol"}, {"key": "10.1111/bcp.13656-BIB0102|bcp13656-cit-0103", "doi-asserted-by": "crossref", "first-page": "1364", "DOI": "10.1002/hep.20948", "article-title": "Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study", "volume": "42", "author": "Larson", "year": "2005", "journal-title": "Hepatology"}, {"key": "10.1111/bcp.13656-BIB0103|bcp13656-cit-0104", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1080/20014091111677", "article-title": "Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches", "volume": "31", "author": "Bessems", "year": "2001", "journal-title": "Crit Rev Toxicol"}, {"key": "10.1111/bcp.13656-BIB0104|bcp13656-cit-0105", "first-page": "363", "article-title": "Acetaminophen-related acute renal failure without fulminant liver failure", "volume": "17", "author": "Eguia", "year": "1997", "journal-title": "Pharmacotherapy"}, {"key": "10.1111/bcp.13656-BIB0105|bcp13656-cit-0106", "first-page": "48", "article-title": "Acute renal failure due to acetaminophen ingestion: a case report and review of the literature", "volume": "6", "author": "Blakely", "year": "1995", "journal-title": "J Am Soc Nephrol"}, {"key": "10.1111/bcp.13656-BIB0106|bcp13656-cit-0107", "doi-asserted-by": "crossref", "first-page": "1255", "DOI": "10.1136/jcp.34.11.1255", "article-title": "Analgesic nephropathy in the United Kingdom: incidence, clinical features and pathogenesis", "volume": "34", "author": "Cove-Smith", "year": "1981", "journal-title": "J Clin Pathol"}, {"key": "10.1111/bcp.13656-BIB0107|bcp13656-cit-0108", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1056/NEJM199802123380707", "article-title": "Analgesic nephropathy", "volume": "338", "author": "De Broe", "year": "1998", "journal-title": "N Engl J Med"}, {"key": "10.1111/bcp.13656-BIB0108|bcp13656-cit-0109", "doi-asserted-by": "crossref", "first-page": "768", "DOI": "10.2215/CJN.04901107", "article-title": "Analgesic nephropathy and renal replacement therapy in Australia: trends, comorbidities and outcomes", "volume": "3", "author": "Chang", "year": "2008", "journal-title": "Clin J Am Soc Nephrol"}, {"issue": "Suppl. 2", "key": "10.1111/bcp.13656-BIB0109|bcp13656-cit-0110", "doi-asserted-by": "crossref", "first-page": "291S", "DOI": "10.1111/j.1365-2125.1980.tb01812.x", "article-title": "Kinetics and metabolism of paracetamol and phenacetin", "volume": "10", "author": "Prescott", "year": "1980", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0110|bcp13656-cit-0111", "doi-asserted-by": "crossref", "first-page": "1675", "DOI": "10.1056/NEJM199412223312502", "article-title": "Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs", "volume": "331", "author": "Perneger", "year": "1994", "journal-title": "N Engl J Med"}, {"key": "10.1111/bcp.13656-BIB0111|bcp13656-cit-0112", "doi-asserted-by": "crossref", "first-page": "2259", "DOI": "10.1046/j.1523-1755.2000.00410.x", "article-title": "Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad hoc Committee of the International Study Group on Analgesics and Nephropathy", "volume": "58", "author": "Feinstein", "year": "2000", "journal-title": "Kidney Int"}, {"key": "10.1111/bcp.13656-BIB0112|bcp13656-cit-0113", "doi-asserted-by": "crossref", "first-page": "e004365", "DOI": "10.1136/bmjopen-2013-004365", "article-title": "Medication use in pregnancy: a cross-sectional, multinational web-based study", "volume": "4", "author": "Lupattelli", "year": "2014", "journal-title": "BMJ Open"}, {"key": "10.1111/bcp.13656-BIB0113|bcp13656-cit-0114", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1016/S1734-1140(12)70847-2", "article-title": "Prenatal tolerability of acetaminophen and other over-the-counter non-selective cyclooxygenase inhibitors", "volume": "64", "author": "Burdan", "year": "2012", "journal-title": "Pharmacol Rep"}, {"key": "10.1111/bcp.13656-BIB0114|bcp13656-cit-0115", "first-page": "57s", "article-title": "Maternal and fetal effects of acetaminophen and salicylates in pregnancy", "volume": "58", "author": "Collins", "year": "1981", "journal-title": "Obstet Gynecol"}, {"key": "10.1111/bcp.13656-BIB0115|bcp13656-cit-0116", "first-page": "895", "article-title": "Letter: evidence of placental transfer of acetaminophen", "volume": "55", "author": "Levy", "year": "1975", "journal-title": "Pediatrics"}, {"key": "10.1111/bcp.13656-BIB0116|bcp13656-cit-0117", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/j.curtheres.2014.12.001", "article-title": "Clinical pharmacology of paracetamol in neonates: a review", "volume": "77", "author": "Pacifici", "year": "2015", "journal-title": "Curr Ther Res Clin Exp"}, {"key": "10.1111/bcp.13656-BIB0117|bcp13656-cit-0118", "doi-asserted-by": "crossref", "first-page": "178.e1", "DOI": "10.1016/j.ajog.2007.08.040", "article-title": "Acetaminophen use during pregnancy: effects on risk for congenital abnormalities", "volume": "198", "author": "Rebordosa", "year": "2008", "journal-title": "Am J Obstet Gynecol"}, {"key": "10.1111/bcp.13656-BIB0118|bcp13656-cit-0119", "doi-asserted-by": "crossref", "first-page": "706", "DOI": "10.1093/ije/dyp151", "article-title": "Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes", "volume": "38", "author": "Rebordosa", "year": "2009", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0119|bcp13656-cit-0120", "doi-asserted-by": "crossref", "first-page": "1702", "DOI": "10.1093/ije/dyt183", "article-title": "Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study", "volume": "42", "author": "Brandlistuen", "year": "2013", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0120|bcp13656-cit-0121", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1001/jamapediatrics.2013.4914", "article-title": "Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders", "volume": "168", "author": "Liew", "year": "2014", "journal-title": "JAMA Pediatr"}, {"key": "10.1111/bcp.13656-BIB0121|bcp13656-cit-0122", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1002/aur.1591", "article-title": "Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish national birth cohort study", "volume": "9", "author": "Liew", "year": "2016", "journal-title": "Autism Res"}, {"key": "10.1111/bcp.13656-BIB0122|bcp13656-cit-0123", "first-page": "1987", "article-title": "Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms", "volume": "45", "author": "Avella-Garcia", "year": "2016", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0123|bcp13656-cit-0124", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1093/toxsci/kft329", "article-title": "Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice", "volume": "138", "author": "Viberg", "year": "2014", "journal-title": "Toxicol Sci"}, {"key": "10.1111/bcp.13656-BIB0124|bcp13656-cit-0125", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/j.neubiorev.2014.03.012", "article-title": "The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology", "volume": "43", "author": "Homberg", "year": "2014", "journal-title": "Neurosci Biobehav Rev"}, {"key": "10.1111/bcp.13656-BIB0125|bcp13656-cit-0126", "doi-asserted-by": "crossref", "first-page": "1085", "DOI": "10.1016/j.jhep.2014.12.020", "article-title": "Prenatal acetaminophen induces liver toxicity in dams, reduces fetal liver stem cells, and increases airway inflammation in adult offspring", "volume": "62", "author": "Karimi", "year": "2015", "journal-title": "J Hepatol"}, {"key": "10.1111/bcp.13656-BIB0126|bcp13656-cit-0127", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1136/thoraxjnl-2014-205280", "article-title": "Perinatal paracetamol exposure in mice does not affect the development of allergic airways disease in early life", "volume": "70", "author": "Lee", "year": "2015", "journal-title": "Thorax"}, {"key": "10.1111/bcp.13656-BIB0127|bcp13656-cit-0128", "doi-asserted-by": "crossref", "first-page": "958", "DOI": "10.1136/thorax.57.11.958", "article-title": "Paracetamol use in pregnancy and wheezing in early childhood", "volume": "57", "author": "Shaheen", "year": "2002", "journal-title": "Thorax"}, {"key": "10.1111/bcp.13656-BIB0128|bcp13656-cit-0129", "doi-asserted-by": "crossref", "first-page": "583", "DOI": "10.1093/ije/dyn070", "article-title": "Pre-natal exposure to paracetamol and risk of wheezing and asthma in children: a birth cohort study", "volume": "37", "author": "Rebordosa", "year": "2008", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0129|bcp13656-cit-0130", "doi-asserted-by": "crossref", "first-page": "512", "DOI": "10.1093/ije/dyv366", "article-title": "Prenatal and infant paracetamol exposure and development of asthma: the Norwegian mother and child cohort study", "volume": "45", "author": "Magnus", "year": "2016", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0130|bcp13656-cit-0131", "doi-asserted-by": "crossref", "first-page": "1378", "DOI": "10.1046/j.1365-2222.1999.00662.x", "article-title": "A retrospective study of the relationship between childhood asthma and respiratory infection during gestation", "volume": "29", "author": "Hughes", "year": "1999", "journal-title": "Clin Exp Allergy"}, {"key": "10.1111/bcp.13656-BIB0131|bcp13656-cit-0132", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1093/ije/28.4.723", "article-title": "Maternal infections in pregnancy and the development of asthma among offspring", "volume": "28", "author": "Xu", "year": "1999", "journal-title": "Int J Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0132|bcp13656-cit-0133", "doi-asserted-by": "crossref", "first-page": "e0135775", "DOI": "10.1371/journal.pone.0135775", "article-title": "Prenatal paracetamol exposure and wheezing in childhood: causation or confounding?", "volume": "10", "author": "Migliore", "year": "2015", "journal-title": "PLoS One"}, {"key": "10.1111/bcp.13656-BIB0133|bcp13656-cit-0134", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/j.jaci.2014.07.065", "article-title": "Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children", "volume": "135", "author": "Sordillo", "year": "2015", "journal-title": "J Allergy Clin Immunol"}, {"key": "10.1111/bcp.13656-BIB0134|bcp13656-cit-0135", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1093/humupd/dmm027", "article-title": "Epidemiology and pathogenesis of cryptorchidism", "volume": "14", "author": "Virtanen", "year": "2008", "journal-title": "Hum Reprod Update"}, {"key": "10.1111/bcp.13656-BIB0135|bcp13656-cit-0136", "doi-asserted-by": "crossref", "first-page": "1479", "DOI": "10.1172/JCI34241", "article-title": "Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism", "volume": "118", "author": "Welsh", "year": "2008", "journal-title": "J Clin Invest"}, {"key": "10.1111/bcp.13656-BIB0136|bcp13656-cit-0137", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1093/humrep/deq323", "article-title": "Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat", "volume": "26", "author": "Kristensen", "year": "2011", "journal-title": "Hum Reprod"}, {"key": "10.1111/bcp.13656-BIB0137|bcp13656-cit-0138", "doi-asserted-by": "crossref", "first-page": "288ra80", "DOI": "10.1126/scitranslmed.aaa4097", "article-title": "Prolonged exposure to acetaminophen reduces testosterone production by the human fetal testis in a xenograft model", "volume": "7", "author": "Driesche", "year": "2015", "journal-title": "Sci Transl Med"}, {"key": "10.1111/bcp.13656-BIB0138|bcp13656-cit-0139", "doi-asserted-by": "crossref", "first-page": "47006", "DOI": "10.1289/EHP2307", "article-title": "Effects of exposure to acetaminophen and ibuprofen on fetal germ cell development in both sexes in rodent and human using multiple experimental systems", "volume": "126", "author": "Hurtado-Gonzalez", "year": "2018", "journal-title": "Environ Health Perspect"}, {"key": "10.1111/bcp.13656-BIB0139|bcp13656-cit-0140", "doi-asserted-by": "crossref", "first-page": "779", "DOI": "10.1097/EDE.0b013e3181f20bed", "article-title": "Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism", "volume": "21", "author": "Jensen", "year": "2010", "journal-title": "Epidemiology"}, {"key": "10.1111/bcp.13656-BIB0140|bcp13656-cit-0141", "doi-asserted-by": "crossref", "first-page": "1191", "DOI": "10.1093/humrep/der474", "article-title": "Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the generation R study", "volume": "27", "author": "Snijder", "year": "2012", "journal-title": "Hum Reprod"}, {"key": "10.1111/bcp.13656-BIB0141|bcp13656-cit-0142", "doi-asserted-by": "crossref", "first-page": "610", "DOI": "10.1097/EDE.0b013e31821eca69", "article-title": "Analgesics during pregnancy and cryptorchidism: additional analyses", "volume": "22", "author": "Jensen", "year": "2011", "journal-title": "Epidemiology"}, {"key": "10.1111/bcp.13656-BIB0142|bcp13656-cit-0143", "doi-asserted-by": "crossref", "first-page": "2642", "DOI": "10.1093/humrep/dew196", "article-title": "Prenatal paracetamol exposure is associated with shorter anogenital distance in male infants", "volume": "31", "author": "Fisher", "year": "2016", "journal-title": "Hum Reprod"}, {"key": "10.1111/bcp.13656-BIB0143|bcp13656-cit-0144", "doi-asserted-by": "crossref", "first-page": "340", "DOI": "10.1111/j.1479-828X.1991.tb02816.x", "article-title": "Use of prescription drugs in the first trimester and congenital malformations", "volume": "31", "author": "Correy", "year": "1991", "journal-title": "Aust N Z J Obstet Gynaecol"}, {"key": "10.1111/bcp.13656-BIB0144|bcp13656-cit-0145", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1097/AOG.0b013e3181c52616", "article-title": "Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study", "volume": "115", "author": "Feldkamp", "year": "2010", "journal-title": "Obstet Gynecol"}, {"key": "10.1111/bcp.13656-BIB0145|bcp13656-cit-0146", "doi-asserted-by": "crossref", "first-page": "e499", "DOI": "10.1111/j.1365-2605.2011.01211.x", "article-title": "Prospective study on the prevalence and associated risk factors of cryptorchidism in 6246 newborn boys from nice area, France", "volume": "34", "author": "Wagner-Mahler", "year": "2011", "journal-title": "Int J Androl"}, {"key": "10.1111/bcp.13656-BIB0146|bcp13656-cit-0147", "doi-asserted-by": "crossref", "first-page": "665", "DOI": "10.1002/ppul.22881", "article-title": "Prenatal inflammatory risk factors for development of bronchopulmonary dysplasia", "volume": "49", "author": "Eriksson", "year": "2014", "journal-title": "Pediatr Pulmonol"}, {"key": "10.1111/bcp.13656-BIB0147|bcp13656-cit-0148", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1111/ppe.12082", "article-title": "Maternal infections during pregnancy and cerebral palsy: a population-based cohort study", "volume": "27", "author": "Miller", "year": "2013", "journal-title": "Paediatr Perinat Epidemiol"}, {"key": "10.1111/bcp.13656-BIB0148|bcp13656-cit-0149", "doi-asserted-by": "crossref", "first-page": "e154", "DOI": "10.1542/peds.2013-3898", "article-title": "Association of maternal hypertension and chorioamnionitis with preterm outcomes", "volume": "134", "author": "Gagliardi", "year": "2014", "journal-title": "Pediatrics"}, {"key": "10.1111/bcp.13656-BIB0149|bcp13656-cit-0150", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1038/nrendo.2015.106", "article-title": "Paracetamol-induced endocrine disruption in human fetal testes", "volume": "11", "author": "Jegou", "year": "2015", "journal-title": "Nat Rev Endocrinol"}, {"key": "10.1111/bcp.13656-BIB0150|bcp13656-cit-0151", "doi-asserted-by": "crossref", "first-page": "D1091", "DOI": "10.1093/nar/gkx1121", "article-title": "The IUPHAR/BPS guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY", "volume": "46", "author": "Harding", "year": "2018", "journal-title": "Nucl Acids Res"}, {"key": "10.1111/bcp.13656-BIB0151|bcp13656-cit-0152", "doi-asserted-by": "crossref", "first-page": "S160", "DOI": "10.1111/bph.13884", "article-title": "The Concise Guide to PHARMACOLOGY 2017/18: Voltage-gated ion channels", "volume": "174", "author": "Alexander", "year": "2017", "journal-title": "Br J Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0152|bcp13656-cit-0153", "doi-asserted-by": "crossref", "first-page": "S272", "DOI": "10.1111/bph.13877", "article-title": "The Concise Guide to PHARMACOLOGY 2017/18: Enzymes.", "volume": "174", "author": "Alexander", "year": "2017", "journal-title": "Br J Pharmacol"}, {"key": "10.1111/bcp.13656-BIB0153|bcp13656-cit-0154", "doi-asserted-by": "crossref", "first-page": "S17", "DOI": "10.1111/bph.13878", "article-title": "The Concise Guide to PHARMACOLOGY 2017/18: G protein-coupled receptors", "volume": "174", "author": "Alexander", "year": "2017", "journal-title": "Br J Pharmacol"}], "container-title": ["British Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fbcp.13656", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13656/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 16]], "date-time": "2018-09-16T11:38:35Z", "timestamp": 1537097915000}, "score": 26.61728, "subtitle": ["Long-term adverse effects of paracetamol"], "issued": {"date-parts": [[2018, 7, 20]]}, "references-count": 153, "journal-issue": {"published-print": {"date-parts": [[2018, 10]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1111/bcp.13656", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0306-5251"], "issn-type": [{"value": "0306-5251", "type": "print"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T22:28:52Z", "timestamp": 1575498532487}, "reference-count": 43, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2019, 8, 19]], "date-time": "2019-08-19T00:00:00Z", "timestamp": 1566172800000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100002428", "name": "Austrian Science Fund", "doi-asserted-by": "publisher", "award": ["P24362"]}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Sci Rep"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.1038/s41598-019-48352-5", "type": "journal-article", "created": {"date-parts": [[2019, 8, 19]], "date-time": "2019-08-19T10:03:05Z", "timestamp": 1566208985000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis"], "prefix": "10.1038", "volume": "9", "author": [{"ORCID": "http://orcid.org/0000-0001-7279-0628", "authenticated-orcid": false, "given": "Angela", "family": "Horvath", "sequence": "first", "affiliation": []}, {"given": "Florian", "family": "Rainer", "sequence": "additional", "affiliation": []}, {"given": "Mina", "family": "Bashir", "sequence": "additional", "affiliation": []}, {"given": "Bettina", "family": "Leber", "sequence": "additional", "affiliation": []}, {"given": "Bianca", "family": "Schmerboeck", "sequence": "additional", "affiliation": []}, {"given": "Ingeborg", "family": "Klymiuk", "sequence": "additional", "affiliation": []}, {"given": "Andrea", "family": "Groselj-Strele", "sequence": "additional", "affiliation": []}, {"given": "Marija", "family": "Durdevic", "sequence": "additional", "affiliation": []}, {"given": "Daniel E.", "family": "Freedberg", "sequence": "additional", "affiliation": []}, {"given": "Julian A.", "family": "Abrams", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Fickert", "sequence": "additional", "affiliation": []}, {"given": "Philipp", "family": "Stiegler", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-5508-8271", "authenticated-orcid": false, "given": "Vanessa", "family": "Stadlbauer", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2019, 8, 19]]}, "reference": [{"key": "48352_CR1", "first-page": "Cr468", "volume": "14", "author": "NC Chavez-Tapia", "year": "2008", "unstructured": "Chavez-Tapia, N. C., Tellez-Avila, F. I., Garcia-Leiva, J. & Valdovinos, M. A. Use and overuse of proton pump inhibitors in cirrhotic patients. Medical science monitor: international medical journal of experimental and clinical research 14, Cr468\u2013472 (2008).", "journal-title": "Medical science monitor: international medical journal of experimental and clinical research"}, {"key": "48352_CR2", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.4292/wjgpt.v7.i1.1", "volume": "7", "author": "A Picardi", "year": "2016", "unstructured": "Picardi, A. & Vespasiani-Gentilucci, U. Proton pump inhibitor prescription abuse and sepsis in cirrhosis. World journal of gastrointestinal pharmacology and therapeutics 7, 1\u20134, \n                    https://doi.org/10.4292/wjgpt.v7.i1.1\n                    \n                   (2016).", "journal-title": "World journal of gastrointestinal pharmacology and therapeutics"}, {"issue": "753\u2013759", "key": "48352_CR3", "doi-asserted-by": "publisher", "first-page": "e751", "DOI": "10.1016/j.cgh.2014.07.060", "volume": "13", "author": "JG O\u2019Leary", "year": "2015", "unstructured": "O\u2019Leary, J. G. et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol 13(753\u2013759), e751\u2013752, \n                    https://doi.org/10.1016/j.cgh.2014.07.060\n                    \n                   (2015).", "journal-title": "Clin Gastroenterol Hepatol"}, {"key": "48352_CR4", "doi-asserted-by": "publisher", "first-page": "695", "DOI": "10.1111/apt.12875", "volume": "40", "author": "YW Min", "year": "2014", "unstructured": "Min, Y. W. et al. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study. Alimentary pharmacology & therapeutics 40, 695\u2013704, \n                    https://doi.org/10.1111/apt.12875\n                    \n                   (2014).", "journal-title": "Alimentary pharmacology & therapeutics"}, {"key": "48352_CR5", "doi-asserted-by": "publisher", "first-page": "134", "DOI": "10.1053/j.gastro.2016.09.007", "volume": "152", "author": "CF Tsai", "year": "2017", "unstructured": "Tsai, C. F. et al. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. Gastroenterology 152, 134\u2013141, \n                    https://doi.org/10.1053/j.gastro.2016.09.007\n                    \n                   (2017).", "journal-title": "Gastroenterology"}, {"key": "48352_CR6", "doi-asserted-by": "publisher", "first-page": "1265", "DOI": "10.1002/hep.28737", "volume": "64", "author": "G Dam", "year": "2016", "unstructured": "Dam, G., Vilstrup, H., Watson, H. & Jepsen, P. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. Hepatology 64, 1265\u20131272, \n                    https://doi.org/10.1002/hep.28737\n                    \n                   (2016).", "journal-title": "Hepatology"}, {"key": "48352_CR7", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1111/apt.13061", "volume": "41", "author": "G Dultz", "year": "2015", "unstructured": "Dultz, G., Piiper, A., Zeuzem, S., Kronenberger, B. & Waidmann, O. Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Alimentary pharmacology & therapeutics 41, 459\u2013466, \n                    https://doi.org/10.1111/apt.13061\n                    \n                   (2015).", "journal-title": "Alimentary pharmacology & therapeutics"}, {"key": "48352_CR8", "doi-asserted-by": "publisher", "first-page": "e110503", "DOI": "10.1371/journal.pone.0110503", "volume": "9", "author": "M Mandorfer", "year": "2014", "unstructured": "Mandorfer, M. et al. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites. PloS one 9, e110503, \n                    https://doi.org/10.1371/journal.pone.0110503\n                    \n                   (2014).", "journal-title": "PloS one"}, {"issue": "6", "key": "48352_CR9", "doi-asserted-by": "publisher", "first-page": "e015735", "DOI": "10.1136/bmjopen-2016-015735", "volume": "7", "author": "Yan Xie", "year": "2017", "unstructured": "Xie, Y. et al. Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans. 7, e015735, \n                    https://doi.org/10.1136/bmjopen-2016-015735\n                    \n                   (2017).", "journal-title": "BMJ Open"}, {"key": "48352_CR10", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1053/j.gastro.2015.06.043", "volume": "149", "author": "DE Freedberg", "year": "2015", "unstructured": "Freedberg, D. E. et al. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. Gastroenterology 149, 883\u2013885.e889, \n                    https://doi.org/10.1053/j.gastro.2015.06.043\n                    \n                   (2015).", "journal-title": "Gastroenterology"}, {"key": "48352_CR11", "author": "CT Seto", "volume": "2", "year": "2014", "unstructured": "Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N. & DiBaise, J. K. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome 2, 42, \n                    https://doi.org/10.1186/2049-2618-2-42\n                    \n                   (2014).", "journal-title": "Microbiome", "DOI": "10.1186/2049-2618-2-42", "doi-asserted-by": "publisher"}, {"key": "48352_CR12", "doi-asserted-by": "publisher", "first-page": "1310", "DOI": "10.1016/j.jpeds.2015.01.004", "volume": "166", "author": "A Sieczkowska", "year": "2015", "unstructured": "Sieczkowska, A., Landowski, P., Zagozdzon, P., Kaminska, B. & Lifschitz, C. Small Bowel Bacterial Overgrowth Associated with Persistence of Abdominal Symptoms in Children Treated with a Proton Pump Inhibitor. The Journal of pediatrics 166, 1310\u20131312 e1311, \n                    https://doi.org/10.1016/j.jpeds.2015.01.004\n                    \n                   (2015).", "journal-title": "The Journal of pediatrics"}, {"key": "48352_CR13", "author": "A Tsuda", "volume": "6", "year": "2015", "unstructured": "Tsuda, A. et al. Influence of Proton-Pump Inhibitors on the Luminal Microbiota in the Gastrointestinal Tract. Clinical and translational gastroenterology 6, e89, \n                    https://doi.org/10.1038/ctg.2015.20\n                    \n                   (2015).", "journal-title": "Clinical and translational gastroenterology", "DOI": "10.1038/ctg.2015.20", "doi-asserted-by": "publisher"}, {"key": "48352_CR14", "doi-asserted-by": "publisher", "first-page": "740", "DOI": "10.1136/gutjnl-2015-310376", "volume": "65", "author": "F Imhann", "year": "2016", "unstructured": "Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740\u2013748, \n                    https://doi.org/10.1136/gutjnl-2015-310376\n                    \n                   (2016).", "journal-title": "Gut"}, {"key": "48352_CR15", "doi-asserted-by": "publisher", "first-page": "G951", "DOI": "10.1152/ajpgi.00268.2014", "volume": "307", "author": "JS Bajaj", "year": "2014", "unstructured": "Bajaj, J. S. et al. Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. Am J Physiol Gastrointest Liver Physiol 307, G951\u2013957, \n                    https://doi.org/10.1152/ajpgi.00268.2014\n                    \n                   (2014).", "journal-title": "Am J Physiol Gastrointest Liver Physiol"}, {"key": "48352_CR16", "doi-asserted-by": "publisher", "first-page": "940", "DOI": "10.1016/j.jhep.2013.12.019", "volume": "60", "author": "JS Bajaj", "year": "2014", "unstructured": "Bajaj, J. S. et al. The Cirrhosis Dysbiosis Ratio defines Changes in the Gut Microbiome Associated with Cirrhosis and its Complications. Journal of hepatology 60, 940\u2013947, \n                    https://doi.org/10.1016/j.jhep.2013.12.019\n                    \n                   (2014).", "journal-title": "Journal of hepatology"}, {"issue": "1314\u20131322", "key": "48352_CR17", "doi-asserted-by": "publisher", "first-page": "1322 e1311", "DOI": "10.1053/j.gastro.2011.06.075", "volume": "141", "author": "JL Wallace", "year": "2011", "unstructured": "Wallace, J. L. et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology 141(1314\u20131322), 1322 e1311\u20131315, \n                    https://doi.org/10.1053/j.gastro.2011.06.075\n                    \n                   (2011).", "journal-title": "Gastroenterology"}, {"key": "48352_CR18", "doi-asserted-by": "publisher", "first-page": "362", "DOI": "10.1111/liv.12593", "volume": "35", "author": "M Merli", "year": "2015", "unstructured": "Merli, M. et al. The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int 35, 362\u2013369, \n                    https://doi.org/10.1111/liv.12593\n                    \n                   (2015).", "journal-title": "Liver Int"}, {"key": "48352_CR19", "author": "C Llorente", "volume": "8", "year": "2017", "unstructured": "Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature communications 8, 837, \n                    https://doi.org/10.1038/s41467-017-00796-x\n                    \n                   (2017).", "journal-title": "Nature communications", "DOI": "10.1038/s41467-017-00796-x", "doi-asserted-by": "publisher"}, {"issue": "8", "key": "48352_CR20", "doi-asserted-by": "publisher", "first-page": "1177", "DOI": "10.1038/s41395-018-0085-9", "volume": "113", "author": "Jasmohan S Bajaj", "year": "2018", "unstructured": "Bajaj, J. S. et al. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. The American journal of gastroenterology, \n                    https://doi.org/10.1038/s41395-018-0085-9\n                    \n                   (2018).", "journal-title": "American Journal of Gastroenterology"}, {"key": "48352_CR21", "doi-asserted-by": "publisher", "first-page": "749", "DOI": "10.1136/gutjnl-2015-310861", "volume": "65", "author": "MA Jackson", "year": "2016", "unstructured": "Jackson, M. A. et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut 65, 749\u2013756, \n                    https://doi.org/10.1136/gutjnl-2015-310861\n                    \n                   (2016).", "journal-title": "Gut"}, {"key": "48352_CR22", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1111/j.1399-302X.1991.tb00466.x", "volume": "6", "author": "EV Frandsen", "year": "1991", "unstructured": "Frandsen, E. V., Pedrazzoli, V. & Kilian, M. Ecology of viridans streptococci in the oral cavity and pharynx. Oral microbiology and immunology 6, 129\u2013133 (1991).", "journal-title": "Oral microbiology and immunology"}, {"key": "48352_CR23", "doi-asserted-by": "publisher", "first-page": "1085", "DOI": "10.1111/j.1462-5822.2004.00420.x", "volume": "6", "author": "Y Mostefaoui", "year": "2004", "unstructured": "Mostefaoui, Y., Bart, C., Frenette, M. & Rouabhia, M. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cellular microbiology 6, 1085\u20131096, \n                    https://doi.org/10.1111/j.1462-5822.2004.00420.x\n                    \n                   (2004).", "journal-title": "Cellular microbiology"}, {"key": "48352_CR24", "doi-asserted-by": "publisher", "first-page": "4163", "DOI": "10.1128/iai.00188-08", "volume": "76", "author": "C Cosseau", "year": "2008", "unstructured": "Cosseau, C. et al. The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infection and immunity 76, 4163\u20134175, \n                    https://doi.org/10.1128/iai.00188-08\n                    \n                   (2008).", "journal-title": "Infection and immunity"}, {"key": "48352_CR25", "doi-asserted-by": "publisher", "first-page": "928", "DOI": "10.1128/aem.03133-13", "volume": "80", "author": "G Kaci", "year": "2014", "unstructured": "Kaci, G. et al. Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract. Applied and environmental microbiology 80, 928\u2013934, \n                    https://doi.org/10.1128/aem.03133-13\n                    \n                   (2014).", "journal-title": "Applied and environmental microbiology"}, {"key": "48352_CR26", "first-page": "1957", "volume": "54", "author": "CV Hughes", "year": "1988", "unstructured": "Hughes, C. V., Kolenbrander, P. E., Andersen, R. N. & Moore, L. V. Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology. Applied and environmental microbiology 54, 1957\u20131963 (1988).", "journal-title": "Applied and environmental microbiology"}, {"key": "48352_CR27", "doi-asserted-by": "publisher", "first-page": "54", "DOI": "10.1016/j.anaerobe.2014.05.003", "volume": "28", "author": "I Mashima", "year": "2014", "unstructured": "Mashima, I. & Nakazawa, F. The influence of oral Veillonella species on biofilms formed by Streptococcus species. Anaerobe 28, 54\u201361, \n                    https://doi.org/10.1016/j.anaerobe.2014.05.003\n                    \n                   (2014).", "journal-title": "Anaerobe"}, {"key": "48352_CR28", "doi-asserted-by": "publisher", "first-page": "1804", "DOI": "10.1128/cvi.00310-09", "volume": "16", "author": "G Matera", "year": "2009", "unstructured": "Matera, G. et al. Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clinical and vaccine immunology: CVI 16, 1804\u20131809, \n                    https://doi.org/10.1128/cvi.00310-09\n                    \n                   (2009).", "journal-title": "Clinical and vaccine immunology: CVI"}, {"key": "48352_CR29", "doi-asserted-by": "publisher", "first-page": "e114277", "DOI": "10.1371/journal.pone.0114277", "volume": "9", "author": "B Bogert van den", "year": "2014", "unstructured": "van den Bogert, B., Meijerink, M., Zoetendal, E. G., Wells, J. M. & Kleerebezem, M. Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PloS one 9, e114277, \n                    https://doi.org/10.1371/journal.pone.0114277\n                    \n                   (2014).", "journal-title": "PloS one"}, {"key": "48352_CR30", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/0014-5793(92)80909-Z", "volume": "307", "author": "M Baggiolini", "year": "1992", "unstructured": "Baggiolini, M. & Clark-Lewis, I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS letters 307, 97\u2013101 (1992).", "journal-title": "FEBS letters"}, {"key": "48352_CR31", "unstructured": "Boussac, M. & Garin, J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 21, 665\u2013672, 10.1002/(sici)1522-2683(20000201)21:3<665::aid-elps665>3.0.co;2-u (2000)."}, {"key": "48352_CR32", "doi-asserted-by": "publisher", "first-page": "883", "DOI": "10.1002/hep.27489", "volume": "61", "author": "P Chen", "year": "2015", "unstructured": "Chen, P., Starkel, P., Turner, J. R., Ho, S. B. & Schnabl, B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology 61, 883\u2013894, \n                    https://doi.org/10.1002/hep.27489\n                    \n                   (2015).", "journal-title": "Hepatology"}, {"key": "48352_CR33", "doi-asserted-by": "publisher", "first-page": "59", "DOI": "10.1038/nature13568", "volume": "513", "author": "N Qin", "year": "2014", "unstructured": "Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364, \n                    https://doi.org/10.1038/nature13568\n                    \n                   (2014).", "journal-title": "Nature"}, {"key": "48352_CR34", "doi-asserted-by": "publisher", "first-page": "E1", "DOI": "10.1038/nature14851", "volume": "525", "author": "JS Bajaj", "year": "2015", "unstructured": "Bajaj, J. S., Betrapally, N. S. & Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1\u20132, \n                    https://doi.org/10.1038/nature14851\n                    \n                   (2015).", "journal-title": "Nature"}, {"key": "48352_CR35", "doi-asserted-by": "publisher", "first-page": "151", "DOI": "10.1162/003465302317331982", "volume": "84", "author": "RH Dehejia", "year": "2002", "unstructured": "Dehejia, R. H. & Wahba, S. Propensity Score-Matching Methods for Nonexperimental Causal Studies. The Review of Economics and Statistics 84, 151\u2013161, \n                    https://doi.org/10.1162/003465302317331982\n                    \n                   (2002).", "journal-title": "The Review of Economics and Statistics"}, {"issue": "9", "key": "48352_CR36", "doi-asserted-by": "publisher", "first-page": "926", "DOI": "10.1111/apt.13788", "volume": "44", "author": "A. Horvath", "year": "2016", "unstructured": "Horvath, A. et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Alimentary pharmacology & therapeutics, \n                    https://doi.org/10.1111/apt.13788\n                    \n                   (2016).", "journal-title": "Alimentary Pharmacology & Therapeutics"}, {"key": "48352_CR37", "author": "V Stadlbauer", "volume": "7", "year": "2017", "unstructured": "Stadlbauer, V. et al. Structural and functional differences in gut microbiome composition in patients undergoing haemodialysis or peritoneal dialysis. Scientific reports 7, 15601, \n                    https://doi.org/10.1038/s41598-017-15650-9\n                    \n                   (2017).", "journal-title": "Scientific reports", "DOI": "10.1038/s41598-017-15650-9", "doi-asserted-by": "publisher"}, {"key": "48352_CR38", "doi-asserted-by": "publisher", "first-page": "2194", "DOI": "10.1093/bioinformatics/btr381", "volume": "27", "author": "RC Edgar", "year": "2011", "unstructured": "Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics (Oxford, England) 27, 2194\u20132200, \n                    https://doi.org/10.1093/bioinformatics/btr381\n                    \n                   (2011).", "journal-title": "Bioinformatics (Oxford, England)"}, {"key": "48352_CR39", "doi-asserted-by": "publisher", "first-page": "D7", "DOI": "10.1093/nar/gkv1290", "volume": "44", "author": "NR Coordinators", "year": "2016", "unstructured": "Coordinators, N. R. Database resources of the National Center for Biotechnology Information. Nucleic Acids Research 44, D7\u2013D19, \n                    https://doi.org/10.1093/nar/gkv1290\n                    \n                   (2016).", "journal-title": "Nucleic Acids Research"}, {"key": "48352_CR40", "doi-asserted-by": "publisher", "first-page": "2460", "DOI": "10.1093/bioinformatics/btq461", "volume": "26", "author": "RC Edgar", "year": "2010", "unstructured": "Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (Oxford, England) 26, 2460\u20132461, \n                    https://doi.org/10.1093/bioinformatics/btq461\n                    \n                   (2010).", "journal-title": "Bioinformatics (Oxford, England)"}, {"key": "48352_CR41", "doi-asserted-by": "publisher", "first-page": "335", "DOI": "10.1038/nmeth.f.303", "volume": "7", "author": "JG Caporaso", "year": "2010", "unstructured": "Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335\u2013336, \n                    https://doi.org/10.1038/nmeth.f.303\n                    \n                   (2010).", "journal-title": "Nature methods"}, {"key": "48352_CR42", "doi-asserted-by": "publisher", "first-page": "782", "DOI": "10.1093/bioinformatics/btw725", "volume": "33", "author": "M Zakrzewski", "year": "2017", "unstructured": "Zakrzewski, M. et al. Calypso: a user-friendly web-server for mining and visualizing microbiome-environment interactions. Bioinformatics (Oxford, England) 33, 782\u2013783, \n                    https://doi.org/10.1093/bioinformatics/btw725\n                    \n                   (2017).", "journal-title": "Bioinformatics (Oxford, England)"}, {"key": "48352_CR43", "doi-asserted-by": "publisher", "first-page": "32", "DOI": "10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3", "volume": "3", "author": "WJ Youden", "year": "1950", "unstructured": "Youden, W. J. Index for rating diagnostic tests. Cancer 3, 32\u201335 (1950).", "journal-title": "Cancer"}], "container-title": ["Scientific Reports"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41598-019-48352-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41598-019-48352-5", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41598-019-48352-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 23]], "date-time": "2019-09-23T20:44:59Z", "timestamp": 1569271499000}, "score": 26.515194, "issued": {"date-parts": [[2019, 8, 19]]}, "references-count": 43, "journal-issue": {"published-print": {"date-parts": [[2019, 12]]}, "issue": "1"}, "alternative-id": ["48352"], "URL": "http://dx.doi.org/10.1038/s41598-019-48352-5", "relation": {"cites": []}, "ISSN": ["2045-2322"], "issn-type": [{"value": "2045-2322", "type": "electronic"}], "subject": ["Multidisciplinary"], "assertion": [{"value": "6 February 2019", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "31 July 2019", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "19 August 2019", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing Interests"}}], "article-number": "12000"}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T16:29:08Z", "timestamp": 1574785748058}, "reference-count": 13, "publisher": "Media Sphere Publishing Group", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ter. arkh."], "published-print": {"date-parts": [[2015]]}, "DOI": "10.17116/terarkh201587458-61", "type": "journal-article", "created": {"date-parts": [[2016, 4, 14]], "date-time": "2016-04-14T15:31:49Z", "timestamp": 1460647909000}, "page": "58", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs"], "prefix": "10.17116", "volume": "87", "author": [{"given": "S. I.", "family": "Pimanov", "sequence": "first", "affiliation": []}, {"given": "E. V.", "family": "Makarenko", "sequence": "additional", "affiliation": []}, {"given": "E. A.", "family": "Dikareva", "sequence": "additional", "affiliation": []}], "member": "6743", "reference": [{"key": "key-10.17116/terarkh201587458-61-1", "unstructured": "Sturkenboom M.C., Burke T.A., Tangelder M.J., Dieleman J.P., Walton S., Goldstein J.L. Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2003; 18 (11\u201412): 1137\u20141147.", "DOI": "10.1046/j.1365-2036.2003.01795.x", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-2", "unstructured": "Sturkenboom M.C., Burke T.A., Dieleman J.P., Tangelder M.J., Lee F., Goldstein J.L. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology 2003; 42 (3): 23\u201431.", "DOI": "10.1093/rheumatology/keg495", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-3", "unstructured": "Goldstein J.L., Howard K.B., Walton S.M., McLaughlin T.P., Kruzikas D.T. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complication. Clin Gastroenterol Hepatol 2006; 4 (11): 1337\u20141345.", "DOI": "10.1016/j.cgh.2006.08.016", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-4", "unstructured": "van Soest E.M., Sturkenboom M.C., Dieleman J.P., Verhamme K.M., Siersema P.D., Kuipers E.J. Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment Pharmacol Ther 2007; 26 (2): 265\u2014275.", "DOI": "10.1111/j.1365-2036.2007.03358.x", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-5", "unstructured": "Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Artritis Rheum 1988; 31 (3): 315\u2014324.", "DOI": "10.1002/art.1780310302", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-6", "unstructured": "Chan F.K., Abracham N.S., Scheiman J.M., Laine L. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008; 103 (11): 2908\u20142918.", "DOI": "10.1111/j.1572-0241.2008.02200.x", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-7", "unstructured": "Pimanov S.I., Semenova E.V., Makarenko E.V., Ruselik E.A. Gastroduodenal'nye yazvy, vyzyvaemye antiagregantnymi i nesteroidnymi protivovospalitel'nymi preparatami: profilaktika po novym rekomendatsiyam. Cons med Prilozhenie. Gastroenterologiya 2009; 11: 13\u201420."}, {"key": "key-10.17116/terarkh201587458-61-8", "unstructured": "Bhatt D.L., Sheiman J., Abraham N.S., Antman E.M., Chan F.K., Furberg C.D., Johnson D.A., Mahaffey K.W., Quigley E.M.; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents ACCF/ACG/AHA 2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008; 118 (18): 1894\u20141909.", "DOI": "10.1161/CIRCULATIONAHA.108.191087", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-9", "unstructured": "Lanza F.L., Chan F.K., Quigley E.M. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009; 104 (3): 728\u2014738.", "DOI": "10.1038/ajg.2009.115", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-10", "unstructured": "Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (1): 67\u201474.", "DOI": "10.1097/00005650-198601000-00007", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-11", "unstructured": "Rebrova O.Yu. Statisticheskii analiz meditsinskikh dannykh. Primenenie paketa prikladnykh programm STATISTICA. M: MediaSfera; 2002: 227\u2014253."}, {"key": "key-10.17116/terarkh201587458-61-12", "unstructured": "Smalley W., Stein C.M., Arbogast P.G., Eisen G., Ray W.A., Griffin M. Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum 2002; 46 (8): 2195\u20142200.", "DOI": "10.1002/art.10425", "doi-asserted-by": "crossref"}, {"key": "key-10.17116/terarkh201587458-61-13", "unstructured": "van Soest E.M., Valkhoff V.E., Mazzaglia G., Schade R., Molokhia M., Goldstein J.L., Hern\u00e1ndez-D\u00edaz S., Trifir\u00f2 G., Dieleman J.P., Kuipers E.J., Sturkenboom M.C. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut 2011; 60 (12): 1650\u20141659.", "DOI": "10.1136/gut.2011.239848", "doi-asserted-by": "crossref"}], "container-title": ["Terapevticheskii arkhiv"], "language": "en", "deposited": {"date-parts": [[2017, 6, 24]], "date-time": "2017-06-24T10:59:19Z", "timestamp": 1498301959000}, "score": 26.284912, "issued": {"date-parts": [[2015]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[2015]]}, "issue": "4"}, "alternative-id": ["terarkh201587458-61"], "URL": "http://dx.doi.org/10.17116/terarkh201587458-61", "relation": {"cites": []}, "ISSN": ["0040-3660"], "issn-type": [{"value": "0040-3660", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:36:48Z", "timestamp": 1574163408601}, "reference-count": 32, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4486, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 6]]}, "DOI": "10.1046/j.1538-7836.2003.00281.x", "type": "journal-article", "created": {"date-parts": [[2003, 5, 23]], "date-time": "2003-05-23T14:54:00Z", "timestamp": 1053701640000}, "page": "1208-1214", "source": "Crossref", "is-referenced-by-count": 28, "title": ["Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study"], "prefix": "10.1111", "volume": "1", "author": [{"given": "E. M.", "family": "Bladbjerg", "sequence": "first", "affiliation": []}, {"given": "J. S.", "family": "Madsen", "sequence": "additional", "affiliation": []}, {"given": "S. R.", "family": "Kristensen", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Abrahamsen", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Brixen", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Mosekilde", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Jespersen", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 5, 21]]}, "reference": [{"key": "10.1046/j.1538-7836.2003.00281.x-BIB1|cit2", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1146/annurev.publhealth.19.1.55", "article-title": "Hormone replacement therapy, heart disease, and other considerations", "volume": "19", "author": "Barrett-Connor", "year": "1998", "journal-title": "Annu Rev Public Health"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1001/jama.280.7.605", "article-title": "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women", "volume": "280", "author": "Hulley", "year": "1998", "journal-title": "JAMA"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB3|cit4", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1001/jama.288.1.49", "article-title": "Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow-up (HERS II)", "volume": "288", "author": "Grady", "year": "2002", "journal-title": "JAMA"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB4|cit5", "doi-asserted-by": "crossref", "first-page": "321", "DOI": "10.1001/jama.288.3.321", "article-title": "Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial", "volume": "288", "author": "Writing group for the Women's Health Initiative Investigators.", "year": "2002", "journal-title": "JAMA"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB5|cit6", "doi-asserted-by": "crossref", "first-page": "1549", "DOI": "10.1161/01.ATV.15.10.1549", "article-title": "Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK haemostasis study", "volume": "15", "author": "Salomaa", "year": "1995", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB6|cit7", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1001/jama.1995.03520270033028", "article-title": "Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) trial", "volume": "273", "author": "The Writing Group for the PEPI trial.", "year": "1995", "journal-title": "JAMA"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB7|cit8", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1161/01.ATV.10.4.531", "article-title": "Ischemic heart disease risk in postmenopausal women: effects of estrogen use on glucose and insulin levels", "volume": "10", "author": "Barrett-Connor", "year": "1990", "journal-title": "Arteriosclerosis"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB8|cit9", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1067/mob.2002.123030", "article-title": "Effect of long-term hormone replacement therapy on plasma homocysteine in postmenopausal women: a randomized controlled study", "volume": "187", "author": "Madsen", "year": "2002", "journal-title": "Am J Obstet Gynecol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB9|cit10", "doi-asserted-by": "crossref", "first-page": "2687", "DOI": "10.1161/01.CIR.102.22.2687", "article-title": "Differential effects of oral and transdermal estrogen replacement therapy on endothelial function in postmenopausal women", "volume": "102", "author": "Vehkavaara", "year": "2000", "journal-title": "Circulation"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB10|cit11", "doi-asserted-by": "crossref", "first-page": "3017", "DOI": "10.1161/01.ATV.17.11.3071", "article-title": "Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women", "volume": "17", "author": "Scarabin", "year": "1997", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1056/NEJM199703063361002", "article-title": "Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women", "volume": "336", "author": "Koh", "year": "1997", "journal-title": "N Engl J Med"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB12|cit13", "first-page": "775", "article-title": "The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism - results from a randomized, double-blind, clinical trial", "volume": "85", "author": "H\u00f8ibraaten", "year": "2001", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB13|cit14", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1042/cs1010093", "article-title": "Effects of combined oral hormone replacement therapy on tissue factor pathway inhibitor and factor VII", "volume": "101", "author": "Peverill", "year": "2001", "journal-title": "Clin Sci"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB14|cit15", "doi-asserted-by": "crossref", "first-page": "3629", "DOI": "10.1210/jcem.86.8.7768", "article-title": "Prospective randomized study of effects of unopposed estrogen replacement therapy on markers of coagulation and inflammation in postmenopausal women", "volume": "86", "author": "Luyer", "year": "2001", "journal-title": "J Clin Endocrinol Metab"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB15|cit16", "doi-asserted-by": "crossref", "first-page": "3235", "DOI": "10.1093/humrep/17.12.3235", "article-title": "Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor", "volume": "17", "author": "Bladbjerg", "year": "2002", "journal-title": "Hum Rep"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB16|cit17", "first-page": "959", "article-title": "Structure and biology of tissue factor pathway inhibitor", "volume": "86", "author": "Bajaj", "year": "2001", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB17|cit18", "doi-asserted-by": "crossref", "first-page": "769", "DOI": "10.1016/S0140-6736(96)11189-2", "article-title": "Tissue-factor antigen and activity in human coronary atherosclerotic plaques", "volume": "349", "author": "Ardissino", "year": "1997", "journal-title": "Lancet"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB18|cit19", "doi-asserted-by": "crossref", "first-page": "2726", "DOI": "10.1182/blood.V98.9.2726", "article-title": "Thrombogenic potential of human coronary atherosclerotic plaques", "volume": "98", "author": "Ardissino", "year": "2001", "journal-title": "Blood"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB19|cit20", "first-page": "5", "article-title": "Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin", "volume": "85", "author": "Mosnier", "year": "2001", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB20|cit21", "first-page": "1", "article-title": "TAFI meets the sticky ends", "volume": "85", "author": "Booth", "year": "2001", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB21|cit22", "first-page": "2855", "article-title": "Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis", "volume": "95", "author": "Van Tilburg", "year": "2000", "journal-title": "Blood"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB22|cit23", "first-page": "9", "article-title": "Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis", "volume": "84", "author": "Meijers", "year": "2000", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB23|cit24", "doi-asserted-by": "crossref", "first-page": "2156", "DOI": "10.1161/01.ATV.20.9.2156", "article-title": "Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors", "volume": "20", "author": "Juhan-Vague", "year": "2000", "journal-title": "Arterioscler Thromb Vasc Biol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB24|cit25", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1046/j.1365-2796.2002.00960.x", "article-title": "Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo-controlled, 12-week study in early postmenopausal women", "volume": "251", "author": "Post", "year": "2002", "journal-title": "J Intern Med"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB25|cit26", "doi-asserted-by": "crossref", "first-page": "867", "DOI": "10.1161/01.ATV.0000015445.22243.F4", "article-title": "Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the North and South of Europe", "volume": "22", "author": "Juhan-Vague", "year": "2002", "journal-title": "Arteriocscler Thromb Vasc Biol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB26|cit27", "first-page": "244", "article-title": "A new T-287C polymorphism in the 5\u2032 regulatory region of the tissue factor pathway inhibitor gene", "volume": "84", "author": "Moatti", "year": "2000", "journal-title": "Thromb Haemost"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB27|cit28", "doi-asserted-by": "crossref", "first-page": "2053", "DOI": "10.1182/blood.V97.7.2053", "article-title": "Identification of polymorphisms in the promoter and the 3\u2032 region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled", "volume": "97", "author": "Henry", "year": "2001", "journal-title": "Blood"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB28|cit29", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/S0378-5122(99)00006-7", "article-title": "The Danish Osteoporosis Prevention Study (DOPS). project design and inclusion of 2000 normal perimenopausal women", "volume": "31", "author": "Mosekilde", "year": "1999", "journal-title": "Maturitas"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB29|cit30", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1161/01.ATV.11.1.138", "article-title": "Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system", "volume": "11", "author": "Sandset", "year": "1991", "journal-title": "Arterioscler Thromb"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB30|cit31", "doi-asserted-by": "crossref", "first-page": "175", "DOI": "10.1002/(SICI)1096-8652(199903)60:3<175::AID-AJH1>3.0.CO;2-X", "article-title": "Decreased plasma tissue factor pathway inhibitor in women taking combined oral contraceptives", "volume": "60", "author": "Harris", "year": "1999", "journal-title": "Am J Haematol"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB31|cit32", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/S0049-3848(00)00228-0", "article-title": "Long-term effect of 17\u03b2-estradiol and thrombin on tissue factor pathway inhibitor release from HUVEC", "volume": "99", "author": "Bilsel", "year": "2000", "journal-title": "Thromb Res"}, {"key": "10.1046/j.1538-7836.2003.00281.x-BIB32|cit33", "unstructured": "Dahm A Van Hylckama Vlieg A Bendz B Rosendaal F Bertina RM Sandset PM Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis Blood 2003"}], "container-title": ["Journal of Thrombosis and Haemostasis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1538-7836.2003.00281.x", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1538-7836.2003.00281.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1538-7836.2003.00281.x/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T21:34:11Z", "timestamp": 1497562451000}, "score": 26.24556, "subtitle": ["Effects of long-term HRT on TFPI and TAFI"], "issued": {"date-parts": [[2003, 5, 21]]}, "references-count": 32, "journal-issue": {"published-print": {"date-parts": [[2003, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1046/j.1538-7836.2003.00281.x", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1538-7933"], "issn-type": [{"value": "1538-7933", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T01:09:23Z", "timestamp": 1574212163959}, "reference-count": 0, "publisher": "BMJ", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Gut"], "DOI": "10.1136/gut.2006.094912", "type": "journal-article", "created": {"date-parts": [[2006, 6, 9]], "date-time": "2006-06-09T23:37:30Z", "timestamp": 1149896250000}, "page": "1056-1057", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Optimising the therapy of exocrine pancreatic insufficiency by the association of a proton pump inhibitor to enteric coated pancreatic extracts"], "prefix": "10.1136", "volume": "55", "author": [{"given": "J E", "family": "Dominguez-Munoz", "sequence": "first", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2006, 2, 16]]}, "container-title": ["Gut"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/gut.2006.094912", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T21:31:11Z", "timestamp": 1482528671000}, "score": 26.240019, "issued": {"date-parts": [[2006, 2, 16]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2006, 2, 16]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1136/gut.2006.094912", "ISSN": ["0017-5749"], "issn-type": [{"value": "0017-5749", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T10:29:30Z", "timestamp": 1575282570397}, "reference-count": 60, "publisher": "American Society for Clinical Investigation", "issue": "8", "funder": [{"name": "Tommy\u2019s Charity", "award": ["2016X32"]}, {"name": "TheirWorld", "award": ["20765AS2"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018, 4, 19]]}, "DOI": "10.1172/jci.insight.120147", "type": "journal-article", "created": {"date-parts": [[2018, 4, 18]], "date-time": "2018-04-18T15:02:49Z", "timestamp": 1524063769000}, "source": "Crossref", "is-referenced-by-count": 2, "title": ["Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice"], "prefix": "10.1172", "volume": "3", "author": [{"given": "Nicola", "family": "Garrett", "sequence": "first", "affiliation": []}, {"given": "Joaquim", "family": "Pombo", "sequence": "additional", "affiliation": []}, {"given": "Michelle", "family": "Umpierrez", "sequence": "additional", "affiliation": []}, {"given": "James E.", "family": "Clark", "sequence": "additional", "affiliation": []}, {"given": "Mark", "family": "Simmons", "sequence": "additional", "affiliation": []}, {"given": "Guillermina", "family": "Girardi", "sequence": "additional", "affiliation": []}], "member": "232", "published-online": {"date-parts": [[2018, 4, 19]]}, "reference": [{"issue": "2", "key": "B1", "first-page": "1", "article-title": "Deaths: final data for 2013", "volume": "64", "author": "Xu", "year": "2016", "journal-title": "Natl Vital Stat Rep"}, {"key": "B2", "DOI": "10.1097/AOG.0b013e3181a45b25", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1016/j.ahj.2008.06.042", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1136/bmj.39335.385301.BE", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1056/NEJMoa0706790", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1016/S0140-6736(05)67726-4", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1161/CIR.0b013e31820faaf8", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1161/HYPERTENSIONAHA.111.175919", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1542/peds.2011-3093", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1097/AOG.0b013e3181e10ebd", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1073/pnas.1011293108", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1016/j.ajog.2015.12.038", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1161/HYPERTENSIONAHA.114.03115", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "B14", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1161/HYPERTENSIONAHA.115.05445", "article-title": "Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia", "volume": "66", "author": "Brownfoot", "year": "2015", "journal-title": "Hypertension"}, {"key": "B15", "DOI": "10.1172/JCI86957", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1038/288373a0", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1358/mf.2009.31.7.1415895", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1161/HYPERTENSIONAHA.115.05484", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1038/ki.1993.312", "doi-asserted-by": "publisher"}, {"key": "B20", "first-page": "S169", "article-title": "Hypertensive glomerular damage as revealed by the expression of alpha-smooth muscle actin and non-muscle myosin", "volume": "55", "author": "Kimura", "year": "1996", "journal-title": "Kidney Int Suppl"}, {"issue": "2 Pt 1", "key": "B21", "doi-asserted-by": "crossref", "first-page": "499", "DOI": "10.1016/S0002-9378(99)70239-5", "article-title": "Preeclampsia: an excessive maternal inflammatory response to pregnancy", "volume": "180", "author": "Redman", "year": "1999", "journal-title": "Am J Obstet Gynecol"}, {"key": "B22", "DOI": "10.1159/000052603", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1159/000057675", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1007/s10554-015-0694-y", "doi-asserted-by": "publisher"}, {"key": "B25", "DOI": "10.1152/ajpregu.00194.2011", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.1161/01.HYP.28.2.265", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1038/nrcardio.2016.127", "doi-asserted-by": "publisher"}, {"key": "B28", "DOI": "10.1161/CIRCRESAHA.116.303697", "doi-asserted-by": "publisher"}, {"key": "B29", "DOI": "10.1016/j.immuni.2013.10.022", "doi-asserted-by": "publisher"}, {"key": "B30", "DOI": "10.1016/j.kint.2016.04.023", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1093/ajh/hpt274", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1016/j.amjcard.2013.04.053", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1038/sj.jhh.1001561", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "B34", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1042/cs0950115", "article-title": "In utero programming of chronic disease", "volume": "95", "author": "Barker", "year": "1998", "journal-title": "Clin Sci"}, {"key": "B35", "author": "Winklewski", "volume": "12", "year": "2015", "article-title": "Brain inflammation and hypertension: the chicken or the egg?", "journal-title": "J Neuroinflammation", "DOI": "10.1186/s12974-015-0306-8", "doi-asserted-by": "crossref"}, {"key": "B36", "DOI": "10.1038/pr.2016.24", "doi-asserted-by": "publisher"}, {"issue": "10", "key": "B37", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1096/fasebj.14.10.1289", "article-title": "Placental isoprostane is significantly increased in preeclampsia", "volume": "14", "author": "Walsh", "year": "2000", "journal-title": "FASEB J"}, {"key": "B38", "DOI": "10.1016/j.anireprosci.2012.08.003", "doi-asserted-by": "publisher"}, {"key": "B39", "DOI": "10.1016/S0143-4004(05)80266-8", "doi-asserted-by": "publisher"}, {"key": "B40", "author": "Bulla", "volume": "3", "year": "2012", "article-title": "The complement system at the embryo implantation site: friend or foe?", "journal-title": "Front Immunol", "DOI": "10.3389/fimmu.2012.00055", "doi-asserted-by": "crossref"}, {"key": "B41", "DOI": "10.1016/bs.pmbts.2016.12.006", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1182/blood-2016-03-705434", "doi-asserted-by": "publisher"}, {"key": "B43", "DOI": "10.1093/cvr/cvs085", "doi-asserted-by": "publisher"}, {"key": "B44", "DOI": "10.1016/j.ajog.2011.02.031", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1258/ebm.2010.009357", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1016/j.ajog.2014.01.010", "doi-asserted-by": "publisher"}, {"issue": "2", "key": "B47", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1161/HYPERTENSIONAHA.115.06357", "article-title": "Pregnancy and long-term maternal cardiovascular health: progress through harmonization of research cohorts and biobanks", "volume": "67", "author": "Staff", "year": "2016", "journal-title": "Hypertension"}, {"key": "B48", "DOI": "10.1016/j.jri.2013.09.001", "doi-asserted-by": "publisher"}, {"key": "B49", "DOI": "10.1016/j.ajog.2013.05.038", "doi-asserted-by": "publisher"}, {"key": "B50", "DOI": "10.4049/jimmunol.0903215", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1111/aji.12586", "doi-asserted-by": "publisher"}, {"key": "B52", "DOI": "10.1152/physiolgenomics.00071.2010", "doi-asserted-by": "publisher"}, {"key": "B53", "DOI": "10.1016/j.lfs.2015.10.025", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1038/260617a0", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1007/978-1-60761-247-6_3", "doi-asserted-by": "publisher"}, {"key": "B56", "DOI": "10.1038/ajh.2008.301", "doi-asserted-by": "publisher"}, {"key": "B57", "DOI": "10.1111/j.1464-5491.1991.tb01688.x", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1161/HYPERTENSIONAHA.115.05333", "doi-asserted-by": "publisher"}, {"key": "B59", "DOI": "10.1016/j.bbi.2013.11.005", "doi-asserted-by": "publisher"}, {"key": "B60", "DOI": "10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J", "doi-asserted-by": "publisher"}], "container-title": ["JCI Insight"], "language": "en", "link": [{"URL": "https://insight.jci.org/articles/view/120147/files/pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 16]], "date-time": "2019-10-16T04:19:28Z", "timestamp": 1571199568000}, "score": 25.949781, "issued": {"date-parts": [[2018, 4, 19]]}, "references-count": 60, "journal-issue": {"published-online": {"date-parts": [[2018, 4, 19]]}, "published-print": {"date-parts": [[2018, 4, 19]]}, "issue": "8"}, "alternative-id": ["10.1172/jci.insight.120147"], "URL": "http://dx.doi.org/10.1172/jci.insight.120147", "relation": {"has-review": [{"id-type": "doi", "id": "10.3410/f.734749859.793554747", "asserted-by": "object"}], "cites": []}, "ISSN": ["2379-3708"], "issn-type": [{"value": "2379-3708", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T22:19:49Z", "timestamp": 1574806789219}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JAMA Intern Med"], "published-print": {"date-parts": [[2016, 6, 1]]}, "DOI": "10.1001/jamainternmed.2016.1863", "type": "journal-article", "created": {"date-parts": [[2016, 6, 6]], "date-time": "2016-06-06T16:32:00Z", "timestamp": 1465230720000}, "page": "869", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease\u2014Reply"], "prefix": "10.1001", "volume": "176", "author": [{"given": "Benjamin", "family": "Lazarus", "sequence": "first", "affiliation": [{"name": "Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland2Division of Medicine, Royal Brisbane and Women\u2019s Hospital, Brisbane, Queensland, Australia"}]}, {"given": "Josef", "family": "Coresh", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland3Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}]}, {"given": "Morgan E.", "family": "Grams", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland3Department of Medicine, Johns Hopkins University, Baltimore, Maryland"}]}], "member": "10", "container-title": ["JAMA Internal Medicine"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2525588", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T04:58:02Z", "timestamp": 1481950682000}, "score": 25.858717, "issued": {"date-parts": [[2016, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 6, 1]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1001/jamainternmed.2016.1863", "ISSN": ["2168-6106"], "issn-type": [{"value": "2168-6106", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:10:35Z", "timestamp": 1574230235527}, "reference-count": 28, "publisher": "Wiley", "issue": "8", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3257, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aliment Pharmacol Ther"], "published-print": {"date-parts": [[2006, 10]]}, "DOI": "10.1111/j.1365-2036.2006.03115.x", "type": "journal-article", "created": {"date-parts": [[2006, 9, 20]], "date-time": "2006-09-20T14:45:16Z", "timestamp": 1158763516000}, "page": "1247-1255", "source": "Crossref", "is-referenced-by-count": 23, "title": ["Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding"], "prefix": "10.1111", "volume": "24", "author": [{"given": "L.", "family": "KEYVANI", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "MURTHY", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "LEESON", "sequence": "additional", "affiliation": []}, {"given": "L. E.", "family": "TARGOWNIK", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "b1_290", "author": "Rockall TA", "volume": "311", "first-page": "222", "year": "1995", "journal-title": "BMJ", "DOI": "10.1136/bmj.311.6999.222", "doi-asserted-by": "crossref"}, {"key": "b2_291", "author": "Vreeburg EM", "volume": "92", "first-page": "236", "year": "1997", "journal-title": "Am J Gastroenterol"}, {"key": "b3_292", "author": "Longstreth GF.", "volume": "90", "first-page": "206", "year": "1995", "journal-title": "Am J Gastroenterol"}, {"key": "b4_293", "author": "Terdiman JP", "volume": "92", "first-page": "1805", "year": "1997", "journal-title": "Am J Gastroenterol"}, {"key": "b5_294", "author": "Fleischer D.", "volume": "84", "first-page": "538", "year": "1983", "journal-title": "Gastroenterology"}, {"key": "b6_295", "DOI": "10.1111/j.1572-0241.2002.06037.x", "doi-asserted-by": "publisher"}, {"key": "b7_296", "DOI": "10.1111/j.1572-0241.2004.30272.x", "doi-asserted-by": "publisher"}, {"key": "b8_297", "author": "Skok P.", "volume": "45", "first-page": "2228", "year": "1998", "journal-title": "Hepatogastroenterology"}, {"key": "b9_298", "author": "Poynard T", "volume": "7", "first-page": "661", "year": "1995", "journal-title": "Eur J Gastroenterol Hepatol"}, {"key": "b10_299", "DOI": "10.1001/jama.276.12.983", "doi-asserted-by": "publisher"}, {"key": "b11_300", "DOI": "10.1056/NEJM200008033430501", "doi-asserted-by": "publisher"}, {"key": "b12_301", "author": "Barkun AN", "volume": "126", "first-page": "A-78", "year": "2004", "journal-title": "Gastroenterology"}, {"key": "b13_302", "DOI": "10.1111/j.1365-2036.2005.02391.x", "doi-asserted-by": "publisher"}, {"key": "b14_303", "author": "Leontiadis GI", "volume": "25", "first-page": "CD002094", "year": "2006", "journal-title": "Cochrane Database Syst Rev"}, {"key": "b15_304", "author": "Barkun A", "volume": "139", "first-page": "843", "year": "2003", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-139-10-200311180-00012", "doi-asserted-by": "crossref"}, {"key": "b16_305", "DOI": "10.1046/j.1524-4733.2003.64262.x", "doi-asserted-by": "publisher"}, {"key": "b17_306", "author": "Chiverton SG", "volume": "166", "first-page": "43", "year": "1989", "journal-title": "Scand J Gastroenterol Suppl", "DOI": "10.3109/00365528909091243", "doi-asserted-by": "crossref"}, {"key": "b18_307", "DOI": "10.1016/S0140-6736(96)90607-8", "doi-asserted-by": "publisher"}, {"key": "b19_308", "DOI": "10.1016/S0016-5107(98)70316-5", "doi-asserted-by": "publisher"}, {"key": "b20_309", "author": "Andrews CN", "volume": "19", "first-page": "667", "year": "2005", "journal-title": "Can J Gastroenterol", "DOI": "10.1155/2005/476205", "doi-asserted-by": "crossref"}, {"key": "b21_310", "DOI": "10.1053/j.gastro.2004.12.046", "doi-asserted-by": "publisher"}, {"key": "b22_311", "author": "Enns R", "volume": "18", "first-page": "567", "year": "2004", "journal-title": "Can J Gastroenterol", "DOI": "10.1155/2004/204968", "doi-asserted-by": "crossref"}, {"key": "b23_312", "DOI": "10.1016/S0016-5107(00)70442-1", "doi-asserted-by": "publisher"}, {"key": "b24_313", "DOI": "10.1046/j.1365-2036.2002.01274.x", "doi-asserted-by": "publisher"}, {"key": "b25_314", "author": "Daneshmend TK", "volume": "304", "first-page": "143", "year": "1992", "journal-title": "BMJ", "DOI": "10.1136/bmj.304.6820.143", "doi-asserted-by": "crossref"}, {"key": "b26_315", "author": "Sung JJ", "volume": "139", "first-page": "237", "year": "2003", "journal-title": "Ann Intern Med", "DOI": "10.7326/0003-4819-139-4-200308190-00005", "doi-asserted-by": "crossref"}, {"key": "b27_316", "DOI": "10.1056/NEJM199704103361503", "doi-asserted-by": "publisher"}, {"key": "b28_317", "DOI": "10.1016/S0002-9343(01)00812-9", "doi-asserted-by": "publisher"}], "container-title": ["Alimentary Pharmacology and Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2006.03115.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T11:16:16Z", "timestamp": 1547378176000}, "score": 25.714718, "issued": {"date-parts": [[2006, 10]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2006, 10]]}, "issue": "8"}, "alternative-id": ["10.1111/j.1365-2036.2006.03115.x"], "URL": "http://dx.doi.org/10.1111/j.1365-2036.2006.03115.x", "relation": {"cites": []}, "ISSN": ["0269-2813", "1365-2036"], "issn-type": [{"value": "0269-2813", "type": "print"}, {"value": "1365-2036", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}